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SUMMARY 
 
 

Summary 
 
Two of the most intriguing properties of the TCR complex are its low affinity but high 
sensitivity to antigen stimulation and its ability to activate different signaling pathways in function of 
the strength of interaction with its peptide-MHC (pMHC) ligands. During T cell development, correct 
discrimination between weak and strong pMHC interactions and subsequent differential activation of 
signaling pathways and genetic programs is the basis for positive and negative selection which 
ensures that only self-MHC restricted, but tolerant T cells mature. After successful completion of 
differentiation in the thymus, T cells enter the peripheral lymphoid organs as naive T cells. Upon 
encounter with their specific antigen naive T cells differentiates into effector cells which are able to 
coordinate the immune response. Part of the effector cells becomes memory T cell which remains 
dormant until the next antigen encounter. Memory T cells respond more vigorously upon reencounter 
with antigen and are more sensitive to low doses of antigen than naive T cells. These properties are 
the basis of immunity. The mechanisms underlying the ability of the TCR to differentiate between high 
affinity and low affinity ligands and to translate this into activation of differential signaling cascades, as 
well as the mechanism providing memory T cells with increased sensitivity are largely unknown. 
It has previously been shown that the TCR is expressed on the surface of resting T cells as a 
combination of oligomers of different sizes and that the larger oligomers are preferentially activated in 
response to low doses of antigen. We hypothesized that enrichment for more and larger oligomeric 
TCR complexes would provide memory T cells with higher antigen sensitivity. In this study, we show 
by quantitative electron microscopy analysis, that previously activated and memory T cells indeed 
have more and larger TCR oligomers at the cell surface than their naive counterparts. We also show 
that a mutation in the transmembrane of CD3ζ impairs oligomeric TCR complex formation and that 
loss of oligomeric TCR complexes causes decreased antigen sensitivity of T cell lines and antigen 
experienced T cells. This provides direct evidence for larger TCR oligomers as directly responsible for 
increased sensitivity of antigen-experienced T cells.  
In the second part of this work we describe a search and initial analysis of proteins that 
associate differentially with the TCR complex during positive and negative selection, hypothesizing 
that such differentially associating proteins provide thymocytes with a mechanism to differentially 
activate downstream signaling pathways. We developed a mouse model of T cell differentiation that 
allowed us to isolate a large number of thymocytes undergoing positive or negative selection in a 
synchronized fashion. Using this model we performed a biochemical screen for differentially 
associating proteins and phosphoproteins. We found that the G protein coupled receptor kinase 2 
(GRK2) associates with the TCR complex during positive selection and dissociates upon induction of 
negative selection. Analysis of T cell differentiation in mice that lack one copy of the GRK2 gene 
indicates that the efficiency of positive selection is reduced. Furthermore, reduction in GRK2 
expression affects the sensitivity of DP thymocytes towards antigen, suggesting a direct role of GRK2 
in TCR-dependent signaling and affects migration of DP and SP thymocytes towards the chemokine 
SDF-1α. The observation that this migration is inhibited by stimulation via the TCR indicates a 
functional link between CXCR4 mediated migration and TCR signaling in these thymocytes. 
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Introduction
 
The adaptive immune system exhibits 
pathogen specificity and antigenic memory. It 
consists of two major cell types: B lymphocytes 
comprise the humoral branch of the immune 
system and recognize soluble antigens via their 
B cell receptor (BCR), while T lymphocytes are 
part of cell mediated branch and recognize 
pathogen derived peptides bound to the MHC 
molecules of antigen presenting cells (APCs) 
via their T cell receptors (TCRs). T cells 
expressing a αβ TCR are the predominant T 
cell population and play a central role in 
coordinating the responses of the innate and 
adaptive immune system and in providing 
antigenic memory. The haematopoetic 
precursors of the T cells differentiate in the 
thymus and upon successful completion of this 
process the now mature, naive T cell migrate to 
the peripheral lymphoid tissues (spleen, lymph 
node and Peyer’s patches). Naive T cells 
migrate from one lymphoid organ to another via 
blood and lymph in search of a potential threat 
to the immune system. Once a naive T cell 
encounters an antigen presented by 
professional antigen presenting cells (APCs), it 
gets activated leading to the initiation of a 
cascade of intracellular biochemical signals that 
results in effector cell generation. Effector T 
cells have a lower activation threshold and high 
capacity of cytokine production. After pathogen 
clearance most of the effector cells die while a 
small fraction persists as a memory T cells 
(Chandok and Farber, 2004). Antigenic 
memory allows a faster and stronger response 
to a reencounter with specific pathogens. At the 
population level, this is due to an increased T 
cell frequency (Askonas et al., 1982) and 
preferential outgrowth of higher affinity T cell 
clones that will form the memory T cell pool 
(Busch and Pamer, 1999; Malherbe et al., 
2004; Zehn et al., 2009). At the cellular level, 
memory T cells are more sensitive to antigen 
stimulation, converts more rapidly into effector 
T cells and produce larger amounts of effector 
molecules (Bachmann et al., 1999; Bruno et al., 
1995; Cho et al., 1999; Veiga-Fernandes et al., 
2000; Zimmermann et al., 1999). 
 
The TCR complex is the defining cell 
surface structure of the T lymphocyte and is 
crucial for its differentiation and function. The 
TCR complex is composed of an antigen-
recognizing clonotypic TCRαβ heterodimer and 
a signal-transducing unit containing the 
invariant CD3γε, CD3δε and CD3ζζ dimers 
(Figure 1). The TCR α and β chains are 
glycoproteins of 45KD, consisting of one 
variable and one constant Ig domain linked by 
a disulfide bridge. The gene segments 
encoding the variable domains are generated 
via a random somatic gene rearrangement 
process (Garman et al., 1986b) to give rise to 
high diversity of antigen specificities needed to 
be able to respond to the rapidly changing 
pathogens. The Ig like domains are followed by 
a stalk region (19 residues in the TCRα chain, 
15 residues in the TCRβ chain), a 22 amino 
acid long transmembrane (TM) domain and a 
short 4-10 amino acid long intracellular region. 
The CD3 subunits (CD3ε ,CD3γ, and CD3δ) 
each have an Ig like ectodomain, a 10 residue 
long connecting peptide , TM region and a long 
cytoplasmic (45-110 residue) domain 
containing one immunoreceptor tyrosine-based 
activation motif (ITAM)(Reth, 1989). The 
cytoplasmic domain of CD3ε contains in 
addition two more recently identified regions,  
INTRODUCTION 
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Figure 1: TCR components. The TCR consists of a ligand binding αβ heterodimer, the CD3 heterodimers, CD3δε, CD3γε, and 
the TCRζζ homodimer. Three basic residues are located in the TM domains of the TCR heterodimer and a pair of acidic 
residues is located in each of the three signaling dimers. 
 
the proline-rich sequence (PRS) and the basic-
rich sequence (BRS) whose function in T cell 
signaling is only beginning to be understood 
(Brodeur et al., 2009a; Brodeur et al., 2009b). 
CD3ε binds noncovalently with CD3δ and CD3γ 
in a mutually exclusive manner yielding CD3δε 
and CD3γε heterodimers (Alarcon et al., 1991; 
Arnett et al., 2004; Sun et al., 2004). CD3ζ 
forms a disulfide linked homodimer (Koning et 
al., 1990) and contains a very small 
extracellular region of 9 amino acid, a TM 
domain and a cytoplasmic tail containing three 
ITAM motifs. Via their ITAM motifs and PRS 
and BRS sequences, the CD3 chains allow the 
TCR complex to connect to the downstream 
signaling pathways. 
 All TCR and CD3 subunits are 
cotranslationally translocated into the ER and a 
strict quality control mechanism assures that 
only fully assembled TCR complexes reach the 
cell surface (Delgado and Alarcon, 2005; 
Mallabiabarrena et al., 1992; Minami et al., 
1987). During assembly, CD3ε first dimerizes 
with either CD3γ or CD3δ and the resulting εγ 
and εδ dimers associate with the TCRα and 
TCRβ subunits (Alarcon et al., 1988; Koning et 
al., 1990; San Jose et al., 1998). Incorporation 
of CD3ζζ is the last step of the assembly and 
only after this step is the TCR transported to 
the plasma membrane (Manolios et al., 1991; 
Minami et al., 1987; Sancho et al., 1989) . ER-
retention motifs in the cytoplasmic tails of the 
CD3 subunits prevent transport of incompletely 
assembled TCR complexes from the ER to the 
cell surface and it has been suggested that 
progressive masking of the retention motifs by 
the subsequently incorporated CD3 subunits 
enables cell surface expression of only the 
completely assembled receptor complex 
(Delgado and Alarcon, 2005). 
 
The stoichiometry (molar ratio of the 
different subunits within a TCR complex) and 
the valency (the number of ligand binding 
TCRαβ heterodimers per complex) of the TCR 
complex on the resting T cells are central 
issues in understanding the mechanism of the 
T cell activation, especially in view of the need 
1.1. Stoichiometry and valency of the αβ T 
cell antigen receptor 
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for multivalent peptide-MHC (pMHC) ligands to 
achieve this activation (Boniface et al., 1998; 
Cochran et al., 2000). Early on, it was observed 
that the initially proposed composition of a 
single TCRαβ dimer associated with one dimer 
each of CD3γε, CD3δε and CD3ζζ met with an 
imbalance in charged residues in the 
transmembrane regions of these components 
(2Figure 2A). Charged TM residues are known 
to be important for the stability of the complex, 
and they were proposed to drive the 
association between TCR and CD3 
components by forming pairwise ionic 
interactions (Cosson et al., 1991; Manolios et 
al., 1990) (Figure 1). TCRα has two basic 
amino acids, TCRβ has one basic amino acid 
(3 basic amino acids in total), and the CD3 
dimers each have one acidic amino acid in their 
trans-membrane regions (6 acidic amino acid in 
total) (Clevers et al., 1988; Klausner et al., 
1990). It was proposed that a structure 
containing two TCRαβ subunits for each of the 
CD3 dimers (an αβ:δε:γε:ζζ stoichiometry of 
2:1:1:1) would equilibrate this charge 
imbalance (2Figure 2B). Indeed, size 
determination of solubilised complexes (Exley 
et al., 1995) and co-immunoprecipitation and 
FRET assay on T cells from mice co-
expressing two different TCRαβ complexes 
(Fernandez-Miguel et al., 1999) suggested that 
the TCR complex contained at least two 
TCRαβ subunits. Importantly, evidence was 
provided that these were cell surface 
expressed TCR complexes, excluding the 
possibility that these were aberrantly 
assembled complexes that had been retained 
intracellularly. However, other studies did not 
find evidence for co-immunoprecipitation of the 
two different TCRs (Hou et al., 1994; Punt et 
al., 1994). In these studies different detergents 
were used to solubilize the TCR complexes 
(the relatively mild detergent Brij 96 vs the 
harsher detergent digitonin) and this could 
explain the differences in the observations: it 
has been shown that the type of detergent 
determines whether TCR subunits can be co-
immunoprecipitated or not (Alarcon et al., 
2006). 
 More recently, an alternative 
explanation has been provided to solve the 
apparent charge imbalance between the 
transmembrane domains of the TCR subunits, 
suggesting once more the classical 
stoichiometry of one TCRαβ dimer and one 
each of the three CD3 dimers (Call et al., 
2002). Combination of wild type TCR and CD3 
chains and TCR and CD3 chains mutated in 
the charged transmembrane residues were 
translated in-vitro in the presence of 
plasmacytoma derived microsomes, followed 
by sequential non-denaturing 
immunoprecipitation and analysis of 
association between the different subunits. This 
study provided evidence that selective 
association of TCRα with CD3δε and TCRβ 
with CD3γε was dependent on the 
simultaneous presence of the basic amino acid 
of the particular TCR chain and the two acidic 
amino acid residues in the associating CD3 
dimer. Similarly, association of CD3ζζ with the 
other subunits was dependent on the 
simultaneous presence of the remaining basic 
amino acid in TCRα and two acidic amino acids 
in the CD3ζζ dimer (2Figure 2). This has led to 
the proposition that three triangular interactions 
between one basic and two acidic amino acids 
form the basis of TCR complex assembly, 
giving rise to a αβ:δε:γε.ζζ stoichiometry of 
1:1:1:1. However, these data do not necessarily 
reflect the stoichiometry of the TCR complex at 
the cell surface, as glycosylation or other post  
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Figure 2: TCR stoichiometry. (A) The monovalent model contains only one ligand binding TCRαβ domain. (B) The bivalent 
model consists of a TCR with two ligand binding αβ domain with one of each CD3δε, CD3γε and TCRζζ subunits. 
 
translational modification may affect the 
assembly of the surface complex. In addition, ζ 
might only assemble with the other subunits in 
the Golgi apparatus in-vivo (Dietrich et al., 
1999). Finally, the choice of detergent 
(digitonin) used to solubilize the TCR complex 
in order to perform the immunoprecipitations 
may have conditioned the results. 
 
Determination of the composition of the 
TCR complex via blue native polyacrylamide 
gel electrophoresis (BN-PAGE) has shown that 
TCR complexes at the cell surface of resting T 
cells co-exist as monovalent and oligomeric 
TCR complexes (Schamel et al., 2005), adding 
an extra layer of complexity to the stoichiometry 
and valency of this complex. BN-PAGE is a 
native protein complex separation technique 
that determines the relative abundance and 
number of different complexes formed by a 
certain protein. Since proteins are not 
denatured, they are separated based on their 
complex size and shape on a polyacrylamide 
gel (Schagger and von Jagow, 1991; Schamel 
and Reth, 2000). Solubilization of membranes 
from resting primary T cells and T cell lines in 
digitonin, followed by size separation by BN-
PAGE and immunoblotting for TCR results in 
detection of only one size of complexes ( 2Figure 
3A) (Hellwig et al., 2005; Schamel et al., 2005; 
Zapata et al., 2004). Gel shift assays have 
provided evidence that these digitonin-
extracted complexes contain only one TCRαβ 
dimer and two CD3ε containing dimers 
(Schamel et al., 2005). When the membranes 
are solubilised in Brij96 instead of digitonin, a 
combination of the digitonin-sized complex and 
larger complexes are detected via BN-PAGE 
and immunoblotting (Schamel et al., 2005), 
showing the co-existence of monomeric and 
oligomeric TCR complexes. The co-existence 
of TCR complexes of different sizes is 
supported by the analysis via electron 
microscopy of the cell surface replicas of 
resting primary T cells and T cell lines labelled  
1.2 TCR oligomers in resting T cells 
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Figure 3: Existence of monomeric and oligomeric TCR complexes on the T cell surface. A) BN-PAGE. 
B) Electron microscopic analysis of cell surface. Figure reproduced from (Schamel et al., 2005) 
 
 
with anti-TCR- or anti-CD3-specific antibodies 
and protein A conjugated gold: single gold 
particles and clusters with a size of up to twenty 
particles can be detected on the cell surface of 
the same resting T cell (2Figure 3B) (Schamel et 
al., 2005).  
 The oligomeric TCR complexes are 
disrupted by treatment of cells with methyl-β-
cyclodextrin, a cholesterol-sequestering agent, 
suggesting that the oligomeric TCRs reside 
within the lipid rafts (Schamel et al., 2005). This 
explains why these complexes can only be 
detected in detergents, such as Brij 96, that do 
not extract cholesterol from the membrane. On 
the other hand, this partitioning into the 
cholesterol-rich rafts has allowed selective 
extraction of oligomeric TCR complexes from 
the cell membrane with saponin. The ratio 
between the TCRαβ dimers, the CD3ε-
containing dimers and CD3ζζ dimers is not 
significantly different between saponin, Brij96 
and digitonin-extracted TCR complexes, 
suggesting that the oligomeric complexes are 
formed by multimers of the digitonin-solubilized 
monovalent complex (unpublished data, 
Schamel’s lab). 
It has been shown that the oligomeric 
TCR complexes are phosphorylated at lower 
concentrations of antigen than the monomeric 
complexes (Schamel et al., 2005). This has led 
to the hypothesis that the oligomeric TCR 
complexes are responsible for the high 
sensitivity of T cells in spite of the low affinity of 
the TCRαβ dimers for their pMHC ligands. 
 
Upon binding to its antigenic peptide-
MHC (pMHC), the TCR complex activates 
various intracellular signaling pathways that are 
necessary both during T cell development and 
triggering of an adaptive immune response. 
While affinity of the TCR for antigenic pMHC is 
low [(1-50µM (Davis et al., 1998)], the T cell is 
very sensitive to these peptides and can be 
activated by a few antigenic peptide molecules 
on the APC (Irvine et al., 2002; Purbhoo et al., 
2004). In spite of a 103 to 104 fold higher 
concentration of self pMHC than the antigenic 
pMHC on the membrane of the APCs and only 
a tenfold difference in affinity, the TCR is very 
specific for the antigenic pMHC. There are 
2. T cell receptor signaling
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various models which explain these complex 
phenomena of TCR-triggering. 
 The clustering or aggregation model 
emphasizes the need of pMHC clustering in 
order to activate a TCR complex, which allows 
clustering of TCR complexes and signal 
spreading through efficient phosphorylation of 
neighbouring TCR complexes. Support for this 
model has come from the observation that 
soluble class I and class II pMHC ligands are 
only able to stimulate T cells when they are in 
multivalent form (Boniface et al., 1998; Cochran 
et al., 2001). Furthermore, it has been shown 
that MHC class II and also MHC class I 
complexes can be found in clusters on the 
surface of APCs (Fooksman et al., 2006; Vogt 
et al., 2002). 
 The conformational change model 
describes how a structural change, associated 
with TCR ligation is transmitted to the 
cytoplasmic tails of CD3 complexes. It has 
been shown that a proline rich region in CD3ε 
is exposed upon TCR stimulation, which leads 
to the binding of the adaptor protein Nck (Gil et 
al., 2002). Neither kinases nor co-receptors are 
required for the induction of conformational 
change, suggesting that the conformational 
change is a direct consequence of ligand 
binding. More recent evidence indicates that 
both the conformational change and clustering 
are necessary for full T cell activation (Minguet 
et al., 2007). 
 The kinetic segregation model is based 
on the hypothesis that a dynamic equilibrium 
exists between phosphatases and kinase 
activities in the cell, which results in low steady-
state phosphorylation (Davis and van der 
Merwe, 2006). T cells form multiple zones of 
close contacts upon binding their pMHC 
ligands, on the APCs. Due to spatial restrictions 
membrane-bound inhibitory phosphatases like 
CD45 and CD148 are excluded from these 
close membrane junctions. As a consequence, 
the equilibrium shifts towards kinases in these 
small areas, which in turn lead to the 
phosphorylation of TCR and signaling 
(Choudhuri and van der Merwe, 2007). Many 
studies showing segregation of CD45 and 
CD148 from areas of TCR triggering supported 
this model (Irles et al., 2003; Lin and Weiss, 
2003; Varma et al., 2006). However, the ability 
of soluble antibodies and soluble pMHC 
oligomers to activate T cells without apparently 
inducing spatial segregation cannot be 
explained by this model. 
 
Signaling through the TCR occurs upon 
binding to its pMHC ligands. The earliest step 
after ligand binding is the phosphorylation of 
ITAMs of the CD3 chains by Src protein 
tyrosine kinase Lck (Danielian et al., 1989).The 
co-receptors CD4 and CD8 can bind to Lck and 
play a role in delivering active Lck to the 
pMHC-engaged TCR (Mallaun et al., 2008; 
Veillette et al., 1988). The extent of ITAM 
phosphorylation correlates with the half life of 
TCR-pMHC binding and the availability of 
activated Lck (phosphorylated at Tyr 394) 
(Kersh et al., 1998). The Syk family kinase 
ZAP-70 (ζ-chain associated protein of 70kD) 
then binds to the phosphorylated ITAMs via its 
tandem SH2 (Src homology 2) domain, and is 
activated. ZAP70 binding to phosphorylated 
ITAMs prolongs the transient TCR-pMHC 
interaction, thereby generating a more 
sustained intracellular signal. ZAP70 
phosphorylates LAT (linker for activation of T 
cells), a raft associated adaptor protein, which 
upon phosphorylation functions as a scaffold 
for various other signaling molecules including 
2.1. Signaling through the TCR complex 
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the adaptor protein Grb2, Gads and 
phospholipase Cγ1(PLCγ1).  
Recruitment of Grb2 to phosphorylated 
LAT leads to the activation of PI3K 
(phosphatidyl inositol 3-kinase), which 
catalyses the conversion of PIP2 (phosphatidyl 
inositol 4, 5-bisphosphate) to PIP3 
(phosphatidylinositol 3, 4 5-triphosphate). In the 
membrane, PIP3 serve as a docking site for PH 
(pleckstrin homology) domain containing 
proteins, like PLCγ1, Itk and Vav. SLP-76 and 
LAT together bind PLCγ1, which catalyses the 
cleavage of phosphatidyl inositol 4,5-
bisphosphate (PIP2) into inositol 1,4,5 
triphosphate (IP3) and diacyl glycerol (DAG) 
(Samelson, 2002). IP3 stimulates calcium 
release for subsequent Ca2+ dependent NFAT 
activation. DAG activates Ras GRP, protein 
kinase C θ (PKCθ), the three MAPK pathways 
(ERK, JNK, p38) and Akt. Activation of MAPK 
results in the activation of the transcription 
factor AP1. PKCθ switches on the 
CARMA/Bcl10/IκB kinase (IKK) pathway 
leading to the activation of NFκB transcription 
factor. Propagation of Stimuli from the TCR 
eventually leads to the nuclear localization of 
NFAT, NFκB and AP1, which in turn leads to 
activation of the genetic programs underlying T 
cell activation ( 2Figure 4). 
Figure 4: TCR proximal signaling. A simplified schematic representation of the TCR proximal 
signaling upon MHCp binding. 
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T cells arise from haematopoietic stem 
cell derived T- lymphoid progenitor cells in the 
bone marrow that migrate to the thymus (Le 
Douarin and Jotereau, 1975). Within the 
thymus the distinct stages of differentiation can 
be distinguished by expression of stage specific 
cell surface proteins, including the TCR 
complex, CD4, CD8, CD44 (hyaluronic acid 
binding adhesion molecule) and CD25 (the α-
chain of the IL2 receptor) (2Figure 5). The most 
immature hematopoietic cells lack the 
expression of CD4 and CD8 and are called 
double negative (DN) thymocytes. At the DN 
stage, thymocytes undergo a differentiation 
program from the DN1 (CD44+CD25-) through 
the c-Kit+ (stem cell factor receptor) 
CD44+CD25+ DN2 stage to become the C-Kit-
CD44-CD25+ DN3 stage. During progression 
through these stages, the precursors become 
progressively restricted in their lineage potential 
(von Boehmer, 2000). At the DN3 stage, V (D) 
J rearrangement at the Tcrb (TCRβ), Tcrg 
(TCRγ) and Tcrd (TCRδ) loci occurs (Garman 
et al., 1986a; Habu et al., 1987). Notch 
signaling and the rearrangement status of 
these loci determine whether the cells develop 
into αβ T cells or γδ T cells. This process is not 
yet clearly defined, although the strength of the 
TCR signal may influence this process (Garbe 
et al., 2006). Upon productive rearrangement of 
the Tcrb locus, the resulting TCRβ chain 
associates with the pre-Tα, and the CD3 
molecules to form the pre-TCR complex. 
Expression of the pre-TCR complex rescues 
thymocytes from cell death and induces 
proliferation and progression through the CD25-
CD44- DN4 stage to the CD4+CD8+ double 
positive (DP) stage (von Boehmer et al., 1989). 
At the DP stage, thymocytes rearrange the 
Tcra locus leading to the expression of the αβ 
TCR complex (Kreslavsky et al., 2008; Shinkai 
et al., 1993), at which stage the thymocytes 
undergo the processes of positive and negative 
selection  
 
 
 
Figure 5: Schematic representation of T-
cell development in the Thymus.  
The thymic microenvironment is divided into 
discrete cortical and medullary areas, 
characterized by the presence of particular 
stromal cell types. Lymphoid progenitors 
enter the thymus through blood vessels at 
the cortico-medullary junction and then 
migrate in a highly defined pattern through 
the thymus, correlating with distinct stages 
of their development. Migration of the cells 
is regulated by stage specific expression of 
the appropriate chemokine receptors. The 
earliest precursors lack expression of the 
TCR and the coreceptors CD4 and CD8 (DN 
thymocytes), and can be subdivided into 
distinct stages based on the expression 
pattern of CD25 and CD44. Rearrangement 
of the TCRβ chain occurs at the 
CD25+CD44- DN3 stage in the outer cortex. 
Upon formation of the pre-TCR complex, 
cells progress to CD4+CD8+ DP stage while 
moving to the inner cortex. Upon 
rearrangement of the TCRα chain cells 
undergo positive selection. Negative 
selection is predominantly mediated by 
dendritic cells in the medulla. Cells that have 
successfully passed both selective 
processes finally mature into the appropriate 
CD4 or CD8 SP lineage via the process of 
lineage commitment and leave the thymus. 
3. αβ T cell differentiation 
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Knock-out mice for each of the TCR 
and CD3 chains have confirmed the essential 
role of these components in thymic 
development. Thymocytes of mice lacking the 
rearrangement associated genes (RAG) 1 or 2 
are unable to rearrange the TCR loci and are 
blocked at the DN3 stage (Mombaerts et al., 
1992). Thymocytes of mice with a null mutation 
in the Tcrb locus or the CD3ε gene are also 
completely arrested at this stage (DeJarnette et 
al., 1998; Malissen et al., 1995). These 
components are therefore absolutely critical for 
transition to DN4 to DP stage. However in mice 
with inactivated CD3γ or pre-Tα genes a low 
number of thymocytes reaches the DP (Haks et 
al., 1998), while thymocytes lacking expression 
of CD3δ or CD3ζ reach the DP stage in 
appreciable numbers (Love et al., 1993; 
Malissen and Schmitt-Verhulst, 1993). These 
differences in phenotype may reflect 
differences in the extent to which each of these 
chains is critical for expression at the cell 
surface of the pre-TCR and TCR itself, but also 
suggest unique contributions of these chains or 
their domains to the signaling events necessary 
for each of the differentiation steps. In line with 
this latter possibility, progressive deletion of the 
cytoplasmic domains of CD3ε shows that the 
PRS is absolutely required for pre-TCR driven 
cell expansion while the BRS is necessary for 
DN to DP transition (Brodeur et al., 2009b). 
 
Each of the thymic differentiation steps 
takes place at a specialized anatomical location 
in the thymus and differentiating thymocytes 
migrate through the thymus in a spatially and 
timely coordinated pattern to reach these 
locations (2Figure 5) (Lind EF, 2001; Petrie., 
2003). Chemotaxis is one of the main 
mechanisms underlying this migration. 
Chemokine receptors, a subfamily of the G-
protein coupled receptors (GPCRs) are 
expressed in a stage specific manner by 
thymocytes and the corresponding chemokines 
are expressed in defined thymic locations 
(Campbell JJ, 1999; Misslitz A, 2006). This 
provides a mechanism of stage-dependent 
migration. 
Bone marrow derived precursors enter 
into the thymus at the cortico-medullary 
junction via high endothelial venules and 
migrate towards the outer cortex. CXCR4 is 
highly expressed on thymocytes from the DN2 
to the DP stage and signaling by CXCR4 upon 
interaction with its ligand CXCL12 (SDF1α) is 
required for proper migration of early 
progenitors to the cortex (Ara et al., 2003; 
Plotkin et al., 2003; Plotkin J, 2003). A 
complete block in thymocyte development 
observed upon conditional deletion of CXCR4 
in DN1 cells (Plotkin et al., 2003), indicates that 
transition to the next differentiation stage and 
migration to the appropriate location are tightly 
linked. CXCR4 mediated PI3K signaling along 
with signaling via Notch and pre-TCR has also 
been shown to promote differentiation from the 
DN3 stage to the DP stage (Janas et al.,2010). 
CXCR4 is downregulated on DP thymocytes 
upon receiving signals that lead to positive 
selection (Suzuki et al., 1998). This 
downmodulation is thought to facilitate 
migration of DP thymocytes from the cortex to 
the medulla. Positively selected DP thymocytes 
also increase expression of CCR7. Its ligands 
CCL19 and CCL21 are produced by mTEC in 
the thymus (Nitta et al., 2009; Ueno et al., 
2004). In medulla CCR7-mediated migration 
contributes to the negative selection of tissue-
restricted antigens (TRA)-reactive CD4 or CD8 
thymocytes (Nitta et al., 2009). Chemokine 
receptor CCR7 contributes to the chemokinesis 
3.1. Thymic migration and egress
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of SP cells and is necessary for attracting them 
towards the medulla (Ehrlich et al., 2009). 
CCR9 is expressed at all stages of 
thymocytes differentiation, but with maximum 
expression at DP stage (Carramolino et al., 
2001; Poznansky et al., 2002). CCR9 is down 
regulated in mature thymocytes and loss of 
response to its ligand CCL25 occurs just before 
thymocytes emigration, which shows that 
CCL25/CCR9 interaction acts as a retention 
factor for thymocytes in thymus.  
 After T cell development mature 
thymocytes exit from the thymus and reach the 
peripheral lymphoid organs. Sphingosine-1-
phosphate (S1P) and S1P receptor1 (S1P1) 
regulate the T cell exit. S1P is more highly 
expressed in blood than in tissues including the 
thymus (Schwab et al., 2005). Its receptor 
S1P1 is highly expressed by mature 
thymocytes and last stage of thymocytes 
development upregulate its expression (Allende 
et al., 2004; Kurobe et al., 2006; Matloubian et 
al., 2004). S1P1 deficiency results in retention 
of T cells in both thymus and peripheral lymph 
nodes (Matloubian et al., 2004). CD69 has 
been shown to have a role in thymic egress. 
Downregulation of CD69 is necessary for 
thymocytes exit as mice that constitutively 
express high level of CD69 on mature T cell fail 
to exit and they accumulate in medulla (Feng et 
al., 2002).( 2Figure 5). 
 
Upon expression of αβ TCR DP 
thymocytes undergo one of the three fates: 
death by neglect, resulting in death of 90-95% 
of DP thymocytes due to the failure of the αβ 
TCR to bind to the self pMHC and thereby not 
providing survival signals to the cell; positive 
selection, promoting survival and development 
of self tolerant T cells and negative selection 
which ensures removal of autoreactive cells. 
Thus the processes of thymic selection 
establish a diverse T cell repertoire that is self 
MHC restricted and self tolerant (referred as 
central tolerance) (Hogquist et al., 2005) 
(2Figure 6) 
Figure 6: Thymic selection process. DP thymocytes that 
expresses TCRs that do not recognizes self-peptide-MHC ligand 
undergo apptosis termed as death by neglect, thymocytes having 
TCRs which interact with self peptide-MHC ligands with high 
affinity undergoes apoptosis (negative selection), whereas DP 
thymocytes that expresses TCRs with low affinity for self 
peptide-MHC ligands differentiate into SP thymocytes (positive 
selection). SP thymocytes then exported from the thymus to 
populate peripheral lymphoid organs [reproduced from (Palmer, 
2003)] 
 
Positive and negative selections are 
both dependent on interaction of the TCR 
complex with the self pMHC molecules of the 
thymic stroma. Two hypotheses have been put 
forward to understand how the interaction 
between the same receptor-ligand pair can lead 
to such opposite outcomes. The Avidity model 
predicts that the sum of affinities provided by 
the TCR-pMHC interactions determine whether 
a thymocyte is positively or negatively selected. 
This model is supported by experiments in 
which it was shown that agonist peptides 
promoted positive selection in FTOC at very 
low concentration, but induced negative 
selection at high concentrations (Ashton-
Rickardt et al., 1994; Sebzda et al., 1994). The 
Affinity model emphasises the quality of the 
individual TCR-pMHC interaction, where low 
4. Positive and negative selection of
thymocytes 
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affinity pMHC ligands induces positive selection 
and high affinity pMHC ligands induce negative 
selection (Hogquist et al., 1994). Recent work 
has shown that a very narrow affinity threshold 
exists that discriminates between positive or 
negative selection for a given TCR specificity 
(Naeher et al., 2007).  
Determination of the characteristics of 
the interaction of the TCR and positively and 
negatively selecting ligands by plasmon 
resonance has shown a correlation among 
ligand affinity, half life and selection outcome 
(Alam et al., 1999). Agonist peptides were 
shown to have longest half life of binding and 
lowest KD value and this coincided with 
negative selection. Antagonist peptides had 
very fast dissociation rate and the highest KD 
value, coinciding with positive selection. This 
suggested that the half life of the interaction 
between the TCR and pMHC was responsible 
for the activation of the different signaling 
pathways discriminating between positive and 
negative selection. Later the role of co-
receptors in the thymic selection process was 
investigated, leading to the concept of apparent 
affinity (Naeher et al., 2007).  
 
Figure 7: Affinity threshold. Thymic selection depends on 
the apparent affinity of peptide-MHC complexes for the 
TCR-co-receptor pair. Apparent affinity threshold of the 
interaction of the TCR-co-receptor with a self peptide-MHC 
complex (with a dissociation constant of ~ 6µM; indicated in 
purple) defines whether a self antigen will induce positive or 
negative selection 
This describes the trimeric interaction between 
the pMHC complex and the TCR-co-receptor 
pair. With the use of pMHC tetramer 
representing positively selecting, negatively 
selecting and boundary ligands for three 
different MHC class I restricted TCRs the 
apparent affinity threshold and half life of 
binding were calculated: small increases or 
decreases around a KD of 6µM and half life of 
1-3 seconds led to negative and positive 
selection (Daniels et al., 2006; Naeher et al., 
2007) (2Figure 7). 
 
In DP thymocytes engagement of TCR 
with self-pMHC complexes triggers signaling 
through the TCR that leads to positive selection 
or negative selection. There is evidence that 
distinct TCR-linked signaling pathways lead to 
these alternate fates. 
 
The Bcl-2 family consists of the pro-
apoptotic members Bax, Bak, Bim and Bid and 
anti-apoptotic members such as Bcl-2 and Bcl-
XL. Overexpression of either Bcl-2 or Bcl-XL 
protects DP thymocytes from dying, and 
deletion of Bim leads to delayed apoptosis of 
thymocytes (Bouillet et al., 1999). Deletion of 
both Bax and Bak results in the prolonged 
survival of thymocytes in culture (Rathmell et 
al., 2002). Apart from the role of Bcl-2 family 
members in death by neglect they have also 
shown to be involved in negative selection of 
thymocytes. Pro-apoptotic Bim defiency makes 
thymocytes resistant to apoptosis induced by 
anti-CD3 antibodies or antigen in OT-I and HY 
TCRtg mice (Bouillet et al., 2002). 
 
5. Differential signaling through TCR-
CD3 complex leading to alternate fates 
of DP thymocytes 
5.1. Bcl-2 family member proteins
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Ras is a member of the large 
superfamily of small GTPases. Conversion of 
its inactive form (GDP bound) to active form 
(GTP bound) leads to the engagement of many 
downstream signaling pathways. Guanine 
nucleotide exchange factors (GEFs) are 
involved in this GDP to GTP exchange. Ras is 
required for thymocytes development, T-cell 
proliferation and IL2 production (Cantrell, 
2002). Positive selection is specifically blocked 
in mice expressing a dominant negative form of 
Ras while negative selection remains 
unaffected (Swan et al., 1995). 
 
Differential MAPK activation in positive 
and negative selection is widely accepted as a 
mechanism underlying the discrimination 
between these two events. Activation of MAPK 
pathway involves sequential phosphorylation 
and activation of a three kinase cascade: 
MEKK, MEK, MAPK (Sohn et al., 2003). In T 
cells MAP kinase, ERK1/2, p38 and JNK are 
activated in response to TCR crosslinking 
(Dong et al., 2002). Targeted disruption of the 
erk gene or expression of dominant negative 
Ras, specifically blocks positive selection 
(Pages et al., 1999; Swan et al., 1995) while 
inhibition of p38 with inhibitors or disruption of 
the jnk gene and expression of dominant 
negative JNK results in block in negative 
selection (Sabapathy et al., 2001; Sugawara et 
al., 1998). Differences in the kinetics of ERK 
activation is considered to be the basis of 
positive and negative selection, as positively 
selecting ligands induces a slow and sustained 
ERK activity, where as negatively selecting 
ligand provoke a strong and robust  but 
transient ERK activity. In comparison both 
positively and negatively selecting ligands 
induce p38 and JNK with similar kinetics 
(McNeil et al., 2005; Werlen et al., 2000). 
The MAPK pathway is regulated by 
Ras. The adaptor protein Grb2 which is 
constitutively associated with Sos (son of 
sevenless) through its SH3 domain, connects 
Ras to TCR induced signaling pathways. Sos is 
a GEF with dual activity for Ras and Rac, and 
can therefore activate both the ERK and 
JNK/p38 pathway. Thymocytes heterozygous 
for Grb2, show inefficient JNK/p38 activation 
but normal ERK activation and as a 
consequence show impaired negative selection 
but normal positive selection (Gong et al., 
2001)  
 RasGRP (Ras Guanine nucleotide 
releasing protein1), another GEF for Ras, has 
been shown to be required for TCR mediated 
Ras-Erk activation, and hence shown to be 
critical for positive but not negative selection 
(Dower et al., 2000). Moreover there is no Ras 
activity in PLCγ1 deficient T cells as PLCγ1 
produces the secondary messenger DAG that 
directly binds to RasGRP1 and activates it. 
However, Ras can be activated at the plasma 
membrane by Grb2/Sos in response to in 
strong but not to weak stimuli (Parez de castro 
et.al., 2004). From these observations, positive 
selection signals were thought to induce 
RasGRP/Ras/ERK pathway, and negative 
selection signals were thought to induce Grb2-
Sos/Rac/JNK p38 pathway. 
Recently, it was shown that positive 
selection inducing signals resulted in 
subcellular compartmentalization of 
RasGRP/Ras/Erk to the Golgi membrane, 
where as negative selection inducing signals 
led to localization of Grb2-Sos/Ras/Erk to the 
plasma membrane. (Daniels et al., 2006). 
5.2. Ras
5.3. MAPK
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Positive selector induced activation of ERK has 
been shown to last longer in Golgi than in the 
plasma membrane. In contrast, JNK remains 
distributed throughout the cell independent of 
the type of TCR input. Therefore the retention 
of ERK in the plasma membrane upon 
signaling leading to negative selection may 
thus releave competition between ERK and 
JNK and enable phosphorylated JNK and other 
effector molecules to initiate negative selection 
successfully. Thus, subcellular 
compartmentalization of Ras-GEF and Ras 
upon TCR stimulation is now widely accepted 
to be the branch point of positive and negative 
selection (Yasuda and Kurosaki, 2008). 
 
MINK (misshapen-Nck-interacting 
kinase (NIK)-related kinase) has a preferential 
role in negative selection (McCarty et al., 
2005). TCR stimulation with a negatively 
selecting peptide induces association of MINK 
to Nck. This association in turn leads to JNK 
activation and upregulation of Bim and BimEL 
proapoptotic proteins that have a role in 
negative selection (Bouillet et al., 2002). The 
Nck-MINK interaction potentially links MINK to 
the TCR complex. Nck binds to the TCR 
complex of mature T cells upon induction of a 
conformational change by strong TCR ligands. 
The conformational change exposes a 
polyproline rich sequence in CD3ε, which can 
be detected in a pull down assay with the N 
terminal SH3.1  domain of Nck (Gil et al., 
2002). In the thymus, both positively and 
negatively selecting ligands induce the 
conformational change, as detected in the Nck 
SH3.1 pull down assay (Gil et al., 2005), 
making it difficult to draw a direct correlation 
between Nck binding and negative selection. 
However, an alternative method to detect the 
exposure of the proline-rich sequence of CD3ε, 
i.e. labelling with the APA1/1 antibody, only 
occurs in thymocytes upon stimulation with 
negative selection inducing antibodies (Risueno 
et al., 2005), showing a strong correlation. The 
reason for this apparent discrepancy has not 
yet been resolved. 
 
The G protein-coupled receptor 
kinases (GRKs) family consists of seven 
serine/threonine protein kinases that have been 
divided into three subfamilies based on a 
sequence homology: the visual GRKs GRK1 
(rhodopsin kinase) and GRK7 (cone opsin 
kinase); the β-adrenergic receptor kinases, 
GRK2 (β-ARK1) and GRK3 (β-ARK2); and the 
GRK4 subfamily consisting of GRK4, GRK5 
and GRK6. The main role of GRKs is to 
specifically recognize and phosphorylate 
agonist activated G-protein coupled receptors 
(GPCRs). In addition to this GRKs 
phosphorylates many non-receptor substrates 
such as tubulin, synucleins or phosducins 
(Ruiz-Gomez et al., 2000). GRKs have also 
been implicated in desensitization of several 
GPCRs independent of phosphorylation leading 
to attenuation of signal transduction of GPCR, 
showing secondary role of their kinase activity 
(Pao and Benovic, 2002,Carman et al., 1999) 
and suggesting a scaffold role for this family of 
proteins. GRKs interact with variety of proteins 
implicated in signaling and trafficking involved 
in essential biological pathways assigning novel 
roles for GRKs in physiology and diseases. 
 
GRKs share a common structural 
architecture: they contain a central catalytic 
domain varying between 263-266 amino acids  
  
5.4. MINK-Nck
6 G protein-coupled Receptor Kinase 2
6.1 Structure and substrate specificity
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Figure 8: Domain structure of GRK2. GRK2 contains three primary domains: The NH2-terminal domain involved in GPCR 
binding followed by a central catalytic domain that involved in serine-threonine phosphorylation of targeted proteins, and a 
variable COOH-terminal domain that regulates phospholipid association. 
 
 
that mediates substrate phoshphorylation, 
about 185 amino acid long NH2 terminal 
domain that is important for receptor binding, 
and a variable COOH-terminal domain that is 
involved in phospholipid association.The N-
terminal region of GRKs consists of a RH 
domain of 120 aa, which in case of GRK2 and 
3 provide a potential mechanism of 
phosphorylation independent regulation of 
GPCR signaling and a Gαq/11 binding site 
(Carman et al., 1999). A Gβγ-binding site has 
been described in the N-terminal domain of 
GRK2 that helps in membrane targeting of 
GRK2 (Willets et al., 2003). The C-terminal 
domain of GRKs is important for their 
subcellular localization and agonist dependent 
translocation to the membranes. GRK2 and 3 
contain a plekstrin homology domain (PH) 
which facilitates its interaction with membrane 
phospholipid PIP2 and free Gβγ subunits 
(Ribas et al., 2007). 
 
 
Out of the seven members of the GRK 
family, GRK2 is the most thoroughly 
characterized member, it not only binds and 
phosphorylates a large number of GPCRs, but 
its substrates also include large number of 
cytosolic proteins which are not GPCRs. Apart 
from its kinase activity, GRK2 has the capacity 
to modulate the activity of various signaling 
proteins by scaffolding signaling complexes 
and transporting them to receptors, in an 
agonist dependent manner. 
 
Phosphorylation of GPCRs: classical role 
Upon ligand binding, GRK2 associates 
with agonist coupled GPCRs and 
phosphorylate serine-threonine residues within 
the intracellular loops and C-terminal domain of 
these receptors. In an agonist unbound state 
G-protein coupled receptors (GPCR) remain in 
an inactive conformation, but upon agonist 
binding this receptor undergoes a 
conformational change to expose a surface that 
acts as a guanine nucleotide exchange factor 
for the heterotrimeric G-proteins. After 
activation GDP is released from the G-protein 
which in turn facilitates binding of GTP. The 
GTP-bound G-protein undergoes a 
conformational change that causes its release 
from the receptor and dissociation into 
activated α and βγ subunits, which leads to the 
activation of downstream signaling pathway. 
GRK2 also recognises the activated form of the 
receptor and becomes catalytically active. 
6.2 Roles of GRK2
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Figure9. Schemetic representation 
of GRK2 mediated desensitization 
of GPCRs. In the absence of 
receptor stimulation, the Gα subunit 
is GDP bound and remain associated 
with Gβγ subunits. Upon ligand 
binding GTP is exchanged for Gα 
bound GDP, which leads to the 
conformational change in Gα subunit 
and its dissociation from Gβγ 
subunits. The dissociated Gα and 
Gβγ subunits activate several 
downstream intracellular signaling 
pathways. Subsequently GRK2 is 
recruited to agonist occupied GPCRs 
and phosphorylates threonine-serine 
residues within the intracellular 
domains of the GPCRs, which results 
in subsequent recruitment of β-
arrestins. β-arrestins target GPCRs 
to clathrin-mediated internalization 
which resulta in further inhibition of 
GPCR signaling. 
 
Activated GRKs then phosphorylate 
intracellular domain of the receptor and are 
then released. As a result of GRK2 mediated 
phosphorylation of the receptor, recruitment of 
β-arrestin occurs. Later, β-arrestin initiate 
clathrin dependent internalization of GPCRs 
resulting in receptor degradation or 
resensitization inside endosomal compartments 
(2Figure9). 
 
GRK2 has been shown to interact with 
a variety of proteins and these interactions are 
both phosphorylation-dependent and 
independent (2Table 1). It was shown that GRK2 
binds to several proteins involved in 
intracellular signaling and receptor trafficking 
such as PI3kinase, Akt, caveolin, G protein 
subunits, clathrin and MAPKs. Many of these 
proteins are predominantly required for TCR 
signaling and hence, GRK2 interaction with 
them may be of particular importance in T cells. 
Recently it has been shown that 
p38MAPK associates with endogenous GRK2 
and is phosphorylated by GRK2 (Peregrin et 
al., 2006). Phosphorylation of p38 by GRK2 
attenuates binding and activation of p38 by its 
upstream activator MKK6 which results in the 
inhibition of activation of downstream 
substrates of p38. GRK2 directly 
phosphorylates p38 at Thr123 which is located 
at the entrance of the docking groove and is 
highly conserved. Activation of p38 by MKK6 is 
dependent on the expression of GRK2, and is 
reduced or enhanced when GRK2 expression 
is increased or decreased respectively. 
Moreover altered GRK2 expression modifies 
p38-mediated cellular processes such as LPS 
induced TNFα production in macrophages. 
Recently, association of GRK2 with MEK and 
ERK has been found which seems to control 
the chemokine induction of MAPK activation 
(Jimenez-Sainz et al., 2006). The GRK2-
MEK1/2 interaction reduces CCL2 induced 
ERK1/2 activation in HEK293 cells 
overexpressing GRK2, while a decreased level 
of GRK2 promote a more robust ERK activation 
upon agonist treatment. Moreover, GRK2 
mediated inhibition of CCL2 induced ERK 
activation did not require kinase activity of 
GRK2 nor its interction with G-protein subunits. 
   
6.3 GRK2 Interactions
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Table 1. GRK2 interacting proteins [adapted from (Hansen et al., 2004; Ribas et al., 2007)] 
 
GRK2 interacting protein Functinal consequences 
 
GPCR GPCR desensitization 
Gβγ Activated Gβγ subunits increases GRK2 kinase activity by binding and recuting it to 
plasma membrane 
Gα GRK2 inhibits Gαq/11-mediated signaling via a phosphorylation independent 
mechanism. 
Caveolin Caveolin inhibits GRK2 activity 
Calmodulin Calmodulin inhibits GRK2 activity 
Clathrin GPCR internalization 
Tubulin GRK2 phosphorylates tubulin,which may affects its interaction with microtuble 
associated proteins 
Actin Inhibition of GRK2 activity 
Synucleins GRK2 phosphorylates synucleins 
c-Src c-Src phosphorylates GRK2 and increases its kinase activity 
MEK1 GRK2-MEK1/2 interaction inhibits chemokine mediated ERK1/2 activity. 
ERK1/2 ERK1/2 Phosphorylate GRK2 and decreases GRK2 mediated receptor 
phosphorylation, and inhances GRK2 degradation 
p38 MAPK GRK2 phosphorylates p38 MAPK and impairs its activation 
PI3K GRK2 mediated recruitment of PI3K increases receptor endocytosis 
PKA PKA phosphorylates GRK2 and promotes its binding to Gβγ 
PKC PKC phosphorylates GRK2 and reverts the inhibition of GRK2 by Calmodulin and 
there by increases the GRK2 activity 
Akt GRK2 inhibits Akt kinase activity 
GIT1 GRK2 translocate GIT1 to the membrane 
 
GRK2 binding to PI3Kγ promotes its plasma 
membrane recruitment after agonist 
stimulation, which results in increased receptor 
endocytosis in HEK293T cells overexpressing 
GRK2 (Naga Prasad et al., 2001). The 197aa 
PIK domain of PI3K is important for this 
interaction, and overexpression of PIK 
domains inhibits PI3K-GRK2 interaction 
attenuating β2-adrenoreceptor endocytosis 
(Naga Prasad et al., 2002; Perrino et al., 
2005). Furthermore, GRK2 interacts with the 
serine threonine kinase Akt directly through its 
C-terminus, leading to agonist dependent 
inhibition of Akt via a so far unknown 
mechanism, (Liu et al., 2005). Grk2 also 
interacts with GIT and act as anchoring 
proteins for this protein. (Premont et al., 1998). 
 
Most GRK2 proteins are located in the 
cytosol and translocate to the plasma 
membrane upon GPCR stimulation. Specific 
interaction of the PH domain of GRK2 directly 
with the phospholipid PIP2 leads to its 
translocation to the plasma membrane 
(DebBurman et al., 1995). In addition, binding 
of PH domain to Gβγ subunit liberated after 
receptor mediated G protein activation also 
leads to its membrane targeting. GRK2 binding 
to Gβγ subunit is promoted by agonist induced 
phosphorylation of GRK2 at Ser685 by PKA 
(Cong et al., 2001b). As described previously, 
GRKs play a key role in GPCR signaling and 
6.4. Subcellular localization and regulation 
of GRK2 activity 
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activity of GPCR is strongly dependent on the 
cellular complement and functionality of GRK 
proteins. It has been shown that several 
pathological conditions are associated with 
altered expression of GRK2 and has been 
associated with impaired GPCR signaling. 
Hence, GRK2 activity and subcellular 
distribution are tightly regulated (2Figure 10). 
 GPCR activation leads to production 
of intracellular messengers, which can 
regulate the GRK2 activity. Calmodulin, a 
universal mediator of Ca2+ signal can regulate 
the GRK2 activity. Calmodulin interact with 
GRK2 at both the amino and carboxyl terminal 
and directly inhibits its activity (Krasel et al., 
2001). Receptor phosphorylation by GRK2 is 
also modulated by the action of several protein 
kinases that directly phosphorylate GRK2. 
Activation of β2AR lead to a rapid and 
transient increase in c-Src mediated 
phosphorylation of GRK2 at tyrosine residues 
of the N-terminus (Y13, Y86 and Y92), 
resulting in an upregulation of GRK2 kinase 
activity (Sarnago et al., 1999). cSrc-mediated 
phosphorylation of GRK2 also enhances its 
interaction with Gαq, and promotes its 
degradation by the proteasome pathway 
(Mariggio et al., 2006). P42/p44 MAPK is also 
shown to regulate the GRK2 activity. ERK1/2 
phosphorylate GRK2 at serine670 leading to 
inhibition of receptor phosphorylation by 
GRK2. MAPK phosphorylation at Ser 670 
impairs the association of Gβγ subunit with 
GRK2 resulting in inhibition of its catalytic 
activity towards receptors substrate and also 
leads to impairment of its translocation to the 
membrane (Elorza et al., 2000). Both c-Src 
and ERK1/2 mediated phosphorylation of 
GRK2 leads to its degradation via proteasome 
mediated pathway (Elorza et al., 2003; Penela 
et al., 2001).  
Figure 10: Regulators of GRK2 activity. Schematic 
representation of the mechanism involved in regulation of 
subcellular level, localization and degradation of GRK2. [ 
adapted from (Ribas et al., 2007)] 
 
In addition PKC can also modulate GRK2 
activity. PKC phosphorylates GRK2 at Ser 29, 
which prevent GRK2 inhibition by calmoduluin 
and enhances membrane targeting of GRK2 
(Krasel et al., 2001; Winstel et al., 1996). In 
addition PKA activated through G-coupled 
receptors directly phosphorylate GRK2 at Ser 
685, leading to its membrane targeting and 
enhanced activity towards GPCRs (Cong et 
al., 2001a). 
  
Cells of the immune system express 
high levels of GRK2 (Chuang et al., 1992; De 
Blasi et al., 1995), and its levels in immune 
cells are dynamically regulated, suggesting an 
important role in regulation of immune activity. 
Moreover, altered expression of GRK2 
correlates with many disease phenotypes; for 
example rheumatoid arthritis (RA) or multiple 
sclerosis (MS) show significant down-
regulation of GRK2 and GRK6 expression 
(Lombardi et al., 1999; Vroon et al., 2005) in 
lymphocytes. However, hypertension in 
6.5. Roles for GRK2 in Immune response
and lymphocyte migration 
       
 
30
Introduction 
humans is associated with increased 
expression of GRK2 in lymphocytes (Gros et 
al., 1999). In inflammatory diseases, disease 
pathologies need the activation and 
recruitment of T cells, monocytes and 
neutrophils. Migration of these cell types is 
enhanced and chemokine receptor signaling is 
also increased. GRK2 has been shown to 
have a prominent role in regulation of GPCRs 
signaling, desensitization and internalization. 
Further research has revealed a complex 
GRK2 interactome and show a role for GRK2 
kinase activity in inhibiting chemokine-induced 
immune cell migration. 
 Studies using murine GRK2+/- T 
lymphocytes have shown its effect on cell 
migration. It has been shown that around 50% 
reduction of GRK2 levels in T cells isolated 
from these mice correlates with a significant 
increase in the in-vitro chemotactic response 
of these cells as well as their signaling. Low 
GRK2 activity significantly enhances CCR5 
agonist-induced calcium mobilization, signaling 
to protein kinase B (PKB) and ERK1/2 as well 
as directed migration of these cells to CCR5 
(Vroon et al., 2004) and CXCR4 (Jimenez-
Sainz et al., 2006) agonists gradients in vitro. 
In contrast, Penela et al has shown that GRK2 
positively regulates the integrin dependent 
motility in epithelial cell types and fibroblasts, 
GRK2 appears to function as a positive 
regulator of both S1P receptor activation of the 
ERK cascade and the migration machinery 
(Penela et al., 2008a). Moreover it was shown 
that this activity was dependent on 
phosphorylation dependent association of 
GRK2 with GIT1, a scaffold protein involved in 
cell migration processes. It has been reported 
that GRK2 phosphorylate and activates ezrin 
in the transformed epithelial cell lines (Cant 
and Pitcher, 2005). This could play a role in 
dynamics of actin cytoskeleton which is linked 
to motility of certain cell types. Furthermore, 
GRK2 could also contribute to migration by 
specifically phosphorylating tubulin (Yoshida et 
al., 2003). 
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Previously activated and memory T cells 
(antigen experienced T cells) have a lower 
activation threshold in comparison to naive T 
cells. Their activation is less dependent on co-
stimulatory signals and is initiated with lower 
amounts of antigen. However, the precise 
mechanisms underlying this increased 
sensitivity are not clear. Recently it has been 
shown through biochemical and electron 
microscopy techniques that both monomeric 
and oligomeric TCR complexes co-exist on the 
cell surface of resting T cells. Moreover, it has 
been shown that the oligomeric complexes 
become preferentially activated at low doses of 
antigen, suggesting that they provide T cells 
with their high antigen sensitivity. We therefore 
hypothesized that the increased sensitivity to 
antigen experienced T cells is caused by an 
increase in the number and size of oligomeric 
TCR complexes. To address this hypothesis, 
the principal objectives of the first part of my 
thesis work were: 
1) To compare the number and size of 
oligomeric TCR complexes on naive 
and antigen experienced T cells. 
2) To design and generate mutants of the 
TCR complex that specifically impairs 
oligomeric TCR formation. 
3) To investigate the role of oligomeric 
complexes in T cell differentiation and 
T cell activation. 
 
 
 
 
The second part of my thesis work was aimed 
at finding new molecular mechanisms via 
which the TCR complex is able to transmit the 
appropriate signal for positive and negative 
selection of DP thymocytes. Several signaling 
pathways downstream of the TCR complex 
have been shown to be involved in positive 
and negative selection in a quantitatively or 
qualitatively different manner, but the 
molecular mechanism that allow TCR to 
differentially activate one or the other of these 
signaling cascades are largely unknown. We 
hypothesised that differential signaling during 
thymic selection is dependent on the 
differential association of intracellular factors to 
the TCR complex depending on the strength of 
interaction of the TCR complex with pMHC 
ligands expressed by the thymic stroma. To 
address the validity of this hypothesis the 
principal objectives of the second part of my 
thesis work were: 
1) To standardized a mouse model to 
obtain large number of double 
positive thymocytes undergoing 
positive and negative selection in- 
vivo. 
2) To perform a biochemical screen 
using this model to search for 
proteins associating differentially with 
the TCR complex during either 
positive or negative selection. 
3) To investigate the role of such 
differentially associating proteins in T 
cell selection. 
 
AIMS OF THE STUDY 
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COS: The COS-7 cell line was obtained by 
immortalizing a CV-1 cell line derived from 
kidney cells of the 9African green monkey with 
a version of the SV40 9genome that can 
produce 9large T antigen but has a defect in 
genomic replication (Gluzman, 1981). 
293T: Human Embryonic Kidney 293 cells, 
often referred to as HEK 293 were generated 
by 9transformation of cultures of normal human 
embryonic kidney cells with sheared 
9adenovirus 5 9DNA (Graham et al., 1977). 
2B4: The 2B4 cell line is a murine T cell 
hybridoma which has been obtained by 
immunization of a B10A mouse with pigeon 
cytochrome C (Samelson et al., 1983).It 
recognizes the minimal pigeon and moth 
cytochrome C derived epitope 
(ANERADLIAYLKQATK) bound to I-Ek. 
MA5.8: MA5.8 cell line is a derivative of 2B4 
cell line which lacks CD3 ζ chain (Sussman et 
al., 1988). 
DCEK: The DCEK fibroblast cell line stably 
transfected with plasmids encoding I-Ek and 
CD80 used as a antigen presenting cells for 
2B4 and AND T cells.(R. Germain National 
Institutes of Health, Bethesda, MD). 
T2Kb: T2Kb is a H2-Kb transfected derivative 
of the human cell T2, a fusion between a T-
lymphoid blastoid cell line (LCL) and B-LCL 
(Alexander et al., 1989)  
 
C57BL/6: C57BL/6 and CD45.1-congenic 
C57BL/6 mice (kindly provided by Dr. C. 
Ardavin, Centro Nacional de Biotecnología, 
Madrid) were used as recipient animals for 
bone marrow reconstitution experimemts. 
OT-I:  OT-1 is a MHC class I restricted TCR 
transgenic line. This TCR recognizes the 
octameric peptide SIINFEKL (derived from 
OVA) in the context of H2Kb molecule 
(Hogquist et al., 1994). All T cells in these 
animal expresses Vα2 and Vβ5 molecule. 
CD3ζ-deficient mice (Love et al., 1993), 
acquired from the Jackson Laboratories were 
crossed to OT-1 TCRtg mice and used as a 
bone marrow donors. 
AND: AND is MHC class II restricted TCR 
transgenic animal which expresses AND TCR 
(Vα11.1 Vβ3) which recognises MCC88-103 
and PCC88-104 in context of I-Ek molecule 
(Kaye et al., 1983). 
TANDRAG:The TANDRAG triple-transgenic 
mice express the AND TCR together with a 
TIM construct containing the I-Ek-restricted 
MCC epitope under regulation of a 
tetracycline-responsive promoter (Tet-off) TA; 
(van Santen et al., 2004). These mice were 
bred onto a RAG1-deficient H-2k-positive 
background. 
GRK2: GRK2+/- mice (Jaber et al., 1996) on a 
C57BL6 background were a gift from Dr. 
Fedrico Mayor Jr. This line was crossed to OT-
1 and AND TCR transgenic lines. 
 
All animals were bred and maintained 
under SPF conditions in the animal facility of 
the ‘Centro de Biología Molecular Severo 
Ochoa’ in accordance with applicable national 
and European guidelines. All animal 
procedures were approved by the ethical 
committee of the ‘Consejo Superior de 
Investigaciones Científicas’. 
 
MATERIALS
1. Cell lines
2. Animal models
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COS and 293T cell lines were maintained in 
DMEM (Gibco) supplemented with 2 mM L-
Glutamine, 100 U/ml penicillin, 100 U/ml 
streptomycin and 10% FCS. 
Bone marrow derived cells were 
maintained in Iscove’s medium (IMDM, sigma) 
supplemented with 10%FBS, 25ng/ml IL7, 
25ng/ml IL6, 50 ng/ml SCF and 50ng/ml Flt3-
ligand (all cytokines from Preprotech). Cell 
lines MA5.8 and 2B4 were cultivated in 
RPMI1640 (sigma) supplemented with 2 mM 
L-Glutamine, 100 U/ml penicillin, 100 U/ml 
streptomycin and 5% FCS. Primary T cells and 
Blast cells were maintained in RPMI1640 
(sigma) supplemented with 2 mM L-Glutamine, 
100 U/ml penicillin, 100 U/ml streptomycin 
,10µM β-mercaptoethanol, 1 mM Na-pyruvate 
and 10% FCS. 
 
 
Table 2 : List of peptides 
Peptide Sequence 
MCCp ANERADLIALKQATK 
OVAp SIINFKEL 
 
 
Table 3: List of antibodies 
Antibody Clone Isotype Species Generated by 
CD3ζ 448 Polyclonal Rabbit San Jose et al,1998 
CD3ε APA1/1 IgG1 Mouse Alarcon et al,1991 
h,Mcd3ε M20 Polyclonal Goat Santa Cruz Biotechnology 
mCD3εγ 
mCD3εδ 
145-2C11 IgG1 Hamster ATCC 
GRK2 C5/1.1 IgG2a Mouse Upstate 
GRK2 Polyclonal IgG Rabbit Santacruz 
Actin DM1A IgG1 Mouse Sigma 
GFP 7.1 and 13.1 IgG1κ Mouse Roche 
4G10biot 4G10 IgG2b Mouse Upstate 
448bio 448 Polyclonal Rabbit San Jose et al,1998 
Phospho-tyrosine 4G10 IgG2b Mouse Upstate 
 
 
 
3 Reagents 
3.1 Culture medium
3.2 Peptides
3.3 Primary Antibodies
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Table 4: List of secondary antibodies 
Antibody Specificity Source 
Anti-mouse IgG-HRPO Murine HC and LC GE Healthcare UK limited 
Anti-rabbit IgG-HRPO Rabbit F(ab’)2 fragment GE Healthcare UK limited 
 Anti-goat IgG HRPO Goat IgG (H+L) Thermo Scientific 
 
Table 5. List of fluorescent antibodies 
Antibody Source 
CD4-FITC/PE/ /Biotin ImmunoTools/ BD pharmingen 
CD8-perCP/Biotin BD pharmingen 
2C11-PE/biotin BD pharmingen 
H57-biotin eBioscience 
αβTCR-FITC ImmunoTools 
Vα11-biotin BD pharmingen 
Vα2-PE/biotin BD pharmingen 
T370-biotin eBioscience 
CD5-biotin eBioscience 
CD69-FITC/PE/biotin BD pharmingen 
CD44-FITC/biotin ImmunoTools/ BD pharmingen 
CD25-biotin/APC BD pharmingen 
CD62L-FITC BD pharmingen 
CD90-biotin BD pharmingen 
CD19-PE/Biotin eBioscience/ BD pharmingen 
CD3PE/biotin BD pharmingen 
B220-FITC/biotin BD pharmingen 
IFN-γAPC MACS Milteny biotech 
CD4-perCP BD pharmingen 
CD8-FITC ImmunoTools 
HSA-FITC/CD24biotin BD pharmingen 
CD3(17A2)-FITC/PE BD pharmingen 
VB14-FITC BD pharmingen 
VB3 -PE/biotin BD pharmingen 
CD16/32 BD pharmingen 
CD8-VIO BLUE MACS Milteny biotech 
CD45.2-APC BD pharmingen 
H2kb- biotin BD pharmingen 
CD44-PE BD pharmingen 
CD90.2-PE BD pharmingen 
CD8-PE BD pharmingen 
H2Kb-PE BD pharmingen 
 
3.4. Secondary Antobodies 
3.5 Fluorescent Antibodies
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Thymocytes and transformed cells 
were lysed in Brij 96 lysis buffer (0.33% v/v Brij 
96, Fluka), 150mM NaCl, 20mM Tris HCl, 
pH7.8. 
Phosphatase and protease inhibitors 
Sodium orthovanadate (100x) - 50mM solution 
in dH2O 
Sodium fluoride (100x)-1M solution in dH2O 
Aprotinin (1000x) - 10mg/ml solution in dH2O 
Leupeptin (1000x) – 10mg/ml solution in dH2O 
PMSF (100x) – 100mM solution in ethanol. 
 
1.1. Kits Gel extraction- QIAquick gel 
extraction kit (Qiagen) and Mutagenesis- 
QuikChangeTM Site directed mutagenesis kit 
(Stratagene) were used according to 
manufacturer’s instruction. 
1.2.Oligonucleotides  
The oligonucleotides used were HPLC grade 
and were purchased from Invitrogen. All 
sequences are shown in the 5’ to 3’ direction 
with mutated residues stain in red. 
Table 6: List of primers used for site directed mutagenesis 
Name Sequence Use
Bal448(5’) GCTACTTGCTAGATGGAATCGCC
TTCATCTACGGAGTCATC 
L9A 
Bal449(3’) GATGACTCCGTAGATGAAGGCG
ATTCCATCTAGCAAGTAGC 
 
Bal450(5’) CGGAGTCATCATCACAGCCGCG
TACCTGAGAGCAAAATTCAGC 
L19A 
Bal451(3’) GCTGAATTTTGCTCTCAGGTACG
CGGCTGTGATGGATGACTCCG 
 
 
Table 7: Primers used for cloning 
Name Sequence Use 
Bal197 CCCCTCGAGAAGCAGAAG
ATGAAGTGG 
addition 5’Xho site 
in murine zeta chain 
costruct 
Bal466 GGCTCGAGTGGCTGTTAG
CGAGGGGC 
addition 3’ Xho1 
site in murine zeta 
chain construct 
Bal556 CCCAGATCTACCATGAAGT
GGAAAGTGTCTGTT 
addition 5’ BglII site 
in murine zeta chain 
construct 
Bal557 GGGGCGGCCGCTTAGCGA
GGGGCCAGGGTGAC 
addition 3’NotI site 
in murine zeta chain 
construct 
Bal 630 GGGGCGGCCGCTTTATTG
CTACAGCTCGTC 
addition 3’NOT-1 
site in EGFP of 
pLEGP-N1 
 
Table 8: Primers used for sequencing 
Name Sequence Use 
Sp6 GAT TTA GGT GAC ACT 
ATA 
Reverse sequencing 
primer  
T7 AAT ACG ACT CAC TAT 
GG 
Forward sequencing 
primer for pGEM3 
pSRα CCTTTGTCCGGCGCTCCC
TTGG 
Forward sequencing 
primer  
pLEGFP-
N1 
CGTCCCGCCGTCCAGCTC
GACCAG 
Forward sequencing 
primer  
pCR2.1 CTGGCCGTCGTTTTAC Forward sequencing 
primer 
Plasmids were diluted to 5ng/µl. A 1x PCR mix 
containing the following components was 
prepared. Stratagene reaction buffer, 10ng 
plasmid, 125 ng each primer, 1µl dNTPs mix, 
2.5U/µl Pfu Turbo polymerase (Stratgene), 
sterile dd H2O to a final volume of 50µl. The 
PCR program was as followos: 
95ºC: 0:30 
3.6. Lysis buffer
METHODS 
1. Molecular Biology 
1.3. Site directed mutagenesis:-
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95ºC: 0:30 
55 ºC: 1:00 
68 ºC: 2 min/kb plasmid length 
Go to 2 16 cycles 
4 ºC:<< forever 
End 
After PCR, reactions were placed on ice for 2 
minutes. 10U DpnI were added to the PCR 
reaction and incubated for 1 hour at 37 ºC to 
digest parental supercoiled methylated 
dsDNA. DNA was then transformed into 
competent bacteria. 
 
 
 
 
 
 
1.4. Cloning procedure:
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I.Transient transfection through 
electroporation: 5x106.COS7 cells, cells were 
suspended in 200μl DMEM supplemented with 
10% FBS and 20 mM HEPES pH7.4. COS 
cells were incubated in the cuvette of 
transfection with 20 μg salmon sperm DNA, 5 
μg of the plasmid of interest and 37.5 μM NaCl 
(150mM). The cells were pulsed at 200 mV 
and 960 μF. After transfection cells were 
mixed gently and resuspended in 10 ml DMEM 
supplemented with 10% FBS in 100 mm falcon 
plate. Expression of the plasmid was checked 
24-48 hrs post transfection. 
5-10x106 MA5.8 cells, were used were 
resuspended in 500 μl of RPMI with 20%FCS 
and 10mM HEPES. Cells were incubated in 
the cuvette of electropration with 40 μg of 
plasmid of interest for 10 min at room 
temperature. The cells were pulsed at 240mV 
and 500 mF approximately for 22 ms. After the 
pulse cells were resuspended in 10 ml 
complete RPMI with 5%FCS. Expression of 
plasmid was checked 24 or 48 hrs after 
transfection.  
 
II. Stable Transfection: For generation of 
stable transfectants, electroporated cells were 
plated after 48 hrs in 96 well flat bottom plate 
at 20,000 cells/well, in 100 µl complete RPMI 
with 10% FCS and selection of Geniticin 
(G418,1mg/ml). After another 2 days, 100 μl of 
fresh medium was added. 100 μl of medium 
was then replaced every 4 days, until single 
clones could be seen in the plates. The 
selected clones were transferred to 24 well 
plates and analysed by FACS or western 
blotting, to check for the expression of 
plasmid. 
 
III. Lentiviral Transfection and 
transduction: 
Day 1:293T packaging cell lines were plated at 
250,000 cells/well of a p6 plate in 2 ml of 
DMEM complete medium with 10% FCS. 
Day 2:293T cells were transfected by JetPEI 
method. For each p6 well 1.5μg of the relevent 
lentiviral vector construct,.1 μg of pCMV8.9 
(gag-pol) and 0.5 μg of pMDG (VSVg 
envelope) plasmids were mixed together in 
100 μl of 150mM NaCl. Then 6 μl of JetPEI 
reagent was mixed in 100 μl of 150 mM NaCl 
and added to the DNA mixture, vortexed and 
centrifuged. The mixture was incubated for 20 
min at RT before addition to the 293T cells.. 
and then cells were grown for 2 days. 
Day 3: MA5.8 or 2B4 cell were thawed.and put 
in culture. 
Day 4: supernatant of harvested 293T cell 
culture was filtered through a 0.45 micron filter 
(millipore), polybrene(sigma) was added to the 
filterd supernatant at 8 μg/ml. 2B4 or MA5.8 
cells were plated in p24 well plate at 1x105 
cells per well, and 1 ml filtered supernatant 
containing viral particles was added. Plates 
were centrifuged for 90 minutes at 975g at 
32ºC. After centrifugation plates were 
incubated at overnight 37 ºC. 
Fresh medium was added to the transfected 
293T cells in order to obtain a second batch of 
viral particles containing supernatants for a 
second round of transduction. 
Day 5: Medium from the transduced cell 
cultures was carefully removed without 
disturbing the live cells settled to the bottom. 
Then the cells were transduced with the 
second batch of viral supernatant in presence 
of polybrene at the same condition as of 1st 
round. After 6hrs cells were diluted in fresh 
RPMI+5%FCS and after 48 hrs of transduction 
cells were checked for the expression of 
1.5. Transfection:
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relevent proteins through FACS and western 
blotting. 
 
IV. Bone marrow transduction (BMT): 
For bone marrow transduction, the protocol for 
transfection and transduction was similar as 
above with the following modifications. 
Day1: CD3ζ -/- OT-1tg donor animals were 
injected intraperitonially with 5 Flurouracil 
(150mg/kg). 
Day2: 293T cells were harvested as described 
above. 
Day3: Donor mice were sacrificed and bone 
marrow cells were obtained by flushing the 
femurs with PBS+2%FCS. After removal of 
RBCs via hypotonic lysis the remaining cells 
were resuspended in Iscove’s medium 
supplemented with 10% FCS, IL-7 (25ng/ml), 
IL-6 (25ng/ml), SCF (50ng/ml) and Flt3-ligand 
(50ng/ml; all cytokines were obtained from 
Preprotech).Cells were cultured overnight at 
37ºC in p24 well.plates at 1x106 per well. 
Medium from the transfected 293T cells was 
changed for fresh complete IMDM medium. 
Day4: Bone marrow cells were transduced 
with supernatant of the 293T cultures as 
described above. Recpient mice were sub-
lethally irradiated 6Gy. 
Day 5: Transduced bone marrow cells were 
harvested from the p24 plates, washed, 
counted and 3-5x106 cells were injected in the 
plexus of each recipient C57BL/6 or C57BL/6 
CD45.1-congenic mouse. 
Mice were maintained at our animal house 
facility, and kept on drinking water 
supplemented with 200 μg/ml tetracycline 
(Sigma). Animals were sacrificed 6-8 weeks 
after reconstitution and analysed. 
.
2 Cell biological Methods 
 
2.1. Isolation of murine lymphoid cells 
Spleen, lymph nodes (LN) and thymus 
were isolated placed in PBS, and single cell 
suspensions were prepared by gently crushing 
the organs between glass slides. Cells were 
transferred to the falcon tubes, centrifuged, 
washed and resuspended in PBS or culture 
medium. Cells from the spleen were 
centrifuged and resuspended in 4ml of 
erythrocyte lysing buffer (150mM 
NH4Cl,10mM KHCO3, 0.1mM EDTA) for 5 
minutes at RT. PBS was added to fill up the 
tube and then cells were centrifuged at 
1200rpm for 5 minutes. Pelleted lymphocytes 
were resuspended in PBS or culture medium. 
 
2.2. Preparation of T cell blasts  
OT-1 blasts were generated by 
stimulating whole spleen cell suspensions of 
OT-1 mice with 10 pM of OVAp (SIINFEKL, 
synthesized in the proteomic facility of the 
Centro de Biología Molecular via f-moc 
chemistry) and 0,5 μg/ml anti-CD28 in RPMI-
10% FCS, supplemented with 2mM glutamine, 
1 mM sodium pyruvate and 1x10-5 M β-
mercapto-ethanol. After 2 days, cultures were 
centrifuged, resuspended in fresh medium 
supplemented with saturating amounts of 
recombinant human IL-2 and expanded for 6-
12 more days.  
 
i. Antigen stimulation: MA5.8 cells were 
stimulated at 1x105 cells per well in flat bottom 
96 well plates containing a monolayer of 5x104 
I-Ek and CD80 transfected DCEK fibroblasts (a 
kind gift of Dr. R. Germain, National Institutes 
2.3. Cell stimulation
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of Health, Bethesda, MD) loaded with the 
indicated amounts of the MCCp 
(ANERADLIAYLKQATK, synthesized in our 
center via f-moc chemistry). T cells were 
cultured for the indicated times before 
measurement of expression of TCR 
downmodulation,CD25 and CD69 induction . 
 
ii. Tetramer stimulation: Biotinylated KbOVAp 
tetramers (Daniels and Jameson, 2000), 
generated by incubation of pre-folded c-
terminally biotinylated soluble KbOVAp 
complexes (generously provided by Dr. E. 
Palmer) with unlabeled streptavidin, were 
added at the indicated concentrations to T 
cells at the start of culture in R10 medium in 
round bottom 96 well plates. T cell blasts were 
cultured for 24hrs in presence of tetramer and 
then stained intracellulary for measurement of 
IFNγ. 
iii. T cell stimulation: Primary macrophages 
or T2Kb cells were used as antigen presenting 
cells for OT-1 mice, while irradiated spleen 
cells from micen of the H-2k haplotype or 
DCEK cells were used as antigen presenting 
cells for AND TCRtg animals. 
Primary macrophages were obtained 
via peritoneal lavage of C57BL/6 mice that had 
been injected (i.p.) three days before with 
thioglycolate solution (30% thioglycolate-
1ml/mouse). Macrophages were plated at 
0.7x104 cells per well of flat bottom 96 well 
plates the day before the stimulation assay in 
RPMI-10% FCS supplemented with 1mM Na-
Pyruvate and 1x10-5 M βME (complete 
medium). The macrophages were loaded with 
the required amounts of peptide for 7 to 10 
hours followed by washing with PBS before 
addition of T cells (100,000 cells/well) in 
complete medium.  
Cells from one spleen were obtained 
as described before, resuspended in 
RPMI+0.5%FCS or in PBS. and γ-irradiated at 
1500 rads. Cells were then washed and plated 
at 1x106 cells per well of p96 U bottom plates. 
Splenocytes were then loaded with the 
indicated amounts of peptide and incubated 
overnight 
DCEK cells and T2Kb cells were 
plated at 50,000 and 100,000 cells per well of 
p96 flat bottom plate, respectively, and 
incubated with the indicated amounts of 
peptide. 
 
Cells were stained on ice in PBS, 1% 
BSA, 0,02% NaN3 with saturating amounts of 
either directly labelled antibodies or with 
labelled primary antibodies and then 
appropriate fluorescently-labelled secondary 
antibodies. Cells were acquired on a 
FACScalibur flow cytometer (Becton-
Dickinson, Franklin Lakes, NJ). Data were 
analyzed with FlowJo software (TreeStar, 
Ashland, OR). 
Functional assay: 
i. Induction of CD69 and CD25 expression: 
To check for the cell surface expression of 
CD69, cells were stimulated as stated above. 
After 24 hrs of incubation, cells were harvested 
and stained with anti CD69 antibody along with 
either anti CD8 or anti CD4 antibody for OT-1tg 
and ANDtg T cells respectively. CD25 
expression was measured after 48 hrs of 
stimulation. 
ii. TCR downmodulation: Cells were 
stimulated with peptide loaded APCs or anti 
CD3 antibody for 3 hrs. Cells were harvested 
2.4. Flow cytometry
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and stained with anti-TCR antibodies. The. 
percentage of TCR downmodulation was 
calculated by dividing the corresponding MFI 
value of the TCR staining of the stimulated 
cells by the MFI value of non-stimulated cells 
and multiplying by 100. 
iii. IFNγ expression: For detection of 
intracellular IFNγ, cells were treated with 2.5 
µg/ml BFA during the last 4hrs of culture. Cells 
were then surface-stained before fixation and 
permeabilization with a commercially available 
kit (BD Pharmingen), followed by staining with 
saturating amounts of an APC-coupled anti-
murine IFNγ mAb (Miltenyi).  
 
 
Thymocytes were obtained by 
disaggregation of thymus and resuspended at 
10x106cells/ml in RPMI medium without FCS, 
and starved for one hour at 37ºC before start 
of the experiment. 100 µl of thymocytes 
suspension was then added to the top 
chamber of a 5 µM pore polycarbonate 
transwell chamber (coaster, corning,NY). 
Which was then placed in the bottom chamber 
containing 0.4µg/ml SDF1-α (Preproptech) 
After 3hrs of incubation at 37ºC, cells were 
harvested from the upper and lower wells and 
counted. In case of stimulation, 5μg/ml anti 
CD3ε antibody was added to the top chamber 
at the start of at the start of migration. 
Migration was expressed as the % of cell 
input.
3. Protein Biochemistry 
 
Whole thymus was lysed directly in 
0.33% v/v Brij96 lysis buffer (150mM NaCl 
,20mM Tris HCl pH7.8, 20mMNaF, 1mM 
Na3VO4, leupeptin, aprotinin and PMSF) 
using a dounce homogenizer. and incubated 
on ice for 45 minutes. The cell lysate was 
centrifuged at maximum speed at 4ºC for 15 
minutes in a microfuge and the supernatant 
was transferred to a clean tube. 2B4 cells and 
MA5.8 cells were lysed by addition of Brij 96 
lysis buffer to the cell pellet. 
Protein concentration in whole lysates 
was determined using a BCA kit (Thermo 
scientific) according to the manufacturer’s 
instruction. For SDS-PAGE analysis of whole 
lysates, the required amount of lysate was 
mixed with the appropriate volume of 
concentrated sample buffer and boiled. 
Alternatively whole lysates were mixed with an 
equal volume of cold acetone and incubated 
for 20 minutes on ice. and centrifuged for 20 
minutes at 4ºC. The supernatant was 
discarded and the pellet was resuspended in 
sample buffer. Samples were boiled for 5 
minutes at 95ºC, and then stored at -20ºC, or 
loaded directly on SDS-PAGE. 
For imunoprecipitacion lysates were 
cleared through preincubation with the 
sepharose beads for 1 hr. Then 2 μg of 
specific antibody was added to the lysates 
which were incubated for overnight at 4ºC on 
the rotating wheel. 30 μl sepharose A/G beads 
were added and incubated for 1 hr on a 
rotating wheel at 4ºC. IPs was washed 3 times 
with cold lysis buffer. After the final wash, 
beads were resuspended in either reducing or 
non reducing sample buffer. Samples were 
2.5. T cell migration assay
3.I. Whole lysate and immunoprecipitation
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boiled for 5 minutes at 95ºC, and then stored 
at -20ºC, or loaded directly on SDS-PAGE. 
 
 
Protein samples were separated by 
SDS-PAGE. Samples were prepared with 
reducing or non-reducing sample buffer, boiled 
for 10 min at 95ºC and run on 10% or 12% 
gels, depending on the experiment and the 
size of the protein (s) of interest. Gel system 
from BIO-RAD was used for electrophoresis. 
Subsequently, proteins were transferred by 
wet blotting to nitrocellulose (Bio Rad) or 
PVDF membranes (Millipore). membranes 
were incubated in 10% skimmed milk in 
PBS/Tween for 1 hour at RT. For detection of 
specific proteins, membranes were then 
incubated in an antibody dilution (normally in 
5% skimmed milk) overnight at 4ºC. 
Membranes were washed with wash buffer 
(PBS/Tween) and then incubated with the 
appropriate HRPO coupled secondary 
antibody dilution for 1 hr at RT. Membranes 
were washed 3x15 minutes in wash buffer 
followed by detection by enhanced 
chemiluminescence detection system (ECL, 
BIO RAD). 
 
3.3. Antibody array  
 
Detergent extracts were prepared by 
lysing thymuses in brij-lysis buffer containing 
protease and phosphatase inhibitors. Signal 
transduction antibody array (Hypromatrix) 
were blocked for 1 hour at RT in 5% skimmed 
milk in TBST (150 mM NaCl, 25mM Tris, 
0.05%Tween-20, pH7.5) and then incubated 
with whole lysates for 2hrs at RT on shaker. 
Arrays were washed 3x15 minutes with TBST 
and incubated with the appropriate biotinylated 
antibodies for 2 hrs at RT. After washing, the 
arrays were incubated with HRPO-conjugated 
streptavidin and developed through ECL 
system. 
 
 Single cell suspensions of thymocytes 
were prepared in PBS+0.1%BSA and stained 
with anti-CD8 antibody. Stained cells were 
then incubated with anti-rat IgG-conjugated 
magnetic beads (Dynal, Invitrogen) according 
to the manufactrer’s instruction for 45 min. at 
4ºC. Bead bound and unbound cells were 
separated by a magnetic field and separately 
lysed in Brij 96 lysis buffer. Efficiency of 
purification was established by staining an 
aliquot of the cells just after labeling with the 
biotynylated anti-CD8 antibody and aliquot of 
the unbound cells with fluorescently labelled 
anti-CD4 antibody and strepatvidin and 
analysed by flow cytometer. 
 
 
 
Thymuses were isolated from mice 
and fixed in 4% paraformaldehyde (in PBS) at 
RT for 2hrs. They were then incubated in 30% 
sucrose at 4ºC for 16hrs. They embeded in 
OCT (Tissue-Tek, Sakura) and frozen at -70ºC 
Cryostat sections of 10µm were obtained by 
using a 2800 Frigocut cryostat (Leica) and 
adhered on glass slides previously treated with 
gelatine solution. The sections were then 
stored at -20ºC until they were used for 
staining. 
For staining, glass slide containing 
thymic sections were allowed to thaw for 30 
minutes at RT. The sections were fixed again 
3.2. SDS-PAGE and western blotting (WB)
3.4. Cell separation through magnetic 
beads 
4. Microscopy
4.1. Immunohistochemistry 
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with 4% paraformaldehyde for 10 min at RT, 
and quenched with 20mM NH4Cl .They were 
then blocked for 1hour with TNB (100mM Tris-
HCl, pH7.4, 300mM NaCl, 0.25% triton-x100, 
10% FBS) and incubated with primary 
antibody at a dilution of 4μg/ml in TNB for 16h 
at 4ºC or 2hrs at room temperature in a humid 
chamber. They were incubated with 
fluorescently conjugated secondary antibodies 
in TNB for 1 hr at RT. Nucleus were stained 
with topro dye. Sections were mounted in 
DAKO mounting medium.  
Samples were visualized on a 
confocal LSM510 Meta laser scanning 
microscope (Zeiss) at 40x magnification, with 
the pinhole adjusted to a 1.5-μm section. 
Detectors were set to obtain the optimal 
signals below saturation. Images were 
analyzed with the LSM 5 Image Browser and 
imageJ software.  
 
Immunogold labeling, replica preparation 
and EM analysis: 
 Immunogold labeling and cell surface replica 
preparations were performed as previously 
described (Pinto da Silva and Kan, 1984; 
Schamel et al., 2005). In brief, T cell 
preparations were washed in PBS and fixed in 
1% paraformaldehyde, followed by labeling 
with the anti-human CD3 mAb OKT3 or the 
anti-murine CD3ε mAb 145-2C11 (both 
purified from hybridoma supernatants in the 
laboratory) and 10nm gold-conjugated protein 
A (Sigma-Aldrich, St. Louis, MO). Labeled 
cells were adhered to poly-L-lysine-coated 
mica strips and post-fixed with 0.1% 
glutaraldehyde. Samples were covered with 
another strip of mica and frozen in liquid 
propane via plunge freezing. Frozen 
sandwiches were split in liquid nitrogen and up 
to four of the original mica strips were mounted 
at the same time on the sample table of a 
Balzers BAF400 freeze fracture apparatus 
submerged in liquid nitrogen (for a detailed 
description of this apparatus and relevant 
protocols see Severs, 2007 (Severs, 2007)). 
Samples were rapidly transferred to the liquid 
nitrogen-cooled BAF400 apparatus, followed 
by freeze etching under vacuum conditions to 
remove excess of water. Samples were 
shaded with platinum and coated with carbon 
according to experimentally optimized 
conditions (175 Hz of Pt, 350 Hz of C), 
followed by warming to room temperature. 
Samples were removed from the BAF400 
apparatus, and floated on domestic bleach 
solution. After overnight digestion of organic 
material in the bleach solution, replicas were 
extensively washed in distilled water and 
mounted on Ni/Cu grids. Replicas were 
analyzed via transmission electron microscopy 
on a JEOL 1010 microscope operated at 80kV. 
 
4.2. Confocal microscopy 
4.3. Electron Microscopy 
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We have previously shown that the 
TCR complexes in resting human peripheral 
blood T cells and human and murine T cell 
lines is expressed on the cell surface as a 
combination of monomeric TCRs and TCR 
oligomers of different sizes (Schamel et al., 
2005). The oligomeric TCR complexes are 
preferentially activated upon stimulation with 
small amounts of antigen, suggesting that they 
provide T cells with their high sensitivity. Since 
antigen experienced T cells are 
characteristically more sensitive to antigen, we 
therefore analyzed whether previously 
stimulated and memory T cells, were enriched 
for oligomeric TCR complexes at the cell 
surface. We furthermore generated a mutant in 
CD3ζ that impaired oligomeric TCR formation 
in order to provide direct evidence that 
oligomeric TCR complexes provide T cells with 
greater sensitivity. 
 
 
We prepared cell surface replicas from 
anti-CD3 labelled fresh human peripheral 
blood T lymphocytes and peripheral blood 
lymphoblast. Lymphoblasts were generated 
after stimulation for 2 days with PHA and 
expansion for three more days in fresh 
medium containing IL-2. Analysis by electron 
microscopy of replicas of individual cells 
showed the co-existence of single gold 
particles and clusters of gold particles on the 
surface of both freshly isolated and PHA 
activated peripheral blood lymphocytes (2Figure 
11 A). 
 
 
 
 
Figure 11: Distribution of TCRs on 
PHA-stimulated and freshly isolated 
human peripheral blood T cells.  
A) High magnification images 
(100.000x) of replicas showing 
distribution of gold particles on the cell 
surface (scale bar: 50 nm).  
B) Quantification (mean +/- SD) of 
distribution of gold particles between 
clusters of the indicated sizes for 
freshly isolated (grey bars) and PHA-
stimulated (black bars) human T cells. 
Inset shows the distribution of gold 
between clusters of 1, 2, 3, 4, or more 
particles and statistical analysis 
(Student’s T test: * p<0.05; ** p<0.01; 
*** p<0.001). Replicas of 19 PHA-
activated T cells (9414 particles) and 9 
freshly isolated T cells (2707 particles) 
were counted. 
 
 
RESULTS 
1. Section 1
1.1. Increase in the percentage and size of 
oligomeric TCR complexes on previously 
stimulated and memory T cells 
       
 
52
Results 
However, quantitative analysis 
showed that the previously stimulated cells 
had an increased percentage of larger TCR 
oligomers as compared to the freshly isolated 
cells (2Figure 11B), indicating that the T cell 
stimulation leads to a change in distribution of 
the TCR complexes that lasted for days after 
the stimulating agent had been removed. 
We also isolated naïve and memory 
CD4+ T cells from spleen and lymph nodes of 
C57BL/6 mice based on their reciprocal 
CD62L and CD44 expression pattern (Budd et 
al., 1987; Lee and Vitetta, 1991) via a 
depletion strategy in which only 
CD4+CD44loCD62Lhi (mostly naïve) or 
CD4+CD44hiCD62Llo (mostly memory) T cells 
were spared ( 2Figure 12A, left and middle panel 
respectively). The CD4+CD44hiCD62lo T cells 
were resting T cells, as indicated by the 
observation that their size was similar to the 
size of the CD4+CD44loCD62hi T cells (2Figure 
12A, right panel). 
 
A
 
 
Figure 12: Distribution of oligomeric TCR complexes on murine CD62LhiCD44lo and CD44hiCD62Llo CD4+ T cells. 
A) Enrichment of CD62Lhi and CD44hi CD4+ T cell populations. The overlay plot shows the FSC profiles of the CD62Lhi and 
CD44hi CD4+ T cells.  
B) High magnification images (100.000x) of replicas of the cell surface of CD62Lhi and CD44hi CD4+ T cells (scale bar: 100 nm). 
C) Quantitative (mean +/- SD) analysis of distribution of gold particles between clusters of the indicated sizes for CD62Lhi (grey 
bars) and CD44hi (black bars) CD4+ T cells. The inset shows the distribution between clusters of 1, 2, 3, 4, or more particles 
and statistical analysis (* p<0.05; ** p<0.01; *** p<0.001). Quantification of 5 replicas of CD62Lhi cells (2718 particles) and 5 
CD44hi cells (3198 particles) is represented. 
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This suggested that these were true 
memory cells and not recently activated 
CD44hi T cells. Both T cell populations were 
fixed and labeled with the anti-CD3 mAb 145-
2C11, followed by labeling with gold-
conjugated protein A and preparation of cell 
surface replicas. Quantitative analysis of the 
replicas showed an increased percentage of 
gold particles forming part of large oligomeric 
clusters on the population enriched for 
memory T cells, as compared to the naïve 
population (2Figure 12B and C). Thus, 
polyclonal CD4+ memory T cells, that were 
activated under completely physiological 
conditions, i.e. not by experimentally 
administered antigens, had more and larger 
TCR oligomers on the cell surface than naïve 
CD4+ T cells. 
 
In order to establish a causal 
relationship between TCR oligomers and 
sensitivity to antigen, we wished to design 
mutants of the TCR or the CD3 chains that 
could impair oligomer formation. CD3ζ 
appeared to be a promising candidate based 
on a biophysical study in which it was shown 
that peptides representing the transmembrane 
region of this molecule could form both dimers 
and tetramers (Torres et al., 2002). 
Importantly, the same study defined amino 
acid residues within the transmembrane region 
that selectively showed high interaction energy 
within the tetramers (2Figure 13A). 
 
 
 
Figure 13: Transmembrane region of CD3ζ. A) Comparison between the transmembrane sequences of CD3ζ in different 
species. Non-conserved residues are inside boxes and residues with high interaction energy in dimer and tetramer are 
represented by open and filled circles, respectively (Torres et al., 2002) 
B) Representation of the transmembrane sequences of WT, L9A, and L19A CD3ζ. The alanine substitution are shown in bold, 
while residues implicated in tetramer formation are shown in blue. C) Representation of the transmembrane region of the CD3ζ 
dimer, as determined via NMR. (Call et al., 2006). The alpha-helix forming backbone of the amino acids is shown as a ribbon 
diagram with all amino acids implicated in tetramer formation represented in blue and with side chain residues as lines.. The L9 
and L19 residues are indicated and their side chains are represented as stick. 
 
1.2. Design and generation of mutations in 
the TCR complex to impair TCR oligomer 
formation 
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Out of these residues we chose to 
mutate two leucines in position 9 and 19 of the 
transmembrane region into alanines (L9A and 
L19A mutants, (2Figure 13B), as these leucine 
residues (i) had high interaction energy only in 
the tetramer structure, (ii) appeared to be in 
small islets of residues with high interaction 
energy in the tetramer (2 out of 3 surrounding 
residues for the leucine in position 9 [L9] and 3 
out of 4 surrounding residues for the leucine in 
position 19 [L19]), (iii) were conserved among 
species and (iv) had long amino acid side 
chains that should have a higher probability of 
interacting with neighboring molecules. 
In the course of the generation of L9A 
and L19A mutant CD3ζ chains, the structure of 
the transmembrane domain of the CD3ζ dimer 
was published (2Figure 13C). This structure 
indicated that the CD3ζ dimer formed a 
perfectly symmetrical unit, with most of the 
residues implicated in tetramer formation 
forming an interface outwards of the dimer 
(2Figure 13C bottom view, blue coloured amino 
acid residues). These residues were thus 
potentially in a position to interact with a 
neighbouring CD3ζ dimer or with other 
molecules. The L19 residue was one of these 
residues pointing out, in a position favourable 
to form contacts with other proteins. However, 
the L9 residue appeared to be involved in 
hydrophobic interactions between the two 
transmembrane regions of the CD3ζ dimer. 
 
 
Wild type (WT), L9A or L19A CD3ζ 
chains were transfected into the CD3ζ-
deficient MA5.8 cell line, which is derived from 
the murine T hybridoma 2B4, specific for a 
moth cytochrome c (MCC)-derived peptide 
(Sussman et al., 1988). Pools of transfectants, 
expressing these CD3ζ chains, were analyzed 
for their ability to express the TCR complex at 
the cell surface (2Figure 14A). Transfectants 
expressing the L19A CD3ζ chains 
reconstituted expression of the TCR complex 
at the cell surface to a level similar to 
transfectants expressing wild type CD3ζ and to 
the parental 2B4 line. However, the L9A CD3ζ 
mutant only partially reconstituted cell surface 
expression of the TCR complex which 
coincided with the effect of this mutation in 
dimer formation (Call et al., 2006). 
 
 
Figure 14: Analysis of CD3ζ mutant. A) Flow cytometric measurement of CD3ε expression by MA5.8 cells (filled grey 
histogram), 2B4 cells (dashed black line), and MA5.8 cells transfected with wild type CD3ζ (grey line), L9A CD3ζ (dashed grey 
line) and L19A CD3ζ (black line).  
B) Association between wild type or L19A CD3ζ chains and CD3ε complexes. Whole lysates or immunoprecipates of the 
indicated antibodies were run on non-reducing SDS gels, followed by immunoblotting with the indicated antibodies. 
 
1.3. Reconstitution of a CD3ζ deficient cell 
line with the L9A and L19A CD3ζ chains. 
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As the amount of TCR expressed at 
the cell surface could influence the distribution 
of the TCR and the sensitivity of T cells to 
antigenic stimuli, thereby complicating 
interpretation of the results, we excluded this 
mutant from further analysis and focused our 
attention on the L19A mutant. 
 
To check whether L19A CD3ζ formed 
homodimers and assembled correctly with the 
other components of the TCR complex, we 
performed immunoprecipitation and 
immunoblot experiments. Transfectants 
expressing the WT or L19A CD3ζ chain were 
lysed in the mild detergent Brij96 and whole 
lysates and immunoprecipitates with 
antibodies specific for the CD3ε and CD3ζ 
chains were separated by non-reducing SDS-
PAGE and transferred to nitrocellulose 
membranes. The membranes were 
sequentially probed with antibodies specific for 
CD3ζ and CD3ε (2Figure 14B). WT and L19A 
CD3ζ transfectants expressed equal amounts 
of the respective CD3ζ chains, formed 
homodimers and were capable of associating 
with the other CD3 components to a similar 
extent. 
 
 
WT and L19A CD3ζ transfectants 
were then immuno-labelled with an anti CD3ε 
antibody and with 10 nm gold-conjugated 
protein-A. 
  
Figure 15: A mutation in the transmembrane 
region of CD3ζ impairs oligomeric TCR formation. 
A) High magnification images (100.000x) of cell 
surface replicas of MA5.8 cells transfected with wt ζ 
and mutated L19A ζ (scale bar: 100 nm) showing 
distribution of gold particles.  
B) Quantification (mean +/- SD) of distribution of TCR 
complexes in oligomeric clusters in MA5.8 cells 
reconstituted with wild type (black bars) or L19A CD3ζ 
(grey bars). Inset shows distribution of gold particles 
between clusters of 1, 2, 3, 4 or more particles and 
statistical analysis (* p<0.05; ** p<0.01; *** p<0.001). 
Quantification of replicas of 15 WT CD3ζ reconstituted 
cells (12041 particles) and 21 L19A CD3ζ 
reconstituted cells (8348 particles) is shown. 
 
 
 
 
 
 
 
 
 
1.4. The L19A CD3ζ chain impairs 
oligomeric TCR formation 
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Analysis of cell surface replicas by 
electron microscopy showed that over 50% of 
the gold particles in WT CD3ζ transfectants 
were detected as clusters, and about 15% 
were in clusters larger than 3 particles 
reaching a size of up to 17 gold particles 
(2Figure 15A and B). In sharp contrast, in L19A 
CD3ζ transfectants barely any gold cluster 
bigger than 3 particles were observed (~1%), 
with the largest clusters reaching only 6 
particles. Hence the L19A CD3ζ chain 
impaired the organization of the TCR into 
oligomeric complexes without affecting the 
TCR expression level at the cell surface or its 
association with the other CD3 chains. 
 
 
WT and L19A CD3ζ transfectants 
were stimulated with graded amounts of MCCp 
presented by the DCEK cell line. After 24 hrs 
the transfectants were analyzed for expression 
of CD69 and after 48hrs they were stained 
intracellularly to determine IFNγ production. 
L19A CD3ζ transfectants were able to respond 
to the stimulus showing that the mutation did 
not affect signaling per se, but they needed 
much higher amounts of the antigen than WT 
transfectants to reach a similar level of IFNγ 
production and did not reach the level of CD69 
expression by WT transfectants at the 
amounts of antigen tested (2Figure 16). 
Thus, a mutation in CD3ζ that 
diminished the formation of TCR oligomers, 
without affecting the level of expression of the 
TCR at the cell surface, reduced sensitivity of 
T cells to antigen stimulation. This showed that 
oligomeric TCR complexes endow T cells with 
high sensitivity to antigen. 
 
 
 
 
 
 
Figure 16: Impairment of oligomeric TCR complex formation reduces sensitivity to antigenic stimulation. MA5.8 cells 
reconstituted with WT (black circles) or L19A (open circle) CD3ζ were stimulated with the indicated amounts of MCCppresented 
by DCEK and A) CD69 induction and B) IFNγ production were measured at 24 and 48hrs, respectively. 
 
 
1.5. L19A CD3ζ transfectants have reduced
antigen sensitivity  
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We wished to determine the potential 
role of oligomeric TCR complexes during T cell 
differentiation and activation in-vivo. We chose 
to transduce bone marrow precursors from 
CD3ζ deficient mice (Love et al., 1993) with 
lentiviral vectors coding for the WT and L19A 
CD3ζ chain and to use these transduced bone 
marrow cells to reconstitute irradiated recipient 
mice. To facilitate this analysis we also 
decided to use CD3ζ-deficient bone marrow 
precursors that were also transgenic for the 
OT-1 TCR (OT-1tg), specific for an ovalbumin 
derived peptide (OVAp) presented by the H2Kb 
molecule (Hogquist et al., 1994). Finally, we 
decided to generate fusion proteins of WT and 
L19A CD3ζ with GFP, in order to be able to 
unequivocally detect cells transduced with the 
WT or L19A CD3ζ chains in the reconstituted 
animals. 
 
Verification of CD3ζ-GFP fusion proteins: 
MA5.8 cells were transduced with lentiviral 
vectors coding for the WT or L19A CD3ζ-GFP 
chains.The GFP fusion proteins were tested 
for their ability to restore cell surface 
expression of the TCR and for their capacity to 
associate with the other TCR components 
(2Figure 17A and B).Both WT and L19A CD3ζ-
GFP chains reconstituted cell surface 
expression of the TCR to a similar extent and 
were capable of associating with the other 
TCR components.  
 
 
Figure 17: Generation of GFP-linked wild type and L19A CD3ζ chains. A) Cell surface expression of the TCR complex in 
MA5.8 cells transduced with wild type and L19A CD3ζ-GFP chains. 2B4 cells and MA5.8 cells reconstituted with GFP only are 
included as controls. Cells were surface-stained with a mAb against CD3ε and signals for both this staining and GFP were 
measured by flow cytometry. Note that both constructs are able to rescue TCR cell surface expression to a similar extent and 
that they quantitatively associate with CD3ε.  
B) Biochemical analysis of homodimer formation by wild type and L19A GFP-linked CD3ζ and their capacity of interaction with 
TCRαβ and CD3ε. Whole lysates (WL) and immunoprecipitates of the anti-TCRβ mAb H57.597 or the anti-CD3ζ serum of 
Brij96-solubilized cells were separated by non-reducing SDS-PAGE and immunoblotted with the indicated antibodies. 
1.6 Analysis of oligomeric TCR complexes
in vivo. 
       
 
58
Results 
  
Figure 18: Reduced oligomeric TCR formation and 
reduced antigen sensitivity of GFP linked L19A CD3ζ 
reconstituted MA5.8 cells. A) Quantification (mean +/- 
SD) of the distribution of TCR complexes on the cell 
surface of MA5.8 T cells reconstituted with wild type or 
L19A GFP-linked CD3ζ chains. The inset shows the 
distribution of gold particles between clusters of 1,2,3,4 or 
more gold particles and the statistical analysis (* p<0.05; ** 
p<0.01; *** p<0.001). Quantification of 6 WT CD3 ζ-GFP 
reconstituted cells (5375 particles) and 6 L19A CD3 ζ-GFP 
reconstituted cells (6462 particles) is shown. 
 B) Production of interferon-γ by reconstituted MA5.8 cells 
upon stimulation by DCEK cells loaded with the indicated 
amounts of the MCCp (black circles: wild type GFP-linked 
CD3ζ; open circles L19A GFP-linked CD3ζ). 
 
 
However, as observed for the L19A 
CD3ζ transfected cells, L19A CD3ζ-GFP 
expressing cells were less sensitive to 
antigenic stimulation and had fewer and 
smaller oligomeric complexes at the cell 
surface than WT CD3ζ-GFP expressing cells 
(2Figure 18A and B). The L19A GFP-fusion 
protein could therefore be used to study the 
role of oligomeric TCR complexes in-vivo. 
 
 
Bone marrow cells isolated from OT-
1tg, CD3ζ-deficient mice were transduced with 
lentiviral vectors encoding for WT or L19A 
mutant CD3 ζ-GFP chains, or GFP alone and 
inoculated into sub-lethally irradiated B6 
recipients. Four to six weeks after 
reconstitution, the ability of WT and L19A 
mutant CD3ζ-GFP expressing bone marrow 
precursors to reconstitute both thymic and 
peripheral T cell populations was compared. 
Wild type and L19A CD3ζ-GFP 
expressing thymocytes differentiated similarly 
into CD8 SP thymocytes, while GFP 
expressing thymocytes did not differentiate 
beyond the DP stage ( 2Figure 19A). This 
showed that differentiation beyond the DP 
stage was dependent on expression of the WT 
or L19A CD3ζ-GFP chains, and that the L19A 
CD3ζ-GFP protein permitted the TCR 
signaling necessary for positive selection. 
Consistent with normal thymic differentiation, 
both WT and L19A CD3ζ-GFP expressing 
CD8+ OT-1tg T cells were found in peripheral 
lymphoid organs (2Figure 19B). These cells had 
similar amounts of the TCR at the cell surface, 
and their expression of CD69, CD25, CD28, 
LFA-1, CD44 and CD62L was very similar to 
that observed on control OT-1tg T cells,
4.1.7. T cell differentiation in L19A CD3ζ-
GFP reconstituted mice 
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indicating that they were naïve, resting T cells. 
Thus, the L19A CD3ζ chain permitted normal 
differentiation of OT-1tg T cell precursors into 
naïve CD8+ T cells, suggesting that oligomeric 
TCR complexes did not play an essential role 
in OT-1tg T cell differentiation or that such 
complexes were not present on these T cell 
precursors. 
 
 
 
Figure 19: The role of oligomeric TCR complexes in thymic development. A) Differentiation capacity of thymocytes from 
CD3ζ-deficient, OT-1tg bone marrow precursors transduced with the indicated constructs.  
B) Expression of the L19A CD3ζ-GFP chain allows generation of naive OT-1tg CD8+ T cells. Overlay plots show expression of 
the indicated molecules on Vα2+ cells of OT-1tg mice (shaded histogram) and Vα2+GFP+ cells from wild type (dashed black 
line) and L19A (grey line) CD3ζ-GFP reconstituted animals. 
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WT and L19A CD3ζ-GFP expressing 
naïve OT-1tg T cells were stimulated overnight 
with OVAp-loaded macrophages to test their 
sensitivity to antigen. These cells showed 
equal OVAp dependent up-regulation of CD69 
(2Figure 20), indicating that they were equally 
sensitive to TCR stimulation. 
 
Figure 20: Activation of naive wild type and L19A 
CD3ζ.GFP reconstituted T cells. WT (black circles) or 
L19A (open circles) CD3ζ.GFP -expressing peripheral T 
cells (naïve).Cells were stimulated overnight with OVAp-
loaded macrophages and CD69 expression was 
measured via flow cytometry. 
 
We also stimulated these cells for 2 
days with OVAp and expanded them for five 
more days in fresh medium supplemented 
with. IL2. At this point both cultures consisted 
almost exclusively of GFP+CD8+ T cells that 
expressed similar amounts of the TCR at the 
cell surface (2Figure 21A). However, when we 
compared the response of these in-vitro 
activated and expanded WT and L19A CD3ζ-
GFP expressing OT-1tg T cells, we observed a 
clear difference in response to antigen 
stimulation. L19A CD3ζ-GFP expressing cells 
responded worse in terms of CD69 expression 
and IFNγ production than their WT CD3ζ-GFP 
expressing counterparts (2Figure 21B and C). 
This suggested that impairement of oligomeric 
TCR complex formation reduced the sensitivity 
of previously activated T cells. 
 
 
Figure 21: A) TCR expression of lymphoblast generated 
from transduced T cells.  
Antigen sensitivity of previously activated WT and 
L19A CD3ζ-GFP reconstituted T cells B&C: Previously 
stimulated WT (black circle) and L19A (open circle) CD3ζ-
GFP reconstituted OT-1tg T cells were restimulated in-vitro 
with B) OVAp loaded macrophages or C) kb-OVA 
tetramers and expression of CD69(B) and production of 
IFNγ (C) was measured 24hrs later by flow cytometry. 
 
 
To establish whether the difference in 
sensitivity of the previously stimulated L19A 
CD3ζ-GFP expressing OT-1 T cells was
1.8. L19A CD3ζ reconstituted OT-1tg T 
cells show a weaker response upon
restimulation than WT CD3ζ
reconstituted cells  
1.9. Expression of the L19A CD3ζ-GFP 
chain disrupts oligomeric TCR complex 
formation in previously stimulated OT-1tg T 
cells. 
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indeed due to a difference in the number and 
size of oligomeric TCR complexes, we labeled 
part of these cells with CD3-specific antibodies 
and 10nm gold-conjugated protein A and 
prepared cell surface replicas. Analysis of the 
cell surface replicas of the previously 
stimulated WT and L19A CD3ζ-GFP 
expressing OT-1tg T cells showed a significant 
reduction in the number and size of the 
oligomeric TCR complexes in the L19A CD3ζ-
GFP expressing cells (2Figure 22).This showed 
that the reduced sensitivity of the previously 
stimulated L19A CD3ζ-GFP reconstituted T 
cells indeed correlated with reduction in the 
number and size of oligomeric TCR 
complexes.  
Together these data indicated that the 
role of oligomeric TCR complexes in-vivo was 
most pronounced in cells that had received 
previous antigenic stimulation; in line with the 
observation that these complexes are enriched 
in previously stimulated and memory T cells. 
 
 
 
 
 
 
Figure 22: Distribution of 
TCR complexes on 
previously activated WT 
and L19A CD3ζ-GFP 
expressing T cells. 
A) High magnification 
images (100.000x) of cell 
surface replicas of 
transduced T cell blasts 
showing distribution of gold 
particles on the cell surface. 
(Scale bar-100nm)  
B) Quantification (mean +/- 
sem) of distribution of TCR 
complexes on the cell 
surface of T cell blasts 
expressing WT (black bars) 
or L19A (grey bars) CD3ζ-
GFP chains. Inset shows 
distribution of gold particles 
between clusters of 1, 2, 3, 
4 or more particles and 
statistical analysis  
(* p<0.05; ** p<0.01; *** 
p<0.001).Quantification of 7 
WT CD3-ζ GFP 
reconstituted cells (3137 
particles) and 7 L19A CD3-ζ 
GFP reconstituted cells 
(4257 particles) is shown. 
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We hypothesized that the capacity of 
the TCR-CD3 complex on thymocytes to 
differentially activate downstream signaling 
pathways in function of the strength of 
interactions with its pMHC ligands depended 
on the differential association with other 
proteins involved in signal production. We 
decided to perform a biochemical screen for 
such proteins, and therefore developed a 
dynamically controlled murine model of T cell 
differentiation that would allows us to obtain a 
large number of DP thymocytes undergoing 
positive or negative selection in-vivo. This 
model system should enable us to perform the 
biochemical screen for such differentially 
associating proteins, without the need of 
extensive purification of this population ex-
vivo. One of the major advantage of such a 
model should be the better conservation of 
protein-protein associations or signaling-
induced protein modifications in T cells, which 
have been shown to be dependent on 
continued contact of the TCR with the pMHC 
molecules (Germain et al., 2002). Moreover, 
the ability to enrich for the populations actively 
undergoing positive or negative selection 
should facilitate the detection of differential 
TCR signaling during these events.  
 
The basis of our model is a double 
transgenic mouse line in which expression of a 
recombinant reporter gene encoding for a 
strong T cell agonist can be regulated by a 
tetracycline (tet) sensitive transactivator 
expressed under control of a tissue specific 
promoter (Kistner et al., 1996; van Santen et 
al., 2004). The reporter gene, TIM codes for a 
MHC class II associated invariant chain (Ii) in 
which the CLIP region is replaced by the 
minimal moth cytochrome c (MCC) derived T 
cell epitope (ANERADLIALKQATK) under 
control of a minimal CMV promoter and 7 TetO 
sequences (2Figure 23A) (van Santen et al., 
2004). Ii associates with MHC class II 
molecules upon cotranslational translocation 
into the ER and the CLIP region embeds itself 
in the peptide binding groove of the MHC class 
II molecule, thereby preventing that the MHC 
class II molecule bind peptides in the ER. Ii 
directs the MHC class II molecules to the 
endocytic route, where Ii is degraded by the 
resident proteases. Removal of the CLIP 
region from the peptide binding groove is 
catalysed by the the DM complex, allowing the 
MHC class II molecule to bind peptides 
generated in the endocytic route and to 
present these peptides at the cell surface to 
CD4+ T cells (Pieters, 2000). Removal of the 
CLIP by the DM complex is not complete and 
upto 10% of the MHC class II molecules at the 
cell surface present CLIP (Eastman et al., 
1996). It has been shown previously that by 
changing CLIP for the desired MHC class II 
binding peptide one can efficiently obtain MHC 
class II molecules presenting these peptides at 
the cell surface (Nakano et al., 1997). The TIM 
construct therefore permits efficient 
presentation of the MCC peptide by the MHC 
class II complexes. Expression of the TIM 
gene is controlled by the TA gene, consisting 
of the tet sensitive transactivator (‘tet-off’) 
under control of a MHC class II promoter 
(2Figure 23A). In the TA transgenic line used in 
these studies, expression of the transactivator 
is restricted to stromal cells of the thymus (van 
Santen et al., 2004; Witherden et al., 2000). 
Binding of the transactivator to the regulatory  
2.Section 2
2.1. Development of a dynamic in-vivo
model of synchronous T cell differentiation
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Figure 23: Animal model: A) The TANDRAG line consists of a negative selection-inducing pMHC ligand (TIM) whose 
expression can be controlled in vivo via a tetracycline (tet)-regulated gene expression system (TA) (van Santen et al., 2004)).  
B) This ligand is specifically recognized by AND TCR-transgenic thymocytes and T cells. As in almost all other TCR-transgenic 
models, the AND TCR is already expressed at the CD4-CD8- double-negative (DN) pre-selection stage, and differentiation is 
blocked at this stage due to premature induction of apoptosis (compare CD4 vs. CD8 profiles of TIM- (left plot) and TIM+ (right 
plot) animals, and the overlay showing TCR expression on the DN populations in these mice ). 
 
 
sequences upstream of the reporter gene 
allows transcription of the reporter gene. When 
tetracycline binds to the transactivator, it 
induces a conformational change in the 
transactivator that inhibits its binding to the 
regulatory sequences of the reporter gene and 
thereby abrogates its expression (2Figure 23A). 
We crossed these double transgenic mice with 
mice transgenic for the AND (ANDtg) TCR, 
recognizing the MCC epitope bound to the 
MHC class II I-Ek molecules (Kaye et al., 
1989). We brought the resulting line onto a 
RAG1 deficient background (Mombaerts et al., 
1992), thereby assuring that the T cells could 
only express the ANDtg TCR. Thymocytes in 
such mice (reffered to as TANDRAG) did not 
differentiate beyond the DN stage (2Figure 23 
B).This is due to recognition of the MCC 
epitope by the prematurely expressed ANDtg 
αβ TCR complexes on this population (2Figure 
23B). 
 
I. Optimization of the model to obtain DP 
thymocytes undergoing positive selection: 
 
Treatment of TANDRAG mice with tet 
in the drinking water allowed the DN 
thymocytes to differentiate over the next 4-6 
days into DP thymocytes and during the 
following 4 days into fully mature CD4 SP 
thymocytes that expressed a high level of the 
ANDtg TCR and downmodulated CD24 (2Figure 
24, top row and bottom row). This showed that 
the model recapitulated the expected 
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differentiation pattern from DN thymocytes via 
DP into CD4 SP thymocytes. DP thymocytes 
at day 6 of tet treatment were clearly in the 
process of increasing expression of the TCR 
complex and CD5 at the cell surface, indicative 
of a successfully undergoing positive selection 
process (2Figure 24,bottom row) (Huesmann et 
al., 1991). At this point few CD4 SP 
thymocytes were present, avoiding excessive 
contribution of this population to our planned 
screen. We therefore chose as a source of DP 
thymocytes undergoing positive selection 
TANDRAG animals treated for 6 days with tet. 
 
 
 
 
 
Figure 24: System optimization: positive selection. When mice transgenic for the AND TCR and the 
components of the tet-regulated pMHC ligand (referred to as TANDRAG mice) receive tet (administered via 
their drinking water), expression of the high affinity pMHC ligand is abrogated and the thymocytes differentiate 
over the course of the next 10 days, first into CD4+CD8+ double-positive (DP) thymocytes, and then into CD4+ 
single-positive (SP) thymocytes. The transition through these stages is accompanied by the typical changes in 
expression of other cell surface proteins, such as upregulation of the TCR complex and CD5 at the DP stage  
(middle panels, 6 day Tet) and downregulation of CD24 at SP stage. 
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II Optimization of the model to obtain DP 
thymocytes undergoing signaling events 
leading to negative selection: 
 
We first established whether 
reappearance of the MCC epitope led to 
physical deletion of DP thymocytes, the proof 
of successful negative selection. TANDRAG 
mice were treated for 6 days with tet-
containing drinking water to induce the 
maturation of DN precursors into DP 
thymocytes and were subsequently given 
normal drinking water for a period of 24, 36 or 
48 hrs. The mice were then sacrificed and 
thymuses were isolated. Thymocytes were 
analysed by flow cytometry to determine the 
effect of reappearance of the MCC epitope. In 
parallel a part of the thymus was analysed by 
quantitative PCR for the expression of TIM 
RNA. Withdrawal of tet resulted indeed in 
disappearance of DP thymocytes, starting at 
36 hrs after withdrawing tet (2Figure 25A). 
 
 
 
 
Figure 25: System optimization: negative selection A) Disappearance of double positive thymocytes after removal of 
tetracycline for different time periods. 
B) To obtain thymocytes receiving signals leading to negative selection, 6 day-treated mice were inoculated intravenously with 
a moth cytochrome c-derived peptide (MCCp) recognized by the AND TCR transgenic thymocytes. This allows rapid and 
homogenous formation of the pMHC ligands, in contrast to waiting until levels of Tet in the mice have lowered sufficiently to 
allow transcription of the tet controlled ligand and achieving a sufficient number of ligands at the cell surface to induce negative 
selection. TCR-CD3 interactions with pMHC complexes that lead to negative selection coincide with the appearance of a 
conformational change in the TCR-associated CD3ε chain, which can be detected by a conformation-dependent mAb Apa1/1 
(yellow dots) (Risueno et al., 2006).  
C) Analysis of histological sections of 6 day-treated thymi at various time points after peptide injection show that within two 
hours after peptide injection there is a strong increase in the number of DP cells positive for the conformational change 
(immuno-histological sections and graph). 
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For the purpose of our interactomic 
screen we needed to know when DP 
thymocytes were receiving TCR-mediated 
signals inducing negative selection, not when 
they were dying. We therefore decided to 
determine how much time after exposure to 
the MCC epitope the CD3ε chains of ANDtg DP 
thymocytes underwent a conformational 
change. This conformational change correlates 
with induction of negative selection, is one of 
the earliest indicators of the signaling leading 
to negative selection, and can be detected by 
immunohistochemistry with the conformation 
dependent mAb Apa1/1 (Risueno et al., 2006). 
We also decided not to use tet withdrawal as a 
means to re-introduce expression of the MCC 
epitope and provide the DP thymocytes with 
stimuli leading to negative selection. Instead, 
we chose to inoculate mice intravenously with 
synthetic MCCp. We reasoned that this would 
result in a rapid and homogenous formation of 
the pMHC ligands that induce the signals 
leading to negative selection, thereby creating 
a homogenous population of DP thymocytes 
receiving signals leading to negative selection 
at the same time. We feared that removal of 
tet from the drinking water of the mice would 
lead to a less homogenous and slower 
formation of these pMHC complexes, given 
that this strategy depended on a decrease of 
the concentration of tet in the mouse to a level 
that permitted re-expression of the TIM RNA. 
TANDRAG mice were treated for 6 
days with tet and were then inoculated with 
MCCp (100µg) through the tail vein. At various 
time points after inoculation, mice were 
sacrificed and their thymuses were isolated 
and processed for immunohistological 
analysis. Cryosections were labelled with an 
anti-CD8 antibody to identify the DP 
population, the nuclear marker topro to 
distinguish individual cells and the Apa1/1 
antibody to detect the conformational change. 
Labelled sections were analysed by confocal 
microscopy (2Figure 25B) and then quantified 
for Apa1/1 staining (2Figure 25C). An abrupt 
and significant increase in the percentage of 
CD8+ thymocytes that were labelled by the 
Apa1/1 antibody was apparent at two hours 
after MCCp administration. This percentage 
did not change significantly over the next hour, 
and we therefore decided to use thymuses 
from TANDRAG mice that had been treated for 
6 days with tet and had received MCCp 2 
hours before sacrifice as a source of DP 
thymocytes receiving signals leading to 
negative selection. 
 
TANDRAG mice were treated for six 
days with tet and were sacrificed two hours 
after intravenous inoculation with PBS or 
MCCp to obtain thymuses enriched for DP 
thymocytes undergoing positive or negative 
selection, respectively. Thymuses were 
isolated and the complete organs were directly 
extracted with the detergent Brij96 by Dounce 
homogenization. The Brij96 detergent is 
relatively mild and therefore more apt to 
conserve weak protein-protein interactions. 
Furthermore, it does not extract cholesterol 
from the membranes, thereby conserving the 
lipid rafts that have an important role as 
organizing platforms of intracellular signaling 
(Moran and Miceli, 1998; Viola et al., 1999).
2.2. A screen for proteins associating 
differentially with the TCR complex or 
showing differential tyrosine 
phosphorylation during positive and 
negative selection  
       
 
68
Results 
 We used antibody arrays that permit 
probing for interaction with 400 proteins 
implicated in signal transduction (2Figure 26) to 
search for proteins that interact differentially 
with the TCR complex during positive and 
negative selection. 
 
 
Figure 26: Antibody array: Schematic representation of 
the Ab-array system to identify new proteins in that are 
differentially phosphorylated or associated differentially 
with the TCR complex as a consequence of signals leading 
to positive or negative selection. (Adapted from 
Hypromatrix Antibody Array Instruction manual) 
 
In order to obtain the maximal amount 
of information from these experiments we 
decided not only to screen these arrays for 
differentially interacting proteins but also for 
proteins that were differentially phosphorylated 
on tyrosine residues during positive and 
negative selection. The antibody arrays were 
incubated in parallel with half of the detergent 
extract prepared from thymuses in condition of 
positive and negative selection, followed by 
incubation with a phosphotyrosine specific 
antibody (2Figure 27B). We performed a 
specificity control by incubating another set of 
arrays with the remaining half of detergent 
extract and labelling with the anti-
phosphotyrosine antibody in the presence of 
phenyl phosphate, which competes with 
phosphorylated tyrosine residues for binding to 
the antibody ( 2Figure 27A). The arrays 
incubated with the anti-phosphotyrosine 
antibody in presence of phenyl phosphate 
were sequentially probed with an antiserum 
specific for CD3ζ (2Figure 27C). Taking into 
account the results from the control for non-
specific interactions, we found various 
candidate proteins that showed differential 
tyrosine phosphorylation or association with 
the TCR complex under these conditions. Out 
of these candidates we selected a group of 
proteins for independent confirmation of their 
differential association or phosphorylation, 
based on the criteria of the novelty of their 
implication in T cell differentiation and/or the 
differential implication in positive and negative 
selection, as well as the availability of 
antibodies different from the ones spotted on 
the arrays (2Table 9). In the first series of 
independent confirmation experiments of the 
selected candidates, the differential 
association of GRK2 with the TCR was clearly 
confirmed (see below). 
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Figure 27: Identification of proteins associating differentially during positive and negative selection. Two groups of 
TANDRAG animals were treated with tet for 6 days and then animals were inoculated with PBS (positive selection) or MCCp 
(negative selection) through the tail vein (negative selection condition), 2Hrs prior to the assay. Thymic detergent extracts were 
hybridized,.in parallel with the antibody arrays, followed by incubation of the arrays with a biotinylated phospho tyrosine specific 
Ab in presence (A) or abscence (B) of phenylphosphate or with (C) a biotinylated CD3ζ-specific antibody. Bound antibody was 
detected with SA-HRPO and ECL.The position of the spot on the array allows identification of the proteins in volved in 
differential association or phosphorylation. 
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Table 9: List of proteins identified through antibody array. Antibody array was quantified through gel quantification system
and optical density for spot was calculated. Value written here is the division of value obtained in positive selection condition
divided by value obtained in negative selection condition. Value 1 is control, less than 1 is positive for negative selection
condition while value more than 1 is positive for positive selection condition. Proteins of interest which were further studied are
depicted in red. 
 
Identified protein Detection Positive/Negative (value) 
BRCA1 Tyrosine phosphorylated 1.08 
HSP70 Tyrosine phosphorylated 1.08 
PYK2 Tyrosine phosphorylated 0.06 
Grb7 Tyrosine phosphorylated 2.69 
PTEN Tyrosine phosphorylated 0.48 
SIVA Tyrosine phosphorylated 0.02 
ERK2 Tyrosine phosphorylated 8 
Bcl6 Tyrosine phosphorylated 8 
BclxL Tyrosine phosphorylated 5 
Bim Tyrosine phosphorylated 13 
Lck Tyrosine phosphorylated 15 
c-Src Tyrosine phosphorylated 17 
BRCA1 TCR-Associated 1.08 
β-Catenin TCR-Associated 1.13 
PAR4 TCR-Associated 0.25 
PARP TCR-Associated 0.06 
PTEN TCR-Associated 0.2 
Cyclin E TCR-Associated 3.4 
Rab11 TCR-Associated 0.2 
Rab5 TCR-Associated 0.21 
Apaf1 TCR-Associated 8.5 
Erk1 TCR-Associated 18 
GRK2 TCR-Associated 9 
 
 
We decided to focus our attention on GRK2, 
as it had so far not been shown to be involved 
in T cell differentiation. Furthermore, its 
classically defined role in regulation of G-
protein coupled receptors, such as chemokine 
receptors appaerd interesting in view of the 
importance of thymocytes migration during T 
cell development. 
 
The antibody array showed a clear 
decrease in the signal for TCR-associated 
GRK2 during negative selection (2Figure 28A). 
We confirmed this differential association via 
direct immunoprecipitation assays. We 
prepared detergent extracts from thymuses of 
two groups of mice that had been treated as 
describe above in order to obtain DP 
populations undergoing positive selection or 
negative selection. We immunoprecipitated 
GRK2 from these extracts with a GRK2-
specific antibody that was different from the 
one spotted on the array and upon separation 
of the immunoprecipitate by SDS-PAGE and 
immunoblotting, labelled the membrane with 
anti CD3ζ antibody to check the association 
between GRK2 and CD3ζ (2Figure  28B). This 
confirmed that CD3ζ associated with GRK2 
only under conditions of positive selection. 
 
 
  
 
 
 
2.3. Confirmation of differential GRK2-TCR 
interaction by immunoprecipitation and
immunoblot assay. 
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Figure 28: Association 
between GRK2 and the TCR 
complex during positive 
selection.  
A) A portion of Ab-array 
showing association of GRK2 
with positive selection 
condition while it is absent in 
negative selection condition. 
B) Direct confirmation of the 
differential GRK2 association 
with the TCR complex during 
positive selection by immuno-
precipitation and immuno-blot 
analysis of thymic extracts 
obtained from TANDRAG mice 
treated for 6 days with tet and 
subsequently inoculated with 
PBS or MCCp 
 
 
As we did not know through which 
subunits GRK2 is associated with the TCR 
complex, we verified that the apparent 
dissociation of GRK2 from the TCR complex 
under conditions of negative selection was not 
an artefact caused by dissociation of CD3ζ 
from the other components of the TCR 
complex. We performed immunoblotting 
experiments, immunoprecipitating the TCR 
complex from detergent of positively and 
negatively selecting thymuses with a TCRαβ 
specific antibody and blotted with CD3ε and 
CD3ζ (2Figure  28B, lower panel). Quantitative 
analyses of these blots showed that the ratio 
between CD3ε and CD3ζ did not change 
under these conditions. 
 
As at day 6 of tet treatment both DN 
and DP populations are present in the thymus 
of TANDRAG mice (2Figure 24), we needed to 
formally prove that the association of GRK2 
with the TCR-CD3 complex occurred in DP 
thymocytes by purifying this population. We 
treated TANDRAG mice for 6 days with tet to 
obtain thymuses containing DN and DP 
(2Figure 29A, input 6 days) thymocytes, we 
furthermore treated a group of animals for 9 
days with tet to obtain thymuses containing DP 
and SP thymocytes, allowing us to determine 
whether association also occurred in 4SP 
thymocytes (2Figure 29A, input 9 days).Upon 
isolation of the thymuses of these mice we 
prepared single cell suspensions and 
separated the DP from DN or 4SP populations 
by staining the thymocytes with an anti-CD8 
antibody (which labelled the DP population) 
and then isolating the labelled population by 
the use of magnetic beads ( 2Figure 29A). 
2.4. Identification of the cell populations in
which the GRK2-TCR association occurs 
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Figure 29: Biochemical analysis of the interaction between GRK2 and the TCR complex. Association of GRK2 with the 
TCR complex at DP and SP stage. Cell suspensions, prepared from thymuses isolated from TANDRAG animals treated for 6 
and 9 days with tet, were enriched for DN and DP or DP and SP population respectively, using anti CD8α antibodies and 
magnetic beads.  
A) FACS profile showing thymic populations before and after separation through magnetic beads.  
B) Detergent extracts made from these separated populations were analyzed via immuno-precipitation and immuno-blotting for 
association between GRK2 and the TCR complex. An anti-human CD3 antibody (OKT3) was used as an isotypic negative 
control for the anti-GRK2 antibody used for immuno-precipitation. 
 
Bead-bound, enriched for DP cells, 
and unbound cells, enriched for either DN or 
4SP cells, were separately lysed in Brij96 
detergent and lysates were 
immunoprecipitated with the GRK2-specific 
antibody and analyzed via immunoblotting for 
its association with CD3ζ (2Figure 29B). These 
experiments showed that the interaction 
between GRK2 and the TCR complex was 
above background in the DP and 4SP 
enriched thymocyte and indicated that the 
interaction started at the DP stage. 
  Finally we wished to determine 
whether association of GRK2 with the TCR 
was lost upon stimulation of the 4SP 
population. We treated TANDRAG mice for 9 
days with tet, resulting in the appearance of 
both DP and 4SP thymocytes, and inoculated 
them with MCCp or PBS 2 hours before 
sacrifice and isolation of the thymus. Analysis 
of GRK2 immunoprecipitation via western blot 
showed a decrease in the amount of 
associated CD3ζ, upon MCCp injection (2Figure 
30). This partial reduction of association 
suggested that CD3ζ and the TCR dissociated 
not only in the DP but also in the 4SP 
population upon stimulation with MCCp. 
 
Figure 30: Interaction between GRK2 and TCR complex at 
day 9. TANDRAG were treated for 9 days with tet, and then they 
were injected with MCCp or PBS. GRK2 dissociates from TCR 
upon stimulation (upper left panel) while equal amount of CD3ζ 
remained associated with the TCR under both conditions (lower 
left panel). Left panel shows equal amount of zeta and GRK2 in 
whole lysate. 
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In order to determine whether GRK2 
played a role in T cell differentiation, we 
analyzed mice that lacked one functional copy 
of the GRK2 gene (GRK2+/- mice) (Jaber et al., 
1996). Homozygous knock-out (GRK2+/-) 
animals of the original colony die around 
gestational day 15 (E15) (Jaber et al., 1996) 
prohibiting a direct analysis of the thymic 
phenotype of such animals. We tried to obtain 
fetal liver from GRK2-/- embryos at E10-E11, 
as at that stage of embryonic differentiation the 
haematopoietic stem cells reside in this organ 
(Cumano et.al.2007). These cells could in 
principle be used to reconstitute the 
haematopoietic system of lethally irradiated 
recepients and to test their potential for 
differentiation into the T cell lineage. However, 
when analyzing the genotype of E10-E11 
embryos of our colony, we found that out of 
the 24 embryos analysed only 3 were GRK2-/- 
and they were already in the process of 
resorption (data not shown). This prevented us 
from studying the role of GRK2 in thymocytes 
differentiation via this strategy. 
GRK2+/- mice express 50-60% less 
GRK2 than wild type animals in various tissues 
and it has been demonstrated that such 
reduction affects GRK2 dependent signaling 
(Kleibeuker et al., 2008; Peregrin et al., 2006) 
and migration (Penela et al., 2008b; Vroon et 
al., 2004). We therefore crossed GRK2+/- 
animals with ANDtg mice and with OT-1tg mice 
(Hogquist et al., 1994), which express a MHC 
class I-restricted TCR that recognizes an 
ovalbumin-derived epitope, reasoning that 
such TCR-transgenic animals should allow a 
much clearer detection of any perturbation in 
TCR-dependent processes during T cell 
selection. 
I. Phenotypic analysis of ANDtg GRK2+/+ and 
GRK2+/- animals: 
We first analyzed the expression level 
of GRK2 in thymocytes of ANDtg GRK+/+ and 
GRK+/- mice, and found that ANDtgGRK2+/-
thymocytes expressed about 60% less GRK2 
than ANDtgGRK2+/+ thymocytes (2Figure 31A). 
Phenotypic analysis of thymus showed no 
major block in thymocyte differentiation as a 
consequence of reduced GRK2 expression. 
The distribution of GRK2+/+ and GRK2+/- ANDtg 
thymocytes between the major subsets was 
almost identical (2Figure 31B). Total cell 
numbers were neither significantally different, 
although there was a tendency to fewer cells in 
the GRK2+/- animals. 
However a more detailed comparison 
of the thymus of these mice showed two very 
consistent and statistically significant 
differences. At the DP stage there was a clear 
reduction in the percentage of GRK2+/- ANDtg 
thymocytes expressing a higher level of TCR 
at the cell surface as compared to GRK2+/+ 
ANDtg thymocytes. (2Figure 31C).This reduction 
in TCR expression was specific for the DP 
stage, as 4SP thymocytes of both types of 
animals expressed an equal number of TCR 
complexes at the cell surface. This excluded 
the possibility that GRK2 was involved in 
general mechanisms of regulation of the level 
of TCR expression. Increase in TCR 
expression in the DP stage is a key event 
during positive selection and is dependent on 
interaction with selecting MHC ligands and 
signaling via the TCR complex (Watanabe et 
al., 2000). Our data therefore indicated that the 
efficiency of positive selection in ANDtgGRK2+/-  
2.5. Analysis of T cell differentiation in
GRK2+/- mice 
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Figure 31: Phenotypic 
analysis of GRK2+/- ANDtg 
mice.  
A) Immuno-blot of whole 
lysates of GRK2+/+ and 
GRK2+/- ANDtg total 
thymocytes showing a 60% 
reduction in expression of 
GRK2 in the heterozygous 
thymocytes.  
B) CD4 vs. CD8 profile of 
GRK2+/+ and GRK2+/- ANDtg 
thymocytes on an H-2kb 
background.  
C) Overlays of TCR 
expression (left panels) and 
CD69 expression (right 
panels) on DP and 4SP 
GRK2+/+ (gray lines) and 
GRK2+/- (black lines) ANDtg 
thymocytes. Quantification of 
expression levels and 
statistical analysis are shown 
in the bar graphs below each 
overlay for three independent 
experiments with one or two 
mice per group (gray bars: 
GRK2+/+ thymocytes; black 
bars: GRK2+/- thymocytes; * 
p<0.043 and ** p<0.026, 
student t-test). 
 D) Phenotypic analysis of 
lymphocytes from peripheral 
lymph node (left panel), 
overlay plots of TCR and 
CD69 profiles in GRK2+/+ (gray 
lines) and GRK2+/- (black 
lines) ANDtg lymphocytes. 
 
 
mice was reduced as compared to their wild 
type counterparts, thereby implying a limiting 
role for GRK2 during this process. The other 
phenotype we observed was a statistically 
significant decrease in the downmodulation of 
CD69 at the cell surface of mature CD4 single 
positive thymocytes in GRK2+/- as compared to 
GRK2+/+ mice. ( 2Figure 31C). Downmodulation 
of CD69 has been shown to be essential for 
exit of mature thymocytes to the periphery 
(Feng et al., 2002). Expression of CD69 on 
ANDtgGRK2+/+ and GRK2+/- DP thymocytes 
was not significantly different, indicating that 
this phenotype was also stage specific. 
Peripheral ANDtgGRK2+/- CD4+ T cells 
were present in normal numbers and the 
expression level of the TCR and CD69 on 
these cells was indistinguishable from wild 
type ANDtg T cells (2Figure 31D). This indicated 
that, at steady state conditions, the role of 
GRK2 in ANDtg T  
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Figure 32: Phenotype 
of GRK2+/- OT-1tg 
mice.  
A) Immuno-blot of 
whole lysates of 
GRK2+/+ and GRK2+/- 
OT-1tg total thymocytes 
showing a reduction in 
expression of GRK2 in 
the heterozygous 
thymocytes.  
B) CD4 vs. CD8 profile 
of GRK2+/+ and GRK2+/- 
OT-1tg thymocytes  
C) Overlays of TCR 
expression (left top 
panels) and CD69 
expression (right top 
panels) on DP and 4SP 
GRK2+/+ (gray lines) 
and GRK2+/- (black 
lines) OT-1tg 
thymocytes. 
Quantification of 
expression levels and 
statistical analysis are 
shown in the bar graphs 
below each overlay for 
one out of two 
experiments, with four 
to five mice per group 
(gray bars: GRK2+/+ 
thymocytes; black bars: 
GRK2+/- thymocytes; * 
p<0.01 and ** 
p<0.000001, Student’s t 
test). 
D) Phenotypic analysis 
of lymphocytes from 
peripheral lymph node 
(left panel),overlay plots 
of TCR and CD69 
profiles in GRK2+/+ 
(gray lines) and GRK2+/- 
(black lines) OTtg 
lymphocytes. 
 
 
cells is most limiting during the process of 
thymic differentiation. 
II. Phenotypic comparison of OT-1tg 
GRK2+/+ and GRK2+/- animals:- 
We also compared OT-1tg animals on 
a GRK2+/+ and GRK2+/- background, permitting 
us to determine whether the phenotype 
observed in ANDtg animals was restricted to 
this particular clone and/or to MHC class II-
restricted T cells. The thymic phenotype of OT-
1tgGRK2+/- mice showed confirmed the 
phenotype observed in ANDtgGRK2+/- mice: 
reduction in expression of GRK2 (2Figure 31), 
reduced TCR up-regulation at the DP stage 
and reduced CD69 downmodulation at the SP 
stage. (2Figure  32). Again peripheral GRK2+/+ 
and GRK2+/- OT-1tg T cells were 
indistinguishable for TCR and CD69 
expression (2Figure 32D). 
Together these data suggested that 
GRK2 played limiting roles during positive 
selection at the DP stage and the egress of 
mature thymocytes from the thymus in both 
MHC class I and MHC class II restricted T 
cells. 
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Figure 33: Induction of apoptosis.Percentage of AnnexinV positive cells in the indicated thymic subpopulation of 
GRK2+/+ (gray bars) and GRK2+/- (black bars) of ANDtg thymocytes (A) OT-1tg thymocytes (B) upon 4 hours of culture in 
absence or presence of 5 μg/ml of a soluble stimulatory anti-CD3ε antibody. 
 
 
We cultured ANDtg GRK2+/+ and GRK2+/- 
thymocytes in-vitro in presence or absence of 
a stimulatory anti-CD3ε antibody, in order to 
determine whether apoptosis caused by lack 
of TCR-mediated stimuli or induced by strong 
TCR stimuli was altered in GRK2+/- 
thymocytes. As compared to GRK2+/+ 
thymocytes, the DP subpopulation of ANDtg 
GRK2+/- thymocytes showed slightly increased 
levels of AnnexinV staining upon 4 hrs of 
culture in absence of stimuli ( 2Figure 33A). This 
indicated that these thymocytes were slightly 
more prone to apoptosis, and could explain the 
observed phenotype of reduced efficiency of 
positive selection (taking into account that 
positive selection rescues DP thymocytes from 
programmed cell death). GRK2+/- 4SP 
thymocytes were, if anything, slightly less 
sensitive to apoptosis. Upon stimulation with 
the anti-CD3ε antibody, there was a clear 
increase in Annexin V+ DP ANDtg GRK2+/+ and 
GRK2+/- thymocytes. Interestingly, the increase 
in the percentage of Annexin V+ cells was very 
similar in both cases (about 1.3 fold), 
suggesting that TCR-induced apoptosis was 
not majorly affected by a reduction in GRK2 
levels.  
Similarly, OT-1tg GRK2+/- thymocytes 
cultured for 4 hours in vitro showed slightly 
increased percentages of AnnexinV+ 
thymocytes in the more immature DPhi, DPlo 
and 4int populations, as compared to the 
corresponding GRK2+/+ populations (2Figure 33 
B). Again, stimulation with the stimulatory anti-
CD3ε antibody increased the percentage of 
Annexin V+ cells in the immature GRK2+/+ and 
GRK2+/- populations to a similar extent. 
Thus, while apoptosis in-vitro caused 
by lack of stimuli was slightly increased in 
GRK2+/- DP thymocytes, TCR induced 
apoptosis, reflective of negative selection, was 
not affected. This suggested that the 
phenotype observed in the GRK2+/- animals 
was mostly due to impaired positive selection 
and not to exacerbated negative selection.
2.6. Induction of apoptosis in GRK2+/+ and
GRK2+/- thymocytes 
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Given that positive selection is strictly 
dependent on TCR-CD3 mediated signaling 
and in view of the observation that GRK2 is 
associated with the TCR of DP thymocytes 
during positive selection, we sought to 
determine whether a reduction in the amount 
of GRK2 directly affected TCR dependent 
activation events. In vitro stimulation of ANDtg 
GRK2+/+ and GRK2+/- thymocytes with graded 
amounts of the MCC peptide showed a 
marked reduction in TCR down-modulation  
 
and CD69 up-regulation in GRK2+/- DP 
thymocytes as compared to GRK2+/+ DP 
thymocytes (2Figure  34). This difference in 
response was not observed in CD4+ SP 
thymocytes nor in CD4+ lymphocytes from 
lymph nodes ( 2Figure  35), indicating that the 
reduction in GRK2 does not cause a general 
deffect in internalization of the TCR complex or 
expression of the CD69 molecule at the cell 
surface. These data suggested that GRK2 
plays a direct role in signaling via the TCR 
complex and also suggested that the reduction 
in efficiency in positive selection of ANDtg 
GRK2+/- DP thymocytes was at least partly due 
to a reduction in GRK2-dependent TCR-CD3 
mediated signaling processes. 
 
Figure 34: Functional analysis of DP T cells of GRK2+/+ and GRK2+/- ANDtg mice. In vitro stimulation assays of ANDtg 
GRK2+/+ (gray lines) and GRK2+/- (black lines) DP T cells, measuring up-regulation of A) TCR downmodulation and B) CD69 
upregulation upon stimulation with graded amounts of the MCC peptide presented by DCEK cells. 
 
 
 
 
2.7 Reduced sensitivity of ANDtg GRK2+/-
thymocytes to TCR mediated stimuli 
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Figure 35: Functional analysis of 4SP (thymocytes) and mature lymphocytes from GRK2+/+ and GRK2+/- ANDtg mice. In 
vitro stimulation assays of ANDtg GRK2+/+ (gray lines) and GRK2+/- (black lines) T cells, measuring downmodulation of TCR and 
up-regulation of CD69 and CD25 upon stimulation with graded amounts of the MCC peptide presented by DCEK cells. 
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ANDtg thymocytes can not only be 
positively selected by the I-Ek allele but also by 
the I-Ab allele (Kaye et al., 1992). The 
interaction between the ANDtg TCR and the I-
Ab allele is of weaker strength than its 
interaction with I-Ek (Kaye et al., 1992). If 
positive selection was indeed diminished in 
GRK2+/- animals, and if this depended at least 
partially on reduced signaling capacity of the 
TCR complex in GRK2+/- animals, a weaker 
interaction via the I-Ab allele should 
exacerbate the reduction in positive selection 
observed in the ANDtg GRK2+/- mice in 
presence of the I-Ek allele ( 2Figure 31A).  
 
 
 
Figure 36: Reduced DN to DP transition of GRK2+/- ANDtg thymocytes in presence of weaker positively selecting TCR 
ligands. A) CD4 vs. CD8 profiles and quantification of the indicated thymocyte subsets in GRK2+/+ and GRK2+/- ANDtg mice in a 
H-2bb background (gray bars: GRK2+/+ thymocytes; black bars GRK2+/- thymocytes).  
B) Quadruple staining of thymocytes with CD4, CD8, CD69 and the transgenic Vβ3 TCR segment shows that the CD4loCD8lo 
thymocytes observed in GRK2+/- mice are CD69loTCRlo thymocytes. 
 
 
 
 
 
 
2.8. Reduction in cell number and
appearance of CD4loCD8lo GRK2+/- ANDtg
thymocytes in presence of weaker
positively selecting ligands. 
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The outcome was slightly different 
from the one expected. The total number of 
thymocytes in ANDtg GRK2+/- H-2bb mice was 
reduced by 40% as compared to their wild type 
counterparts and manifested itself as of the DP 
population (2Figure 36A). Thus the tentative 
reduction in cell number observed in the I-Ek 
background became much more pronounced 
in presence of only the weaker I-Ab allele. This 
suggested that positive selection was 
quantitatively affected. 
However, there was a second 
phenotype: the GRK2+/- animals contained a 
CD4loCD8lo population that was not detected in 
GRK2+/+ animals (2Figure 36B). Four colour 
labelling of thymocytes with antibodies specific 
for TCRβ, -CD69, -CD4 and -CD8 showed that 
these cells were contained within the most 
immature TCRloCD69lo subset (2Figure 36B). 
This indicated that these were pre-selection 
thymocytes and not DP thymocytes down-
modulating CD4 and CD8 upon receiving 
signals inducing negative selection, as such 
thymocytes express CD69 (Kishimoto et al., 
1995). It therefore appeared that these were 
thymocytes transitioning from the DN to the 
DP stage. This transition is mediated by the 
pre-TCR complex in mice with a polyclonal T 
cell repertoire, but is usually mediated by the 
TCRαβ complex in TCRtg mice (Croxford et al., 
2008). The reduction in DP and 4SP 
thymocytes could therefore have been the 
consequence of reduced efficiency of DN to 
DP transition. But the observation that 
appearance of this intermediate population in 
ANDtg GRK2+/- mice was allele-dependent 
indicated a role for TCR-mediated signaling in 
this transition and implied a role for GRK2 in 
this signaling process. 
 
Reduction in GRK2 levels leads to 
increased migration of mature T lymphocytes 
(Vroon et al., 2004), most likely caused by less 
efficient GRK2-dependent desensitization of 
activated chemokine receptors. The distinct 
stages of thymocyte differentiation occur at 
strictly defined location within the thymus and 
depend on proper migration of the thymocytes 
to these sites (Petrie., 2003). It was therefore 
of interest to assess whether reduction in 
GRK2 expression changed the migratory 
capacity of thymocytes. CXCR4 is expressed 
predominantly by DN and DP thymocytes and 
is downregulated after positive selection 
(Suzuki et al., 1998). We therefore tested the 
in-vitro migratory response of ANDtg GRK2+/+ 
and GRK2+/- thymocytes to the CXCR4 ligand 
SDF-1α (CXCL12). DN and 4SP GRK2+/- 
thymocytes migrated more to SDF-1α than the 
GRK2+/+ DN and 4SP thymocytes, but DP 
GRK2+/- thymocytes migrated consistently less 
than DP GRK2+/+ thymocytes in response to 
this cytokine (Figure 37 & 2Table 10). As 
observed before for mature T cells co-
stimulation via the TCR reduced migratory 
capacity in both GRK2+/+ and GRK2+/- 
thymocytes. (Peacock and Jirik, 1999; 
Schneider et al., 2009). Together these data 
showed that a reduction in GRK2 altered the 
migration capacity of ANDtg thymocytes and 
suggested that GRK2 regulated migration of 
DP vs DN and 4SP thymocytes in a different 
manner. 
 
2.9. Stage dependent alterations in
thymocyte migration upon reduction in 
GRK2 expression. 
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Figure 37: Migration of GRK2+/+ and GRK2+/- ANDtg thymocytes in response to 
SDF-1α.Unfractionated thymocytes suspensions were added to the upper chamber of a 
transwell plate in presence or absence of the anti-CD3 Ab 2C11. These chambers were 
then placed in the lower chambers of the transwell plate containing medium with or 
without SDF-1α. After 3 Hrs, thymocytes of the lower chamber were collected, counted 
and labelled with anti-CD4 and anti-CD8 antibodies and analysed by flow cytometry. The 
percentage migration was determined by dividing the absolute number of cells of each 
population of the lower chamber by the absolute number of these cells in the input 
population. 
 
 
 
 
 
 
 
 
Table 10: Migration of GRK2+/+ and GRK2+/- thymocytes 
.Quantification and statistical analysis of relative migration of GRK2+/- 
thymocytes of each thymocytes subpopulation for each treatment. 
 
Cell 
population Conditions 
GRK2+/- 
MIGRATION SD p Value 
  (Relative to WT)  
 
DN Control 80.540 20.140 0.265 
 SDF1α 108.470 34.030 0.661 
 SDF1α+2C11 74.640 20.850 0.197 
     
DP Control 91.890 19.750 0.772 
 SDF1α 79.800 3.110 0.018 
 SDF1α+2C11 48.130 16.040 0.004 
     
4SP Control 88.740 45.950 0.673 
 SDF1α 146.100 22.830 0.021 
 SDF1α+2C11 110.000 40.590 0.663 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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The acquired immune system provides 
its host with “antigenic memory”, permitting a 
faster and stronger response when 
reencountering specific pathogens and thereby 
providing immunity. The capacity to respond 
stronger and faster upon reencounter is in part 
the consequence of both an increase in the 
size of T cell precursor population (Askonas et 
al., 1982) and a preferential growth of higher 
affinity T cell clones that will form the memory 
T cell pool (Busch and Pamer, 1999; Malherbe 
et al., 2004; Zehn et al., 2009). Memory T cells 
also convert more rapidly into effector T cells 
and produce larger amounts of effector 
molecules (Bachmann et al., 1999; Bruno et 
al., 1995; Cho et al., 1999; Veiga-Fernandes et 
al., 2000; Zimmermann et al., 1999). Finally, 
previously stimulated and memory T cells 
(‘antigen-experienced’ T cells) are more 
sensitive to stimulation via their TCR than 
naive T cells. This has been directly shown by 
the reduction in the amount of antigen these 
cells need to give rise to T cell activation 
(Ericsson et al., 1996; Kimachi et al., 1997; 
London et al., 2000; Pihlgren et al., 1996; 
Rogers et al., 2000; Slifka and Whitton, 2001). 
 The molecular mechanisms underlying 
the increase in sensitivity of antigen-
experienced T cells have not been well 
defined. The TCR does not undergo somatic 
hypermutation, thereby excluding affinity 
maturation as a mechanism. Instead, other 
molecular changes must be at play. Based on 
previous observations made in our group we 
decided to study whether oligomeric TCR 
complexes might play a role in the increased 
sensitivity of antigen-experienced T cells. 
Biochemical and EM analysis of resting T cells 
and non-stimulated T cell lines had shown that 
TCR complexes co-exist as monomeric and 
oligomeric complexes and that the larger 
oligomeric TCR complexes were preferentially 
activated upon stimulation of the T cell with 
low amounts of antigen (Schamel et al., 2005).  
We hypothesized that, if oligomeric 
TCR complexes provided T cells with 
increased antigen sensitivity, an increase in 
the number and size of oligomeric complexes 
should provide higher antigen sensitivity. In a 
direct comparison of resting with pre-activated 
and expanded human peripheral blood T 
lymphocytes and of murine naïve with memory 
CD4+ T cells, we have shown here that the 
previously stimulated, antigen experienced T 
cells indeed have more oligomeric complexes 
at the cell surface. Similar comparison of naïve 
and antigen-experienced murine monoclonal 
ovalbumin-specific T cells has shown an 
identical change in distribution, correlating with 
increased antigen-sensitivity of the antigen-
experienced T cells (María Férez, Balbino 
Alarcón and Hisse-Martien van Santen, see 
accompanying manuscript). 
It was previuoly described that soluble 
bivalent MHC ligands bind better to previously 
activated mouse 2Ctg CD8+ T cells than to their 
naive counterparts (Fahmy et al., 2001). It was 
suggested that the distribution of TCR 
changes after stimulation. Our data provide 
direct evidence that such changes occur in 
previously stimulated T cells and make it likely 
that the increase in size of oligomeric 
DISCUSSION
Section 1
The number and size of oligomeric
complexes increases in previously
stimulated and memory T cells and
provides these cells with increased antigen
sensitivity. 
       
 
86
Discussion 
complexes upon stimulation is the mechanism 
underlying the increase avidity of bivalent 
pMHC ligands for the TCR complex of these 
previously stimulated T cells. 
 
Oligomeric TCR complexes could play 
an important role in positive and negative 
selection, either because of a need of 
amplification of the signals generated by 
positively selecting ligands, or by amplifying 
the signals generated by few negative 
selection-inducing self-peptides. They might 
thus either serve as an essential component to 
make positive selection possible or to provide 
extra safety in assuring that negative selection 
and hence generation of a self-tolerant T cell 
repertoire, is as efficient as possible. In the 
conditions under which we have studied the 
OT-1tg model it is a positive selection model. 
We found no evidence that positive selection is 
affected by the L19A CD3ζ chain, suggesting 
that oligomeric T cell complexes play no major 
role during this process in OT-1tg T cells. Using 
other positively selecting TCRtg models should 
permit us to assess whether this is generally 
true or not, and negative selection models 
such as the HY model (Kisielow et al., 1988) 
should allow us to address whether negative 
selection is compromised by the L19A 
mutation. Unfortunately we do not know yet 
whether thymocytes express oligomeric 
complexes at any stage of their differentiation. 
The relatively low expression of the TCR on 
thymocytes and the moderate efficiency of the 
EM immuno-labeling technique have so far not 
permitted us to obtain reliable data. 
 Within the peripheral OT-1tg T cell 
pool, the role of oligomeric TCR complexes 
only becomes detectable in the transition from 
naïve to antigen-experienced T cells, where 
L19A CD3ζ expressing OT-1tg T cells show 
less sensitivity towards stimulus than WT 
CD3ζ expressing cells. This defect in 
sensitivity coincides with a strong reduction in 
oligomeric complexes in the cell surface 
replicas of the L19A CD3ζ expressing cells. 
Thus oligomeric TCR formation and function 
could be restricted to antigen experienced T 
cells. 
 
The integrity of oligomeric TCR 
complexes is strictly dependent on the 
presence of cholesterol in the cell membrane 
(Schamel et al., 2005) indicating a key role for 
the lipid environment. However, protein-protein 
contacts between adjacent TCR complexes 
could play a role as well. As previously 
observed (Schamel et al., 2005) the size of the 
gold particles used to detect the TCR clusters 
(10 nm) is in the order of the estimated 
diameter of the extracellular domains of the 
TCR and CD3 chains together (~16 nm) (Sun 
et al., 2004). The spacing between gold 
particles in the clusters we observed on the 
cell surface replicas is small enough to be 
compatible with direct contact between 
individual TCR complexes. 
 If protein-protein contacts are indeed 
necessary for oligomeric TCR complex 
formation, CD3ζ should be one of the subunits 
that are directly involved the formation of these 
complexes. CD3ζ (‘A face’) could either form 
heterotypic, L19 dependent interactions with a 
yet unknown B face or an alternation of 
homotypic, L19 dependent A-A interactions 
and B-B interactions (2Figure 38) The A-A 
interaction would reflect the observed ability of 
the CD3ζ transmembrane domains to form 
tetramers (Torres et al., 2002). The B face 
Normal differentiation of L19A CD3ζ-
expressing OT-1tg T cells. 
Mechanisms of oligomeric TCR complex 
formation  
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could be formed primarily by the Cα domain, 
according to recent findings that the C and F 
strands of Cα play an important role in the 
dimerization of TCRαβ heterodimers (Kuhns et 
al.2010).  
 
Figure 38: models of CD3ζ-dependent TCR 
oligomerization A) Oligomerization via a mechanism in 
which interactions between individual TCR complexes 
(boxes) are dependent on a heterotypic, L19-dependent 
interaction between CD3ζ dimers (A-face) and another, 
not yet defined TCR component (B-face) (top line) or on 
alternation of homotypic, L19-dependent interactions 
between CD3ζ dimers and homotypic interactions 
between the other TCR components (bottom line).  
(B). TCR oligomerization mediated by concatenation of 
homotypic L19-dependent interactions between CD3ζ 
dimers. This model assumes that due to its symmetry, the 
CD3ζ dimer can interact on both sides with adjacent CD3ζ 
dimers. This model is compatible with that of Davis and 
colleagues (Kuhns et al., 2010), since the A-face could 
consist of both the Cα ectodomain and the 
transmembrane domain of CD3ζ. The lower part of the 
figure provides a hypothetical ordering of the 
transmembrane regions (circles) of the TCR components 
indicated, taking into account the proposed orientation of 
these segments in digitonin-solubilized ER microsomes 
(Call et al., 2002) and making it compatible withthe data of 
Davis and colleagues (Kuhns et al., 2010). The red 
squares indicate theinteraction between the CD3ζ dimers 
and the dashed lines the interaction face between the 
ectodomains of Cα 
 
Taking into account the perfect symmetry of 
the CD3ζ transmembrane domain observed in 
NMR studies (Call et al., 2006), an oligomeric 
TCR complex could also be formed by a 
repetition of L19-dependent symmetrical 
interactions between CD3ζ dimers, i.e. based 
exclusively on homotypic interactions. This 
could even occur in combination with the 
previously mentioned Cα domain interactions. 
These interactions must however somehow 
also depend on cholesterol 
Given the importance of cholesterol in 
oligomeric TCR complex formation, a higher 
cholesterol and GM gangliosides content in 
antigen-experienced T cells could thus be an 
important factor for larger TCR oligomers 
formation as compared to naïve T cells. Such 
increases do occur after overnight stimulation 
of mature CD4+ T cells with anti-TCR 
antibodies and are stably acquired by in vivo 
generated memory T cells (Brumeanu et al., 
2007; Kersh et al., 2003). Gene expression 
profiling of naïve, effector and memory cells 
show up-regulation of some cholesterol 
transporters and biosynthesis genes 
(Hashimoto et al., 2003; Holmes et al., 2005). 
Up-regulation of these genes in response to T 
cell activation leads to increased cholesterol 
content in plasma membrane, which could 
allow formation of more oligomeric TCR 
complexes. 
 
Oligomeric TCRs could provide T cells 
with increased sensitivity by permitting 
multivalent TCR-MHC interactions. A number 
of in vitro studies using well-defined soluble 
monovalent and multivalent MHC/peptide 
ligands have shown that T cell activation is 
dependent on interaction with multivalent 
MHC/peptide ligands (Boniface et al., 1998; 
Cochran et al., 2000). At the same time, the 
MHC molecules on the cell surface of APCs 
have been shown to be able to form clusters, 
Oligomeric TCR complexes may increase 
the avidity of the TCR-MHC interaction and 
allow signal spreading. 
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which may even be enriched for particular 
antigenic peptides (Anderson et al., 2000; 
Kropshofer et al., 2002). Stimulation by 
adjacent MHC molecules presenting identical 
antigenic peptides does not appear to be an 
absolute requirement for T cell activation, as 
soluble bivalent MHC complexes presenting 
one antigenic peptide in combination with 
another unrelated peptide can stimulate T cells 
(Krogsgaard et al., 2005). However, the TCR 
of the interacting T cell could trigger activation 
of this T cell, either because the extra strength 
of interaction provided by the adjacent 
MHC/peptide complexes allows a sufficiently 
long time of interaction needed for T cell 
activation, and/or because concomitant 
binding of agonistic and non-agonistic pMHC 
complexes allows spreading of TCR activation 
from the agonistic pMHC interacting TCR to 
the adjacent ones. A mechanism for signal 
spreading could be just be the lateral ITAM 
phosphorylation within the TCR oligomer by 
agonist pMHC-dependent Lck recruitment 
(Schamel et al., 2006). The lateral ITAM 
phosphorylation would thus be a “passive” 
mechanism of signal spreading facilitated 
within TCR oligomers. However, the existence 
of conformational changes as a mechanism to 
transmit information on ligand binding to the 
cytoplasmic tails of the CD3 signaling subunits 
(Gil et al., 2002) led us to propose that TCR 
oligomers could allow the existence of an 
“active” mechanism of signal spreading by 
permitting the transmission of the active 
conformation from pMHC-contacted to non-
contacted TCRs within the same oligomer 
(Schamel et al., 2006). Such a cooperativity 
effect has been recently demonstrated by 
expressing a conformational inactive mutant of 
CD3ε in T cells that carry an excess of 
endogenous wild type CD3ε (Martinez-Martin 
et al., 2009). Expression of the conformational 
inactive mutant prevents the adoption of the 
active conformation by the TCRs containing 
wild type CD3ε. Therefore, in addition to higher 
avidity for antigen, derived from the 
multivalency of TCR oligomers, these provide 
the possibility of extensive cooperativity 
between pMHC-engaged and non-engaged 
TCRs. Accordingly, it would be plausible that 
previously activated and memory T cells would 
have increased antigen sensitivity as 
compared to naïve T cells because more and 
larger TCR oligomers both increase the 
chance of a multivalent TCR-MHC interaction 
and allow for more extensive signal spreading. 
Thus while antigen-experienced T cells cannot 
increase their sensitivity via affinity maturation, 
they achieve this by an avidity maturation 
mechanism. 
 
 
 
Numerous studies have shown the 
importance of differential signaling via the TCR 
complex in positive and negative selection, 
highlighting the role of the MAPK pathways 
and pro or-anti apoptotic pathways (Bouillet et 
al., 1999; Bouillet et al., 2002; Dong et al., 
2002; McNeil et al., 2005; Sugawara et al., 
1998). However we still lack understanding of 
the molecular mechanism which allows the 
TCR complex to connect specifically to one or 
the other of these signaling cascades. Here we 
set out to discover new proteins implicated in 
these pathways, by performing a biochemical 
screen for TCR-associated or differentially 
Section 2
Search for proteins differentially involved 
in positive and negative selection using a 
kinetically controlled model of T cell 
selection. 
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phosphorylated proteins during positive and 
negative selection, assuming that such 
differential association or phosphorylation 
underlies the ability of the TCR to connect to 
the differential signaling pathways. 
 
The Model 
The model we have developed has permitted 
us to perform a biochemical screen for 
proteins that interact differentially with the TCR 
complex or are differentially phosphorylated 
during positive and negative selection. We 
reasoned that a biochemical screen should 
provide complementary information to RNA-
based screens for proteins involved in these 
processes as the RNA screen would not be 
expected to identify proteins whose expression 
level does not change during positive and 
negative selection nor detect proteins that 
undergo post-translational modifications. 
Indeed, the expression level of the candidate 
protein GRK2, whose role in T cell selection 
we investigated in more detail, did not change 
under the conditions used in our screen. 
The model faithfully reproduces typical 
phenotypical changes associated with 
maturation of an MHC class II-restricted T cell 
clone: progression from DN stage to the DP 
stage, where the thymocytes upregulate TCR 
and CD5, and maturation into CD4 single 
positive thymocytes. An important advantage 
of the model is that positive selection occurs 
via the physiological self-MHC complexes. 
Other models in which T cell differentiation can 
be halted, such as the OT-1tgxTAP1-/- model 
(Daniels et al., 2006), generate artificial 
positively selecting pMHC ligands that may not 
necessarily represents all the features of the 
physiological positively selecting pMHC 
ligands. It shares the advantage with the OT-
1tgxTAP1-/- model that peptide-induced 
negative selection occurs in a mouse in which 
no peripheral mature T cells are present. The 
‘bystander’ activation of these mature T cells 
and the concomitant production of cytokines 
and glucocorticoids have been shown to have 
profound side effects on the thymocytes, 
resulting in non-physiological cell death (Martin 
and Bevan, 1998). 
This work shows that the model allows 
sufficient enrichment for DP thymocytes 
undergoing positive or negative selection to 
detect relevant differentially implicated proteins 
without extensive purification of the DP cells. 
This permit to maintain the interactions of the 
thymocytes with the thymic stroma are 
maintained up to the moment of detergent 
extraction, which should better preserve any 
signaling intermediates. For mature T cells it 
has been shown that this continued contact 
strongly improves the posterior biochemical 
detection of signaling intermediates in these 
cells (Germain et al., 2002). During the 
optimization of our model we indeed observed 
better preservation of phosphorylation of p38 
and Vav in detergent extracts directly prepared 
from whole thymus as compared to extracts 
made after first preparing single cell 
suspensions (data not shown). 
Thus, this new model can generate a 
large and enriched population of DP 
thymocytes going synchronously through 
positive or negative selection under 
physiological conditions, thereby facilitating 
biochemical analyses of these processes. It 
may in principle also serve to study crosstalk 
between thymocytes and stroma during 
positive and negative selection. 
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The candidates 
  Out of the proteins that showed the 
clearest changes in TCR association or 
tyrosine phosphorylation in the array during 
positive and negative selection, we focused 
our initial attention on those proteins with no 
documented role in T cell selection (e.g. 
GRK2, Pyk2 and Grb7) or proteins known to 
be implicated in T cell selection but whose 
mechanism of action in this context was 
unknown (e.g. PTEN). PTEN is a negative 
regulator of PI3K and Akt pathway and has 
been shown to have a role in T cell survival 
and TCR signaling (Hagenbeek et al., 2004; 
Wang et al., 2000). A conditional knockout of 
PTEN shows impaired negative selection 
(Suzuki et. al. 2001) but the mechanisms of 
regulation of PTEN activity during positive and 
negative selection are unknown. The 
observation that PTEN could be found 
associated with the TCR and appeared 
tyrosine phosphorylated during negative 
selection therefore appeared of interest. The 
tyrosine kinase PYK2 has been shown to 
regulate adhesion and motility of various 
neuronal, epithelial and hematopoietic cell 
types and has been shown to be 
phosphorylated by TCR ligation (Collins et al.; 
Ostergaard and Lysechko, 2005). A role of 
PYK2 in T cell activation has been reported 
(Katagiri et al., 2000) and it has been found to 
translocate to the T cell-APC contact area 
upon stimulation (Sancho et.al 2002). Grb7 is 
an adaptor molecule that mediates signal 
transduction to downstream pathways through 
various cell surface receptors and has a role in 
cell migration during tumour progression (Shen 
and Guan, 2004). However, role of these 
proteins in context of T cell selection has not 
been addressed. It should be mentioned that 
interactions or phosphorylation events 
detected in the array do not necessarily 
indicate direct interaction of the candidate 
molecule with the TCR complex or direct 
phosphorylation of these proteins, but could 
reflect the presence of other associating 
molecules in the immune complexes detected 
via the array. 
We performed an initial series of 
independent confirmation experiments with the 
limited panel of candidate protein-specific 
antibodies available to us. In these pilot 
experiments the differential association of 
GRK2 with the TCR complex was most readily 
confirmed. Apart from this technical reason we 
thought GRK2 was an interesting candidate to 
study, given the novelty of its potential 
implication in T cell selection. Furthermore, 
while the classical GPCR targets of GRK2, 
especially the chemokine receptors, play an 
important roles in thymocyte migration and 
thus affect T cell differentiation, its more 
recently described broader roles in interacting 
with and regulating a variety of proteins such 
as cSrc, ZAP70, ERK, MEK, p38, GIT and Akt, 
suggested that it could be intricately linked 
with a number of other signaling pathways 
relevant for T cell differentiation. 
 
Our data show that the interaction 
between GRK2 and the TCR complex occurs 
in DP and CD4 SP ANDtg thymocytes but not 
in DN thymocytes, even though they express 
both GRK2 and the ANDtg TCR. This suggests 
that other stage-dependent factors play a role 
in this association. The pre-TCR could be one 
such factor, which in this case would prevent 
interaction. However, the fact that DN 
thymocytes in ANDtg and many other TCR-
transgenc mice express αβ TCR already at the 
GRK2-TCR interaction
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DN stage and effectively displace the pre-
TCR, make the pre-TCR an unlikely candidate. 
We could clearly show that the GRK2 and the 
TCR dissociate in DP thymocytes upon 
interaction with negative selection inducing 
pMHC ligands, and upon stimulation in CD4 
SP thymocytes. 
After we initiated our studies on 
GRK2, another group reported that GRK2 
interacts with the TCR complex of thymocytes 
of C57BL/6 mice (DeFord-Watts et al., 2007). 
In a series of in-vitro assays with recombinants 
proteins the authors clearly showed that GRK2 
interacts directly with the intracellular basic 
rich sequence (BRS) of CD3ε, located 
between the transmembrane region and the 
proline-rich sequence (PRS), and not with 
CD3γ,CD3δ, or CD3ζ. Our ability to visualize 
the GRK2-TCR association via CD3ζ is 
therefore most likely due to the interaction of 
CD3ζ and CD3ε within the TCR complex and 
does probably not indicate a direct interaction 
of CD3ζ with GRK2. It is not yet known which 
domain of GRK2 interacts with the CD3ε BRS. 
The same study did not provide 
evidence in favor or against a differential 
association of GRK2 with the TCR complex. 
Immuno-precipitation of detergent extracts 
prepared from thymocytes suspensions with a 
stimulatory anti-CD3ε antibody and 
immunoblotting with GRK2 showed a very 
weak association (in comparison to the total 
amount of GRK2), but no direct comparison 
was shown of the extent of association in non-
stimulated and stimulated thymocytes. It is 
therefore not clear whether the association 
observed upon treatment with the stimulatory 
anti-CD3ε antibody is indicative of a 
constitutive TCR-GRK2 interaction, contrasting 
with our findings, or whether it represents a 
small amount of GRK2 that has not 
dissociated upon antibody binding. 
The fact that the GRK2-interacting 
BRS of CD3ε is directly adjacent to the PRS is 
interesting in view of possible mechanisms 
that cause dissociation of GRK2 from the TCR 
complex. The PRS undergoes a 
conformational change upon binding of the 
TCR to agonist and negatively selecting pMHC 
ligands or anti-TCR antibodies (Gil et al., 2002; 
Risueno et al., 2005), permitting binding of Nck 
to the CD3ε chain. Either the conformational 
change itself or the binding of Nck to the PRS 
could cause the observed dissociation of 
GRK2 from the BRS. The recently described 
mutants of the extracellular stalk region of 
CD3ε that have been shown to be defective in 
undergoing the conformational change 
(Martinez-Martin et al., 2009) should be 
extremely useful tools to address this potential 
mechanism of association and dissociation. 
 
 
Given that association between GRK2 
and the TCR complex at the DP stage only 
occurred under conditions of positive selection, 
we hypothesized that GRK2 may play a more 
important role in positive selection and less so 
during negative selection. As a first approach 
we used GRK2+/- mice (Jaber et al., 1996), in 
which GRK2 expression is reduced by about 
60% and crossed these mice with OT-1 and 
AND TCR-transgenic mice. It should be 
mentioned that within this model one would not 
exclusively measure the role of the interaction 
between GRK2 and TCR complex but possibly 
also the role of GRK2 in TCR-independent 
processes. Indeed, our results show that  
GRK2 and thymocyte selection
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GRK2 plays a limiting role in both TCR 
dependent and independent processes. 
In agreement with our hypothesis, in 
both mouse model studied the DP population 
of GRK2+/- cells showed reduced upregulation 
of the TCR which is a known marker of 
positive selection (Huesmann et al., 1991). In 
addition, in the ANDtg model on the alternative 
H2bb background, representing weaker ligands 
for the ANDtg TCR (Kaye et al., 1992) a strong 
decrease in the number of DP and 4SP 
thymocytes was observed. The increase 
apoptotic response to in-vitro stimulation with 
CD3-specific antibody was not significantly 
different from GRK2+/+ DP thymocytes in both 
models, indicating that negative selection was 
not affected. This indicates that reduction in 
GRK2 expression has a limiting role in positive 
selection, while negative selection appears 
unaffected. 
The CD4loCD8lo population that we 
observed in ANDtg GRK2+/- animals may very 
well reflect the importance of a GRK2-TCR 
interaction in the DN to DP transition. We do 
not yet have formal proof that this population 
indeed represents a transitional population, 
which will require purification and adoptive 
transfer into a recipient mouse. It is however 
unlikely to represent a population of 
thymocytes that is downmodulating the CD4 
and CD8 receptors upon induction of negative 
selection: the cells express low amounts of 
CD69 and are only detected in mice that 
express generally weaker MHC ligands for the 
AND TCR. While in our analysis of TCR-GRK2 
association in total DN thymocytes we could 
not detect any association, it is possible that it 
occurs in fraction of thymocytes that quickly 
differentiates into DP thymocytes. It has 
recently been shown by reconstituting CD3ε-
deficient mice with CD3ε constructs lacking 
various intracellular domains that the BRS is 
crucial for the DN to DP transition (Brodeur et 
al.,2009b). Our data would indicate that 
interaction between GRK2 and the TCR via 
the BRS would be critical for this transition. 
The fact that the occurrence of this population 
is MHC haplotype dependent indicates the 
implication of TCR-mediated signaling and 
would point out to a direct, quantitative effect 
of GRK2 on the TCR-dependent signaling 
pathways. This would coincide with the 
observed reduction in antigen sensitivity of the 
ANDtg DP thymocytes in vitro. 
While positive selection is a TCR-
signaling dependent process, suggesting that 
GRK2 is directly implicated in TCR-mediated 
signaling, we also checked the response of 
GRK2+/- thymocytes in the TCR mediated 
processes of TCR downmodulation 
(Bachmann et al., 1997; Hemmer et al., 1998; 
Valitutti et al., 1995) and CD69 upregulation 
(Testi et al., 1994). We observed a marked 
reduction in both TCR downmodulation and 
CD69 upregulation in GRK2+/- thymocytes 
compared to GRK2+/+, again indicating that 
GRK2 is a limiting factor in these TCR- 
signaling dependent processes. The reduction 
was specifically observed in DP thymocytes, 
while CD4 SP thymocytes and CD4+ T cells of 
both genotypes responded equally. The 
reasons for this stage specific reduction have 
not yet been clarified. It could be caused by 
the lower expression level of the TCR at the 
DP stage as compared to the 4SP and CD4+ 
stage, making the signaling via the TCR more 
sensitive to small changes in downstream 
pathways or it could reflect differences in the 
wiring of the TCR complex at these stages. 
Detailed biochemical analysis of the role of 
GRK2 in TCR mediated signaling may resolve 
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this issue. Comparison of our kinetically 
controllable TANDRAG model on GRK2+/+ and 
GRK2+/- background should facilitate such 
biochemical analysis. In addition analysis of 
TCR-mediated signaling in T cell lines in which 
GRK2 is knocked-down by interfering RNA 
construct should be a powerful complementary 
approach. 
Thymocyte migration, an integral part 
of thymocyte differentiation, was also affected 
in GRK2+/- mice. Previous reports described 
that mature GRK2+/- T cells migrated more 
than GRK2+/+ T cells towards CCL4, probably 
due to a reduced GRK2-mediated 
phosphorylation of the activated CCR5 
chemokine receptor (Vroon et al., 2004). In-
vitro assay of SDF-1α induced migration 
showed the same effect in ANDtgGRK2+/- 
thymocytes. However, in DP thymocytes we 
observed the opposite effect: GRK2+/- 
thymocytes migrated less. One possible 
explanation for this apparent contradiction may 
come from the recent observation that CXCR4, 
the predominant receptor for SDF-1α uses 
TCR-associated signaling molecules for SDF-
1α induced signaling and migration in mature 
T cells (Kumar et al., 2006; Schneider et al., 
2009) and DN thymocytes (Janas et al.;2010 
Trampont et al.,2010). We hypothesize that in 
DP thymocytes GRK2 is implicated in the 
convergence of the CXCR4 and TCR signaling 
pathways, which seems reasonable given the 
observed association between GRK2 and the 
TCR reported here and in the literature 
(DeFord-Watts et al., 2007) (2Figure 28). This 
GRK2-dependent convergence of the two 
signaling pathways would cause a mutual 
amplification of the signals transmitted via the 
CXCR4- and TCR-dependent pathways. 
Under conditions of positive selection, a 
reduction in the amount of GRK2, as occurs in 
the GRK2+/- mice, would reduce signaling 
capacity of both the TCR complex and the 
CXCR4 receptor. Given the relatively weak 
activation of the signaling pathways 
downstream of the TCR by positively selecting 
ligands, positive selection would be quite 
dependent on input by the CXCR4 receptor 
pathway and a reduction in this input in 
GRK2+/- mice would cause less efficient 
positive selection. Vice versa, migration would 
be reduced as well, by the reduced efficiency 
of GRK2-dependent coupling of the CXCR4-
signaling pathway to the TCR signaling 
pathway. In case of stimulation by negatively 
selecting ligands, GRK2 dissociates from the 
TCR complex and would thereby inactivate the 
CXCR4-dependent pro-migratory signals and 
would cause the thymocytes to stop. This 
would be useful to allow the thymocytes to halt 
long enough next to the stromal cells 
presenting the negatively selecting ligands and 
to allow sufficient time of interaction to fully 
activate the negative selection program. Under 
these conditions the role of GRK2 in promoting 
CXCR4- and TCR-dependent signaling has 
been lost due to its dissociation from the TCR. 
TCR-mediated signaling events are strong 
enough to independently induce negative 
selection. A reduction in the amount of GRK2 
would therefore have no effect on negative 
selection or migration. Interestingly, signaling 
via CXCR4 has also been implicated in 
transmission of survival signals via the pre-
TCR complex (Hernandez-Lopez et al., 2002; 
Trampont et al.). While such a role has not 
been established for CXCR4- mediated 
signaling in DP thymocytes, it is striking that 
we observe a slight increase in spontaneous 
apoptosis in GRK2+/- ANDtg thymocytes as 
compared to GRK2+/+ thymocytes. 
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Figure 39: GRK2-dependent integration of the CXCR4 and TCR signaling 
pathways in DP thymocytes. The model assumes that GRK2-mediated 
integration of the TCR and CXCR4 signaling pathways is a limiting factor in the 
generation of signals necessary for positive selection, migration and survival. 
Given its dissociation from the TCR during negative selection, such an integrating 
role for GRK2 does not exist under these conditions. See main text for details. 
 
Thus, part of the role of GRK2 could 
be to provide DP thymocytes with survival 
signals (2Figure 39) and less efficient 
generation of these signals could be one of the 
underlying causes for the reduced efficiency of 
positive selection we observed in GRK2+/- 
animals. 
The model is not directly applicable to 4SP 
thymocytes, as we observe the opposite 
effects of GRK2 reduction on migration and no 
effect on antigen sensitivity. We do not know 
what causes this difference, but the 
observation itself suggests that the interaction 
of GRK2 with the TCR and CXCR4 signaling 
machinery is quantitatively or qualitatively 
different in DP and 4SP thymocytes. 
Finally GRK2+/- thymocytes show less efficient 
CD69 downregulation at the SP stage. 
Downregulation of CD69 is a prerequisite for 
thymic egress (Feng et al., 2002) and is 
mediated in conjunction with the S1P1 
receptor (Alfonso et al., 2006). The S1P1 
receptor is a direct target for GRK2 (Watterson 
et al., 2002) and the CD69 phenotype we 
observe is probably a reflection of the CD69-
S1P1 receptor interaction. As far as known, 
TCR signaling is not involved in this maturation 
step and we speculate that the phenotype 
observed would be independent of GRK2-TCR 
interaction. 
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Together, the data show that a 
reduction in GRK2 affects the TCR-signaling 
dependent processes of upregulation of the 
TCR at the DP stage during positive selection. 
CD69 induction and TCR downmodulation in 
DP thymocytes as well as migration in DP and 
4SP thymocytes affected as well. Whether this 
indicates a direct effect of GRK2 on TCR 
dependent signaling or whether it reflects an 
indirect effect via the apparent interwinement 
between chemokine recptor mediated 
signaling pathways and the TCR-mediated 
signaling pathways remains to be established.
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1) Antigen experienced T cells express 
more and larger oligomeric TCR complexes on 
the cell surface than naive T cells. 
2) A mutation of alanine to leucine at 
19th position of the CD3ζ transmembrane 
domain impairs formation of oligomeric TCR 
complexes in a T hybridoma, without affecting 
assembly of the TCR complex or its level of 
expression at the cell surface. 
3) Impairment in formation of oligomeric 
TCR complexes in the T hybridoma expressing 
the mutant CD3ζ chain results in decreased 
sensitivity towards antigen, showing that 
oligomeric TCR complexes provide increased 
antigen sensitivity. 
4) Bone marrow precursors expressing 
the mutant CD3ζ chain permit normal T cell 
differentiation and naive T cell generation of a 
TCR-transgenic clone in-vivo, suggesting a 
minor or non-existent contribution of oligomeric 
complexes in these processes. 
5) Primary TCR-transgenic T cells 
expressing the mutant CD3ζ chain show a 
normal primary T cell response, but respond 
worse than their wild type CD3ζ expressing 
counterparts to secondary stimulation. This 
coincides with a reduction in the size and 
number of oligomeric TCR complexes on 
these cells, showing that oligomeric TCR 
complexes are also responsible for increased 
antigen sensitivity in antigen experienced 
primary T cells. 
6) GRK2 associates with the TCR 
complex in DP thymocytes only under 
conditions of positive selection. 
7) OT-1tg and ANDtg thymocytes with 
reduced GRK2 expression show less efficient 
upregulation of the TCR at the DP stage, 
suggesting that positive selection is less 
efficient and that GRK2 plays a role in this 
differentiation step. 
8) ANDtg GRK2+/- DP thymocytes have 
decreased antigen sensitivity in-vitro, 
implicating a role for GRK2 in TCR-mediated 
signaling. 
9) A CD4loCD8loTCRloCD69lo thymocyte 
population is present in ANDtg mice with 
reduced GRK2 expression and weaker 
positively selecting MHC ligands. This 
suggests that GRK2 plays a role in the 
transition of ANDtg thymocytes from the DN to 
DP stage 
10)  Reduction of GRK2 expression has 
opposite effects on the migration capacity of 
ANDtg DP and 4SP thymocytes towards SDF-
1α, indicating differences in GRK2-dependent 
regulation of this process in both populations. 
TCR co-stimulation reduces migration in both 
populations, showing that the TCR signaling 
pathway interacts in both populations with the 
SDF-1α induced signaling pathway. 
 
CONCLUSIONS
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Dos de los aspectos más fascinantes 
del complejo del TCR es su baja afinidad pero 
alta sensibilidad ante una estimulación por 
parte del antígeno, y su habilidad para activar 
diferentes rutas moleculares de señalización 
en función de la fuerza de la interacción con 
su ligando MHC-péptido (pMHC). 
  Durante el desarrollo de las células T, 
la discriminación entre un estímulo fuerte y 
débil con el ligando del MHC y la consecuente 
activación diferencial de rutas de señalización 
y programas genéticos, es la base principal de 
la selección positiva y negativa que tiene lugar 
en el timo, la cual asegura que los linfocitos 
que reaccionen frente a complejos propios 
sean eliminados y solo aquellos linfocitos T 
tolerantes maduren. Tras su completar con 
éxito la diferenciación en el timo, las células T 
entran en los órganos linfoides periféricos 
como células T vírgenes. Tras el encuentro 
con su antígeno específico estas células 
vírgenes se diferencian en células efectoras 
las cuales son capaces de coordinar 
respuestas inmunes. Parte de estas células 
efectoras se convierten en células de memoria 
y se mantienen latentes hasta un próximo 
encuentro con el antígeno. Estas células de 
memoria se caracterizan por responder más 
vigorosamente ante un reencuentro con el 
antígeno y por ser más sensibles a dosis bajas 
de antígeno que las células virgenes. Estas 
propiedades son la base de la inmunidad.  
Los mecanismos que subyacen a esta 
habilidad del TCR de diferenciar entre 
ligandos de alta y baja afinidad y de transducir 
esta unión diferencial en cascadas de 
señalización diferentes, al igual que los 
mecanismos que otorgan a las células de 
memoria su alta sensibilidad, son aún 
desconocidos. 
Previamente se ha descrito que en el 
caso de células en reposo, el TCR es 
expresado en su membrana como una 
combinación de oligómeros de diferentes 
tamaños, de los cuales los más grandes son 
activados preferecialmente en respuesta a 
bajas dosis de antígeno. Nosotros barajamos 
la hipótesis de que el enriquecimiento en un 
mayor número de oligómeros y un mayor 
tamaño de dichos complejos es lo que provee 
a las células de memoria con una alta 
sensibilidad al antígeno. En esta memoria, 
mostramos mediante un análisis cuantitativo 
por microscopia electrónica, que, tanto las 
células previamente activadas como las 
células de memoria tienen más y más grandes 
oligómeros del TCR en su superficie celular en 
comparación con las correspondientes células 
vírgenes. También mostramos que una 
mutación en la región transmembrana del la 
subunidad CD3ζ impide la formación de los 
complejos oligoméricos y que la pérdida de 
dichos complejos causa una reducción en la 
sensibilidad ante el antígeno de líneas 
celulares y de células previamente activadas. 
Estos hechos proporcionan una evidencia 
directa de que son los oligómeros del TCR y 
su incremento en número y tamaño, los 
responsables de la alta sensibilidad de las 
células T previamente activadas. 
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En la segunda parte de este trabajo se 
describe una búsqueda y un análisis inicial de 
los factores asociados de manera diferencial 
con al complejo del TCR en el proceso de 
selección negativa y positiva, barajando la 
hipótesis de que la asociación diferencial de 
determinados factores proporcionan a los 
timocitos la capacidad de activar rutas 
diferentes de señalización en función de la 
fuerza de unión entre el TCR y el pMHC. 
Hemos desarrollado un modelo murino de 
diferenciación de células T que nos permite la 
purificación de un gran número de timocitos 
que están sufriendo selección positiva o 
negativa en una manera sincronizada. Usando 
este modelo hemos realizado un análisis 
bioquímico para la búsqueda de proteínas 
fosforiladas que se unan de manera diferencial 
al TCR. Así encontramos que la quinasa de 
las receptores acoplados a proteínas G 2 
(GRK2), se asocia con el TCR durante la 
selección positiva y se disocia tras la 
inducción de la selección negativa. Análisis de 
la diferenciación de células T en ratones que 
carecen de una copia del gen GRK2 indica 
que la eficiencia de la selección positiva está 
reducida. Además, la reducción en la 
expresión de GRK2 afecta a la sensibilidad de 
los timocitos DP hacia el antígeno, sugiriendo 
una función directa de GRK2 en la 
señalización dependiente del TCR. Además 
dicha ausencia afecta la migración de los 
timocitos DP y SP hacia la quimioquina SDF-
1α. La observación de que esta migración está 
inhibida por la estimulación a través del TCR 
indica una unión funcional entre la migración 
mediada por SDF-1α y la señalización del 
TCR en estos timocitos. 
  
 
 
El sistema inmune adaptativo presenta tanto 
especificidad patogénica como memoria 
antigénica, y comprende dos tipos de 
respuestas: la respuesta humoral y la 
respuesta celular. 
Los precursores hematopoyéticos de 
las células T se diferencian en el timo y migran 
a la periferia como células T vírgenes hasta 
que el encuentro con una antígena 
determinada las diferencia en células T 
efectoras, las cuales presentan un umbral de 
activación bajo pero una elevada capacidad 
de producir citoquinas. Tras la eliminación del 
foco de infección la mayoría de éstas células 
efectoras mueren, mientras que una pequeña 
fracción perduran como células T de memoria 
(Chandok and Farber, 2004). Por lo tanto, la 
memoria inmunológica permiteuna respuesta 
más rápida e intensa frente a un reencuentro 
con patógenos específicos. 
 
El complejo TCR está formado por las 
subunidades α y β, que son las zonas de 
unión al antígeno, asociadas de forma no 
covalente a las subunidades CD3γ, CD3δ, 
CD3ε y CD3ζζ responsables de la transmisión 
de señales al interior celular (B Malissen, G 
Werlen). Las cadenas α y β  están formadas 
por un dominio de inmunoglobulina variable y 
otro constante,y ambos estan unidos por un 
puente disulfuro. Estos dominios están 
seguidos de tallo region, un dominio 
transmembrana y una pequeña región 
intracelular.  
 
INTRODUCCIÓN:
El complejo αβ del receptor de la célula T y 
su organización en la superficie celular 
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Las subunidades CD3ε, γ y δ  contienen un 
ectodominio de inmunoglobulina, un péptido 
conector, una región transmembrana y un 
dominio citoplasmático largo que presenta un 
motivo de activación de inmunoreceptor 
basado en tirosinas (ITAM) (Figura 1). El 
dominio citoplasmático de CD3ε presenta 
además una secuencia rica en prolinas (PRS) 
y otra rica en residuos básicos (BRS). 
La subunidad CD3ζ forma un 
homodiméro unido por puentes disulfuros 
(Koning el al., 1990) y contiene una región 
extracelular muy pequeña, un dominio 
transmembrana, y una cola citoplasmática que 
contiene tres motivos ITAMs. Todas las 
subunidades TCR y CD3 se traslocan al 
retículo endoplasmático y mediante un estricto 
mecanismo de control se asegura que solo 
lleguen a la superfice de la célula los 
complejos TCR que estén totalmente 
ensamblados (Delgado y Alarcon, 2005; 
Mallabiabarrena et al., 1992,; Minami et al., 
1987). 
 
La estequiometría (el ratio de las 
distintas subunidades dentro de un complejo 
TCR) y la valencia (el número de 
heterodímeros TCR αβ por complejo) del 
complejo TCR en las células T, son puntos 
clave para entender el mecanismo de  
activación de estas células y especialmente 
para entender la necesidad de ligandos 
multivalentes de péptido-MHC (pMHC) 
necessarios para alcanzar dicha activación 
(Boniface et al., 1998; Cochran et al., 2000).  
 
Inicialmente, el complejo TCR 
propuesto consiste en un solo dímero αβ 
asociado a los dímeros CD3γε, CD3δε y 
CD3ζζ. Los residuos de las regiones 
transmembrana de estos componentes 
presentan un desequilibrio de cargas. 
Posteriormente, se propuso otro modelo que 
consistía en dos subunidades αβ por cada 
subunidad de CD3 (αβ:γε:δε:ζζ en una 
estequiometría 2:1:1:1); este nuevo modelo 
resolvía el problema de desequilibrio de 
cargas mostrado a través de 
inmunoprecipitación y FRET de células de 
ratón que expresan dos complejos TCRαβ 
diferentes ( Fernandez-Miguel et al., 1999). La 
determinación de la composición de los 
complejos TCR a través de electroforesis de 
geles nativos de poliacrilamida (BN-PAGE) ha 
mostrado que éstos complejos se presentan 
en forma monovalente y oligomérica.  
La coexistencia de complejos TCR de 
diferentes tamaños está respaladada por los 
resultados obtenidos mediante microscopía 
electrónica (Figura 3). Se ha demostrado que 
los complejos oligoméricos se fosforilan a 
concentraciones de antígeno mucho más 
bajas que los monoméricos (Schamel et al., 
2005). Esto ha llevado ha plantear la hipótesis 
de que los complejos TCR oligoméricos son 
responsables de la alta sensibilidad de las 
células T a pesar de la baja afinidad de los 
dímeros αβ por sus ligandos pMHC. 
 
Los distintos estadios de 
diferenciación de las células T en el timo 
coinciden con un patrón estereotipado de 
expresión de las moléculas CD4, CD8, CD25, 
CD44 y el propio TCR. En el estadio más 
temprano, los timocitos son negativos para 
CD4 y CD8 (DN) pero expresan las moléculas 
CD44 y CD25 en una secuencia parcialmente 
solapada. Durante el estadio DN3, CD44-
Diferenciación y activación de células T αβ:
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CD25+, reordenan el locus del TcrB, dando 
lugar a la expresión de la cadena TCRβ. La 
heterodimerización de TCRβ con la cadena 
pre-Tα y la asociación con las subunidades 
CD3γε, CD3δε y CD3ζζ permite la progresión 
de los timocitos al estadio DP ó CD4+CD8+, 
donde se reordena el locus TcrA y se empieza 
a expresar la cadena TCRα. A partir del 
momento en el que los timocitos expresan el 
complejo TCRαβ van a sufrir dos procesos 
selectivos, siendo ambos, dependientes de la 
señalización a través del complejo TCR-CD3. 
La selección positiva permite la maduración y 
supervivencia de aquellos timocitos que 
expresan un complejo TCR-CD3 con baja 
afinidad para los ligandos MHC-péptido 
(pMHC) (expresados por las células 
estromales del timo), dando lugar a las células 
T CD4 y CD8 simple-positivos (SP), que 
posteriormente migran hacia los organos 
linfáticos secundarios. La selección negativa 
promueve la apoptosis de los timocitos que 
expresen complejos TCR-CD3 con alta 
afinidad para los mismos ligandos. La correcta 
ejecución de ambos procesos selectivos es 
esencial para las generaciones de un 
repertorio de células T maduras, capaces de 
reconocer los antígenos presentados por las 
moléculas MHC de las células presentadoras 
de antígenos (APCs) siendo a su vez 
tolerantes al huésped. 
 
Aunque se ha mostrado que las 
interacciones TCR-pMHC que inducen 
selección negativa o positiva activan de forma 
diferencial distintas vías de señalización, no se 
han aclarado los mecanismos moleculares 
que permiten al complejo TCR-CD3 conseguir 
esta activación diferencial. Vista la importancia 
de la correcta ejecución de la selección timica 
para el funcionamiento del sistema inmune es 
de suma relevancia estudiar los mecanismos 
que permiten esta activación diferencial. 
Las distintas fases de la diferenciación 
tímica ocurren en distintas zonas del timo y los 
timocitos tienen que moverse activamente a 
estas zonas. Dichas zonas del timo están 
formadas por distintos tipos de células 
estromales que presentan un alto grado de 
especialización para los distintos procesos de 
desarrollo; y selección. Ademas la correcta 
migración es también un aspecto esencial de 
la diferenciación de las células T. La expresión 
celular de receptores de quimioquinas que 
confieren capacidad de movimiento hacia 
donde están los ligandos correspondientes 
juega por lo tanto un papel fundamental. Los 
receptores CXCR4 y CCR7 son los 
predominantes en los estadios DN y DP, 
mientras que el receptor CCR9 se expresa en 
las poblaciones maduras CD4SP y CD8SP. 
 
 Cuando las células T vírgenes 
reconocen en los organos linfáticos periféricos 
a su antígeno específico presentado por las 
APCs, se diferencian en células T efectora 
siendo capaces de coordinar tanto la 
respuesta inmune innata coma la respuesta 
inmune adaptativa frente al agente infeccioso. 
Cuando el patógeno ha sido eliminado con 
éxito, la mayoría de las células T efectoras 
mueren y sólo una pequeña fracción sobrevive 
como células T de memoria. En un futuro re-
encuentro con el patógeno estas células T se 
re-activan con cantidades mas bajas de 
antígeno que las células T vírgenes, se 
expanden más rápidamente y producen 
moléculas efectoras mas rápidamente y en 
mayor cantidades. Todos estos eventos 
permite que la infección esté controlada de 
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manera mucho más rápido y forma la base de 
la inmunidad y por lo tanto de la eficacia de la 
vacunación. 
 
En esta memoria hemos demostrado 
que los complejos TCR tanto en linfocitos 
humanos de sangre periférica no-estimulados, 
así como en líneas celulares de origen murino, 
existen como una combinación de TCRs 
monoméricos y oligoméricos de distintos 
tamaños. Los complejos TCR oligomericos, 
son activados preferentemente mediante una 
estimulación con bajas dosis de antígeno. Lo 
que sugiere que podrían conferir a las células 
T su alta sensibilidad. Por tanto, decidimos 
analizar si tanto las cellulas activas como las 
cellulas T memoria, de las que se sabe, 
poseen una mayor sensibilidad hacia su 
antígeno, que las células T virgenes, 
presentaban un enriquecimiento de TCRs 
oligoméricos en su superficie. Más aun, 
generamos un mutante en CD3ζ que impide la 
formación de TCRs oligomèricos, y lo usamos 
para demostrar tanto en una línea celular 
como en células primarias, que los complejos 
oligoméricos de TCRs proporcionan a las 
células T una mayor sensibilidad. 
 
La familia de quinasas de receptores 
acoplados a proteína G (GRKs) está 
compuesta por siete proteínas distintas con 
actividad quinasa en serina y treonina. Todas 
las GRKs comparten una arquitectura 
estructural común: contienen un dominio 
catalítico, una secuencia de 185 aminoácidos 
de longitud en el extremo N-terminal 
importante para la unión del receptor a su 
ligando y de un domino C-terminal con alta 
variabilidad. El papel principal que le ha sido 
atribuido a las GRKs es el reconocimiento y 
fosforilación de los receptores acoplados a 
proteínas G (GPCRs), además de fosforilar 
otros sustratos independientes del receptor. 
Las GRKs tienen la capacidad de atenuar la 
traducción de la señal a través de los GPCRs 
independiente a la fosforilación, lo cual 
refuerza un papel alternativo a su actividad 
quinasa (Pao and Benovic, 2002), (Carman et 
al; 1999) además de sugerirse un papel 
adaptador a ésta familia de proteínas. 
 
Muchas de las proteínas GRK2 se 
localizan en el citoplasma y son traslocadas a 
la membrana plasmática una vez que el 
GPCR es estimulado. Tanto la distribución 
como la actividad de GRK2 están finamente 
reguladas mediante la interacción con la 
subunidad Gβγ, lípidos, receptores agonistas 
activados, calmodulina o la fosforilación por 
parte de otras quinasas. 
 
En diferentes trabajos ha sido 
mostrado que GRK2 tiene capacidad para 
interaccionar con una amplia variedad de 
proteínas y modular su actividad. Estas 
interacciones son tanto dependientes como 
independientes de fosforilación y muchas de 
estas proteínas tienen un papel importante en 
procesos biológicos de la célula T, lo que 
presupone un importante papel en el sistema 
inmune. Recientemente, ha sido demostrado 
que la MAPK 38p se asocia con el GRK2 
endógeno y es fosforilada por éste (Peregrin 
et al, 2006). Otra de las proteínas con 
capacidad de interaccionar con GRK2 es 
PI3kinasa. La unión de GRK2 a PI3Kγ 
promueve su reclutamiento a la membrana 
plasmática una vez que ha sido estimulado 
por agonistas que inducen endocitosis del 
GRK2:
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receptor de quimioquinas en la línea celular 
HEK293T que expresa altos niveles de GRK2 
(Naga Prasad et al, 2001). Recientemente se 
ha sugerido que la asociación de GRK2 con 
MEK y ERK controla la activación de MAPK a 
través del receptor de quimioquinas (Jimenez-
Sainz et al, 2006). En este sentido, la 
interacción GRK2/MEK1/2 reduce la activación 
de ERK1/2 en células HEK293 que sobre-
expresan GRK2 estimuladas con el ligando 
CCL2 de igual forma, una reducción de los 
niveles de GRK2 induce una intensa 
activación de ERK después de estimular 
mediante el uso de agonistas. Finalmente, se 
ha descrito que interacción directa entre el 
domino C-teminal de GRK2 y la serina 
treonina quinasa Akt produce la inhición de 
esta última a través de un mecanismo 
actualmente sin identificar. 
La regulación dinámica de la 
expresión de altos niveles de GRK2 en las 
células del sistema inmune (Chuang et al, 
1992; De Blasi et al, 1995) sugiere un 
importante papel de ésta proteína en la 
actividad inmunológica. Estudios en los que se 
utilizaron linfocitos T GRK2+/- mostraban un 
efecto en la movilidad celular. Se ha indicado 
que una reducción de alrededor el 50% de los 
niveles de GRK2 de las células aisladas de 
estos animales se correlaciona con un 
incremento significante de la respuesta “In 
vitro” a quimiotácticos, así como en la 
señalización celular. 
 
 
 Las células T previamente activadas y 
las células T de memoria tienen un bajo 
umbral de activación en comparación con las 
células vírgenes. Su activación es menos 
dependiente de señales co-estimuladoras y es 
iniciada con bajos niveles de antígeno. Sin 
embargo, aún es desconocido el mecanismo 
preciso que debe estar controlando este el 
aumento de sensibilidad de dichas células. 
  Recientemente ha sido descrito, 
mediante técnicas bioquímicas y de 
microscopia electrónica, que en la membrana 
de las células T vírgenes co-existen dos tipos 
de TCR, los TCR monoméricos y los 
oligoméricos. Además ha sido demostrado 
que los complejos oligoméricos se activan 
preferentemente a bajas dosis de antígeno, 
sugiriendo así la idea de que son estos 
complejos multivalentes los que dan la 
cualidad de alta sensibilidad a las células T.  
 Por lo tanto nosotros planteamos la 
hipótesis de qué la alta sensibilidad 
característica de las células T previamente 
activadas o de las células T de memoria es 
debida a un incremento en el número y 
tamaño de los complejos oligoméricos de TCR 
presentes en su membrana. Para abordar e 
intentar demostrar dicha hipótesis, los 
principales objetivos de la primera parte de 
esta memoria fueron: 
1) Comparar el número y tamaño de los 
complejos oligoméricos de TCR presentes en 
células vírgenes y de memoria. 
2) Diseño y obtención de formas 
mutantes del complejo del TCR que impiden 
OBJETIVOS DEL ESTUDIO: 
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específicamente la oligomerización de los 
TCR en membrana. 
3) Investigar la función de los complejos 
oligoméricos en el proceso de diferenciación y 
activación de las células T. 
La segunda parte de esta memoria está 
focalizado en la búsqueda de nuevos 
mecanismos moleculares a través de los 
cuales el complejo TCR-CD3 es capaz de 
transmitir la señal apropiada para dar lugar a 
la selección positiva y negativa que sufren los 
timocitos DP en el proceso del desarrollo 
tímico. Actualmente, han sido descritas 
múltiples rutas de señalización controladas por 
el TCR, que están implicadas de manera 
cuantitativa y cualitativa en el proceso de 
selección que tiene lugar en el timo, pero es 
aún desconocido el mecanismo molecular a 
través del cual el TCR activa de forma 
diferencial las cascadas de señalización que 
van a dar lugar a la selección positiva o 
negativa.  
 Nosotros planteamos la hipótesis de 
que la señalización differencial que puede 
tener lugar en el proceso de selección tímica 
es dependiente de una asociación diferencial 
de factores intracelulares al complejo del TCR, 
dependiendo de la fuerza de la interacción del 
complejo del TCR con los ligandos del MHC 
expresados en las células del estroma del 
timo. Para comprobar la validez de nuestra 
hipótesis los objetivos principales de esta 
segunda parte de esta memoria fueron: 
1) Estandarizar un modelo murino para 
obtener un gran número de timocitos doble 
positivos que estén sufriendo selección 
positiva y negativa in-vivo. 
2)  Realizar una criba bioquímica usando 
este modelo murino para la búsqueda de 
proteínas asociadas diferencialmente al 
complejo del TCR durante la selección positiva 
y negativa.  
3) Investigar la función de dichas 
proteínas y de su asociación diferencial al 
TCR en el proceso de diferenciación tímica.  
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 En primer lugar, analizamos células 
previamente estimuladas, así como células T 
de memoria, de las que se sabe poseen una 
mayor sensibilidad hacia su antígeno que las 
células T vírgenes, y encontramos que 
estaban enriquecidas en TCRs oligoméricos 
en su superficie (Figuras 11 y 12), lo que 
indica que la estimulación de las células T 
conlleva un cambio en la distribución de los 
complejos de TCR. Con el objeto de 
establecer una relación causal entre los 
oligómeros de TCR y la sensibilidad hacia el 
antígeno diseñamos mutantes del TCR. 
Mutamos las leucinas en posiciones 9 y 19 de 
la región transmembrana de CD3ζ, de la cual 
se ha demostrado que muestra una gran 
energía de interacción en la forma tetramérica 
de la región transmembrana de CD3ζ (Torres 
et al., 2002), altamente conservados y en una 
posición favorable para establecer una 
interacción con otras moléculas (mutantes L9A 
y L19A, Figuras 13A y B). Las cadenas Wild 
Type (WT), L9A o L19A de CD3ζ fueron 
transfectadas en la línea celular MA 5.8, 
deficiente para CD3ζ. L19A CD3ζ reconstituyó 
la expresión del TCR a un nivel similar al de la 
forma WT, mientras que L9A, solo lo consiguió 
de forma parcial (Figura 14A). Por ello, 
continuamos el estudio únicamente con el 
mutante L19A. Experimentos de 
inmunoprecipitación e inmunoblot confirmaron 
la asociación correcta de L19A CD3ζ a los 
demás componentes del TCR (Figura 14B). 
Análisis mediante microscopia electrónica de 
una réplica de la superficie celular de la forma 
WT y el mutante L19A de CD3ζ muestran un 
descenso significativo en el número y tamaño 
de los complejos oligoméricos de TCR en 
comparación con la forma WT (Figura 15). 
Este impedimento en la formación de TCRs 
oligoméricos coincide con un descenso en la 
sensibilidad de L19A CD3ζ en respuesta a 
estímulos antigenicos, en comparación con la 
forma WT (Figura 16). Esto pone de 
manifiesto que los complejos oligoméricos de 
TCR proveen a las células T de una alta 
sensibilidad hacia el antígeno. 
 
Con el propósito de determinar el 
papel de los complejos oligoméricos de TCR 
en la diferenciación y activación in-vivo de 
células T, decidimos transducir precursores de 
medula ósea OT-1 TCR-transgénico de un 
ratón deficiente en CD3ζ (Love et al., 1993) 
con las formas WT y L19A de CD3ζ. Para ello, 
generamos una construcción lentiviral en la 
que se hallan fusionados GFP y CD3ζ WT o 
L19A. Las proteínas de fusión resultantes 
fueron probadas en cuanto a su capacidad 
para restaurar la expresión en la superficie 
celular del TCR, y habilidad para asociarse a 
los demás componentes del TCR. (Figura 17). 
Células que expresaban CD3ζ L19A 
resultaron ser menos sensibles a la 
estimulación mediante antígeno y tenían 
menos y más pequeños complejos 
oligoméricos en la superficie que las células 
que expresaban CD3ζ WT (Figura 18). El 
análisis de los animales reconstituidos con 
L19A CD3ζ mostraron un perfil de 
diferenciación timico y periférico normales, en 
comparación con los WT (Figura 19), lo que 
sugiere que los complejos oligoméricos de 
TCR no juegan un papel importante en la 
diferenciación de células T OT-1 transgénicos, 
o que dichos complejos, no estaban presentes 
en los precursores de células T. Análisis 
RESULTADOS:
Sección 1 
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funcionales llevados a cabo en células T 
vírgenes periféricas, no mostraron diferencias 
en la estimulación entre CD3ζ WT y L19A 
(Figura 20), mientras que cuando células T 
activadas y expandidas in-vitro, fueron 
estimuladas frente a distintas concentraciones 
de su antígeno específico, se observó una 
diferencia sustancial entre ellos con respecto a 
la activación. Las células L19A CD3ζ fueron 
menos sensibles a la estimulación en relación 
a las WT (Figura 21) y esta inhibición en la 
actividad coincidió con un descenso del 
número de complejos oligoméricos de TCRs 
en la superficie celular (Figura 22). 
 
Tomados en su conjunto, estos datos 
indican que el papel de los complejos de 
TCRs oligmericos in-vivo es más pronunciado 
en células que han recibido una estimulación 
antigénica previa, lo que está en concordancia 
con la observación de que estos complejos se 
encuentran enriquecidos en células 
estimuladas previamente así como en 
linfocitos T de memoria, de los que se conoce 
su mayor sensibilidad por el antígeno. 
 
Anteriormente propusimos que la 
capacidad que tiene el complejo TCR de 
activar rutas de señalización en los timocitos 
en función de la fuerza de las interacciones 
con sus ligandos pMHC, depende de la 
asociación diferencial con otras proteínas 
involucradas en la producción de la señal. 
Teneido esto en cuenta, realizamos una 
búsqueda bioquímica para dichas proteínas, y 
desarrollamos un modelo de ratón de 
diferenciación de células T que nos permitiría 
obtener un gran número de timocitos DP que 
sufrirían selección positiva o negativa in-vivo 
(Figura 23, 24 y 25). Tras la estandarización 
de las condiciones para la selección de 
timocitos DP que experimentarán selección 
positiva y negativa, preparamos lisados de 
timo a partir de ambos grupos e hibridamos un 
array de anticuerpos, usando los controles 
apropiados (Figura 26 y 27). De entre las 
proteínas identificadas (Tabla 2) decidimos 
continuar con GRK2, confirmando mediante 
experimentos de inmunoprecipitación e 
inmunoblot independientes la asociación de 
GRK2 con el complejo TCR y por ultímo 
verífícado que esta asociación se producía en 
condiciones de selección positiva.  
 
Para determinar si GRK2 juega un 
papel en la diferenciación de las células T, 
analizamos ratones que carecen de una copia 
funcional del gen GRK2 (ratones GRK2+/-) y 
además transgenicos para los TCR OT-1 o/y 
ANDtg ya que los animales GRK2-/- no son 
viables. Analisis de los timocitos DP mostró 
una clara reducción en el porcentaje de 
timocitos GRK2+/- ANDtg que expresaban un 
alto nivel de TCR en la superficie celular 
(Figura 31 y 32C). Además se observó una 
disminución en la downmodulación de CD69 
en la superficie celular de timocitos CD4 
maduros simples positivos en GRK2+/- 
comparados con ratones GRK2+/+. (Figura 31 
y 32C). El aumento de la expresión del TCR 
en membrana en el estado de DP es una 
señal de una selección positiva con éxito y la 
downmodulación de CD69 en las SP es 
necesaria para la salida del timo de los 
timocitos. En conjunto estos datos indican que 
GRK2 realiza un papel limitante durante la 
selección positiva en el estado de DP y de 
igual manera durante la salida de los timocitos 
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maduros del timo tanto en células MHC de 
clase I cómo en MHC de clase II. 
 
A continuación determinamos si la 
apoptosis celular causada por la carencia de 
un estímulo mediado por TCR o inducida por 
un estímulo fuerte de TCR se veía alterada en 
timocitos GRK2+/-. Mientras que la apoptosis 
in-vitro causada por la carencia de un estímulo 
era ligeramente mayor en los timocitos DP 
GRK2+/-, la apoptosis inducida por la 
estimulación del TCR no se veia afectada. 
Esto sugería que el fenotipo observado en los 
animales GRK2+/- era en su mayor parte 
debido a una alteracíon en la selección 
positiva y no a una selección negativa 
exacerbada. 
 
Dado que la selección positiva es 
estrictamente dependiente de la señalización 
mediada por el complejo TCR, tratamos de 
determinar si una reducción en la cantidad de 
GRK2 afectaba directamente a eventos de 
activación dependientes de TCR-CD3. La 
estimulación in-vitro de timocitos ANDtg 
GRK2+/+ y GRK2+/- muestra una reducción 
marcada de la downmodulación y un aumento 
en la expresión de CD69 en timocitos DP 
GRK2+/- comparados con timocitos DP 
GRK2+/+ (Figura 34). Esta diferencia en la 
respuesta no fue observada en 4SP y ní en la 
periferia (Figura 35). Estos datos sugerían que 
GRK2 jugaba un papel directo en la vía de 
señalización del complejo TCR-CD3.  
 
El estudio de la diferenciación de 
timocitos ANDtg GRK2+/+ y GRK2+/- en fondo 
H2bb mostró un fenotipo adicional. En el fondo 
H-2bb las interacciones TCR-MHCp se 
producen de forma más débil, y por tanto la 
selección positiva es menor comparada con el 
fondo H-2kk. Encontramos una población 
intermedia CD4loCD8lo que era TCRloCD69lo 
en ratones GRK2+/- (Figura 36); entonces 
sugirió que eran timocitos en transición del 
estadio DN a DP y no timocitos DP que habían 
downmodulado CD4 y CD8 tras recibir señales 
que inducen la selección negativa, ya que 
estos timocitos expresan CD69. La aparición 
de esta población intermedia en ratones ANDtg 
GRK2+/- era alelo-dependiente, lo que indicaba 
que jugaba un papel importante en la 
señalización mediada por el TCR en esta 
transición e implicaba un papel para GRK2 en 
este proceso de señalización. Finalmente, 
comparamos la capacidad de migración hacia 
SDF1α de ratones GRK2+/+ con GRK2+/- en 
presencia o ausencia de estímulo mediado por 
TCR. La población de ratones GRK2+/- 4SP y 
DN migraban más en comparación con 
GRK2+/+, lo que concuerda con los datos 
presentados anteriormente, aunque 
encontramos aquí un disminución en la 
capacidad migratoria de los timocitos DP 
(Figura 37). En conjunto estos datos muestran 
que la capacidad migratoria de los timocitos 
GRK2+/- estaba alterada y que la reducción en 
migración de los timocitos DP podría contribuir 
a la reducción en selección positiva observada 
en los ratones ANDtg GRK2+/-. 
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El sistema inmune adquirido proporciona 
memoria antigénica, permitiendo una 
respuesta más rápida y más fuerte tras el 
encuentro con patógenos específicos, lo que 
proporciona inmunidad. Hemos demostrado 
en estudios anteriores que coexisten 
complejos del receptor de células T 
monoméricos y oligoméricos en la superficie 
de células T latentes, mediante ensayos 
bioquímicos y estudios de microscopía 
electrónica, y que además estos complejos 
oligomericos son más sensibles a dosis bajas 
de antígeno. De hecho, nosotros 
hipotetizamos que si estos complejos 
oligoméricos proporcionan a las células T una 
mayor sensibilidad al antígeno, la sensibilidad 
de respuesta a éste sería proporcional al 
número de complejos oligoméricos. Aquí se 
demuestra que tanto las células T activadas 
como las de memoria tienen un mayor número 
de complejos TCR, lo que les proporciona una 
mayor sensibilidad de respuesta al antígeno, 
en comparación con las células T vírgenes. 
Nuestros datos muestran una clara evidencia 
de los cambios que sufren los complejos TCR 
en su distribución tras su estimulación. 
Ha sido demostrado previamente que 
la integridad de los complejos TCR 
oligoméricos dependen del contenido en 
colesterol de la membrana celular. Además ha 
observado que cambios en el contenido de 
colesterol tanto en células T previamente 
activadas como en células T memoria. podrían 
permitir la formación de mas complejos TCR 
oligomericos en estas células. Por otro lado, 
nuestros datos también son compatibles con 
un papel para los contactos proteína-proteína 
en la formación de complejos TCR 
oligoméricos. Teniendo en cuenta que el 
tamaño de las partículas de oro empleadas 
para la detección de agregados de TCR es 
casi idéntica al diámetro del complejo TCR- 
que CD3 y el espacio existente entre los 
partículas de oro observado en las técnicas de 
microscopia electrónica, esto índica que 
serían possible contactos proteína-proteína 
entre complejos TCR individuales. Puesto que 
se ha observado anteriormente que el dominio 
transmembrana de CD3ζ está implicado en la 
formación de un tetrámero, y que una 
mutación de una leucina a una alanina en la 
posición 19 (L19A), dentro de este 
transmembrana reduce la formación de 
complejos TCR oligoméricos, proponemos que 
CD3ζ puede formar interacciones heterotipicas 
o con otra cara, aun desconocida, del 
complejo TCR adyacente o una alteración de 
interacciones homotipicas de CD3ζ y de la 
otra cara (Figura 38A). Esta cara B podria 
estar formada principalmente por el dominio 
Cα, ya que recientemente se ha observado 
que las hebras C y F de Cα juegan un papel 
importante en la dimerización del complejo 
TCR. Finalmente una combinación de ambas 
caras (CD3ζ y Cα) podría estar implicada en la 
formación de los complejos TCR oligomericos 
(Figura 38b). 
 Los complejos TCR oligoméricos 
podrían también jugar un papel relevante en la 
selección tanto positiva como negativa de los 
timocitos debido a su propiedad de amplificar 
señales generadas por los ligandos. Sin 
embargo, al menos en el modelo de selección 
positiva que conocemos no hemos observado 
esta función de los complejos de TCR 
olgomericos. En cambio sí hemos observado 
DISCUSIÓN
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una clara reducción en la sensibilidad en 
linfoblastos primarios mutantes provenientes 
de estos ratones, sugiriendo que el papel 
principal de los complejos TCR oligomericos 
consiste en aumentar la sensibilidad tanto  de 
las células T previamente activadas como de 
células T memoría por el antígeno. 
 Los mecanismos que proporcionan 
una mayor sensibilidad a las complejos TCR 
oligomericos probablemente tengan su base 
en la observación de que la estimulación de 
las células T depende estríctamente de 
complejos pMHC multivalentes. Un aumento 
en el valencia de los receptores y de los 
ligandos debería que aumentar la fuerza de 
interacción y por lo tanto la capacidad 
estimuladora. Por otra parte, se ha observado 
que dentro de los complejos TCR oligomerícos 
existen mecanismos de cooperación que 
podrían permitir una extensión la señal de 
activación de un TCR contactado por pMHC a 
los complejos TCR adyacentes no 
contactados. 
 
Numerosos estudios han demostrado 
la relevancia de la señalización diferencial a 
través del TCR durante la selección positiva y 
negativa. En estos estudios, se pone de 
manifiesto la importancia de las vias pro y anti 
apoptóticas asi como de la vía de las MAPK. 
Sin embargo, todavía no se conocen los 
mecanismo de conexión de estas vías con el 
TCR (durante estos procesos). En este trabajo 
hemos realizado un análisis bioquímico en 
busca de nuevas proteínas asociadas con el 
TCR o de proteínas fosforiladas en tirosinas. 
Además desarrollado un modelo de ratón 
transgénico para el TCR que permite un 
enriquecimiento en timocitos DP en proceso 
de selección positiva y negativa. Las ventajas 
de este modelo son, por un lado, que la 
selección positiva ocurre en condiciones 
fisiológicas en presencia de MHC propios y 
por otro que al no ser necesaria la purificación 
de las células DP, la interacción entre los 
timocitos y las células estromales del timo se 
mantiene hasta el momento del procesamiento 
de las muestras para su análisis. Para la 
detección de proteínas q interaccionan con el 
TCR o que son fosforiladas durante la 
selección positiva se utilizaron arrays CHIPS? 
Utilizaron arrays de anticuerpos en lugar de 
arrays de RNA para poder identificar aquellas 
proteínas que sufrían modificaciones post-
traduccionales o cambios de interaccíon 
durante la selección tímica aunque no se 
alterasen los niveles de su RNA mensajero 
correspondiente. 
De entre todas las proteínas que se 
identificaron con esta aproximación, por 
ejemplo PTEN, PYK2, Grb7 y GRK2, 
escogimos GRK2 para continuar el estudio ya 
que su interacción con el TCR fue confirmada 
por varios métodos y porque está bien 
documentado tanto su papel regulador de la 
actividad de diferentes receptores de 
quimioquinas como su interacción con 
proteínas implicadas en la biología de las 
células T. 
GRK2 se asocia al TCR durante el 
proceso de selección positiva y se disocia 
durante la selección negativa. Interacciona 
solamente con el TCR de timocitos DP y SP,  
y no de DN, a pesar de que todas estas 
células expresan tanto el TCR como GRK2. 
Esta asociación diferencial entre el TCR y 
GRK2 debe de ser consecuencia de la 
expresión de factores específicos en cada uno 
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de estos estadios de diferenciación de las 
células T. Otro grupo ha descrito 
recientemente la interacción TCR-GRK2 y, si 
bien no se menciona la asociación diferencial 
descrita en nuestro trabajo (DeFord-Watts et 
al, 2007). Muestran que GRK2 interacciona 
con la secuencia BRS de CD3ε. Puesto que la 
secuencia BRS es adyacente a la secuencia 
PRS un posible mecanismo para explicar la 
disociación de GRK2 del TCR durante la 
estimulación sería que el cambio 
conformacional que ocurre en la región PRS 
tras la unión de un agonista o un péptido que 
promueve la selección negativa, y que va su 
vez permite la unión de Nck a CD3e, induciría 
la disociación de GRK2 de BRS.bien por sí 
mismo o bien gracias a la unión de Nck  
 
Puesto que GRK2 interacciona con el 
TCR durante la selección positiva, 
proponemos que el papel de GRK2 es más 
importante para la selección positiva que para 
la selección negativa. El análisis de animales 
GRK2+/- transgénicos para los TCRs OT-1 y/o 
AND muestra que GRK2 juega un papel 
relevante en la selección positiva mediante 
mecanismos dependientes e independientes 
del TCR. En ambos modelos animales, la 
población DP GRK2+/- muestra un aumento 
menos eficaz de la expresión del TCR, lo que 
sugiere un defecto en selección positiva. Otras 
respuesta mediadas a través del TCR como 
son la regulación negativa de la expresión del 
TCR en la membrana y el aumento de la 
expresión de CD69 en respuesta a 
estimulación antigénica in-vitro, también están 
alteradas en timocitos DP GRK2+/-. Todo esto 
sugiere que GRK2 juega un papel en la 
señalización a través del TCR. El papel 
limitante de GRK2 en células en distintos 
estadios de diferenciación en el timo podría 
explicarse por la baja expresión del TCR en 
células DP en comparación con células 4SP y 
CD4+, lo que haría que la señalización a través 
del TCR en los timocitos DP fuera más 
sensible a pequeñas alteraciones en vías 
‘downstream’. 
En ratones GRK2+/- ANDtg que 
expresan MHC del tipo H2bb (lo que se traduce 
en un ligando más débil del TCR AND) se 
observó una clara disminución en el número 
de timocitos DP y 4SP y la aparición de una 
población con baja expresión de los co-
receptores CD4 y CD8, el TCR y CD69. Estas 
células parecen células transitorias entre los 
estadios DN y DP y el hecho de que su 
detección depende de una disminución del 
nivel de expresión de GRK2 indicaria que 
GRK2 esta implicado en esta transición. A 
favor de esta hipótesis, se ha observado que 
la región BRS de CDε, donde se une GRK2 , 
es esencial para la transición del estadio DN a 
DP. 
La migración de los timocitos GRK2+/- 
DP en respuesta a SDF-1α está reducida. 
Ésta contrasta con el aumento de la capacidad 
migratoria de las células CD4 SP observado 
en nuestro estudio y en estudio de la 
migración de células T maduras. Aun a´si, en 
todas las poblaciones, una estimulación 
paralela del TCR reduce la capacidad 
migratoria hacia SDF-1α. Se ha demostrado 
que el receptor de quimioquinas CXCR4, 
receptor principal para SDF, necesita las  vías 
de señalicaciòn dependientes del TCR para su 
propia señalización, y que el menos en 
timocitos DN la estimulación por CXCR4 es un 
componente esencial para la señalización a 
través del pre-TCR  Proponemos que GRK2 
sierve como un coordinador entr ambas rutas 
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de señalización en timocitos DP, y que ambas 
rutas de señalización dependen del otro para 
generar una señal suficientemente fuerte para 
permitir la migración y selección positiva. Es 
mas CXCR4 también está implicado en la 
transmisión de señales de supervivencia a 
través del pre-TCR. En nuestro trabajo, hemos 
observado un ligero aumento en la inducción 
de la apoptosis de células ANDtg GRK2+/- en 
comparación con timocitos ANDtg silvestre 
para GRK2, por lo tanto GRK2 podría 
promover la supervivencia de los timocitos DP. 
Finalmente, el hecho de que en los timocitos 
SP GRK2+/- la disminución de la expresión de 
CD69 en la membrana sea menor, sugiriendo 
un efecto en la salida de los timocitos maduros 
del timo, apunta hacia un papel de GRK2 
independiente del TCR durante la selección 
positiva. Dado que no se ha descrito todavía la 
implicación de la señalización a través del 
TCR en este proceso. 
 
  
 
 
 
 
 
 
 
 
 
 
 
1.-Las células T previamente 
activadas expresan en su membrana 
plasmática un mayor numero y tamaño de 
TCR oligoméricos que las células T vírgenes. 
2.-La mutación de un residuo de 
Alanina a Leucina en la posición número 19 de 
la región transmembrana de la cadena de 
CD3ζ altera la formación de oligómeros de 
TCR en hibridomas de células T, sin afectar al 
ensamblaje del TCR ni a los niveles de 
expresión en la superficie celular.  
3.-Esta alteración en la formación de 
TCRs oligoméricos en el hibridoma de células 
T que expresa la cadena mutante de CD3 
tiene como consecuencia una disminución de 
la sensibilidad en el reconocimiento de 
antígeno, lo que demuestra que la existencia 
de TCRs oligoméricos provoca un aumento en 
la sensibilidad a antígeno. 
4.-La expresión de la cadena mutante 
de CD3ζ en precursores de un clon TCR-
transgénico no afecta a su diferenciación 
tímica ni a la generación de células T 
virgenes, lo que sugiere que los TCRs 
oligómericos no están implicados en estos 
procesos. 
5.-La respuesta primaria de células T 
vírgenes TCR-transgénicos que expresan la 
forma mutante de la cadena CD3ζ es normal. 
Sin embargo, estas células responden peor 
que aquellas que expresan la forma silvestre 
de CD3ζ a una segunda estimulación. 
Asimismo, estas células presentan un menor 
tamaño y número de TCRs oligoméricos, lo 
que indica que los TCRs oligoméricos son 
responsables del aumento en la sensibilidad a 
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antígeno de las células T primarias 
previamente activadas. 
6.-Mediante el uso de un nuevo 
modelo animal de selección positiva y 
negativa sincronizada en el timo, se muestra 
que GRK2 se asocia con el TCR en timocitos 
DP durante la selección positiva. 
7.-En timocitos de ratones 
transgénicos OT-1 y AND con niveles más 
bajos de expresión de GRK2, se detecta un 
menor aumento en la expresión del TCR en el 
estadio de DP. Esto sugiere que la selección 
positiva es menos eficiente en estas células e 
indica la implicación de GRK2 en este 
proceso. 
8.-Los timocitos DP de animales 
transgénicos AND con menor expresión de 
GRK2 presentan una menor sensibilidad a 
antígeno en ensayos in-vitro, lo que sugiere 
que GRK2 está implicada en la señalización a 
través del TCR. 
9.-Una población de timocitos con 
bajos niveles de CD4, CD8, TCR y CD69 
surge en ratones AND transgénicos que 
expresan un nivel reducido de GRK2 y 
ligandos más debiles para la selección 
positiva. Esta sugiere que GRK2 tiene un 
papel en la transición del estadio DN a DP de 
las células AND-transgénicos. 
10.-La reducción en expresión de 
GRK2 tiene efectos opuestos en la capacidad 
migratoria de las timocitos AND-transgenicos 
DP y 4SP hacia SDF-1α, indicando diferencias 
en la regulación GRK2-dependiente de estos 
procesos en ambas poblaciones. Estimulación 
paralela del TCR reduce la capacidad 
migratoria de ambas poblaciones, mostrando 
que las vías de señalización a través del TCR 
interaccionan funcionalmente con la vía de 
señalización inducida por SDF-1α. 
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Running title: Avidity maturation in T cells 
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Summary 
 
 Although memory T cells respond more vigorously to stimulation and they are 
more sensitive to low doses of antigen than naive T cells, the molecular basis of this 
increased sensitivity remains unclear. We have shown that the TCR exists as different 
sized oligomers on the surface of resting T cells and that larger oligomers are 
preferentially activated in response to low antigen doses. Through biochemistry and 
electron microscopy we now show that previously stimulated and memory T cells have 
more and larger TCR oligomers at the cell surface than their naive counterparts. 
Reconstitution of cells and mice with a point mutant of the CD3ζ subunit which impairs 
TCR oligomer formation, demonstrates that the increased size of TCR oligomers is 
directly responsible for the increased sensitivity of antigen-experienced T cells. Thus, 
we propose that an “avidity maturation” mechanism underlies T cell antigenic memory. 
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Introduction 
 
 The acquired immune system provides its host with “antigenic memory”, 
permitting a faster and stronger response when reencountering specific pathogens. At 
the population level, this antigenic memory is due to an increase in the size of T cell 
precursor population (Askonas et al., 1982) and preferential growth of higher affinity T 
cell clones that will form the memory T cell pool (Busch and Pamer, 1999; Malherbe et 
al., 2004; Zehn et al., 2009). At the cellular level, memory T cells convert more rapidly 
into effector T cells and produce larger amounts of effector molecules (Bachmann et al., 
1999; Bruno et al., 1995; Cho et al., 1999; Veiga-Fernandes et al., 2000; Zimmermann 
et al., 1999). Moreover, previously stimulated and memory T cells (‘antigen-
experienced’ T cells) are more sensitive to stimulation via their TCR than naive T cells. 
This is reflected in their relative independence of costimulatory signals (Croft et al., 
1994; London et al., 2000) and it has been directly shown by the reduction in the 
amount of antigen needed to give rise to T cell activation (Ericsson et al., 1996; 
Kimachi et al., 1997; London et al., 2000; Pihlgren et al., 1996; Rogers et al., 2000; 
Slifka and Whitton, 2001). The increase in sensitivity of antigen-experienced T cells is 
unlikely to be due to an increase in the affinity of their TCR for the specific peptide-
MHC (pMHC) ligands, as rearranged TCRs have not been found to undergo somatic 
hypermutation. Instead, other molecular changes must be at play.  
 Permanent changes in the TCR-associated signal transduction machinery of 
antigen-experienced T cells have been described and correlated with their increased 
sensitivity. For example, different isoforms of the tyrosine phosphatase CD45 are 
expressed by naive and antigen-experienced T cells (Beverley et al., 1992) and these 
isoforms differentially affect the sensitivity of TCR-mediated signaling (Novak et al., 
1994). In addition, antigen-experienced T cells express higher levels of the tyrosine 
kinase Lck than naive T cells, which correlates with their increased sensitivity to 
antigen-specific stimulation (Kersh et al., 2003; Slifka and Whitton, 2001). 
 Lasting changes in the organization of the TCR complexes themselves may also 
be related to the behavior of antigen-experienced T cells. We have shown by 
biochemical and electron microscopy (EM) based approaches that the TCR on the 
surface of human and mouse T cell lines is expressed as a combination of oligomers of 
different sizes and monomeric TCR complexes (Schamel et al., 2005). The presence of 
these TCR oligomers is independent of antigenic stimulation and/or contact with an 
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antigen presenting cell (APC), making them distinct from the TCR microclusters and 
immunological synapses (Yokosuka and Saito, 2010). Importantly, we provided 
evidence that the larger TCR oligomers are preferentially phosphorylated during 
encounters with small amounts of antigen, suggesting that the large TCR oligomers are 
responsible for the exquisite sensitivity of T cells (Schamel et al., 2005).  
 Here, we show that primary antigen-experienced T cells have larger TCR 
oligomers on their cell surface than naive T cells, and that this is correlated with 
increased antigen sensitivity. Furthermore, we describe a mutation in the 
transmembrane domain of the CD3ζ chain that impairs the formation of TCR oligomers 
and that reduces sensitivity to antigen stimulation. This provides direct evidence of the 
importance of oligomeric TCR complexes in the sensitivity towards antigen. Finally, by 
reconstituting bone marrow precursors from CD3ζ-deficient mice with either wild type 
or mutant CD3ζ, we show that the presence of oligomeric TCR complexes on primary T 
cells is critical in the transition from naive to antigen-experienced T cells. 
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Results 
 
Larger oligomeric TCR complexes on previously stimulated and memory T cells 
coincide with increased sensitivity to antigen stimulation. 
 TCR oligomers of different sizes coexist with isolated TCR complexes on the 
cell surface of resting human peripheral blood T cells and human and murine T cell 
lines (Schamel et al., 2005). We assessed whether the stimulation of primary T cells had 
a lasting effect on the size of the TCR complexes. Accordingly, fresh human peripheral 
blood T lymphocytes and peripheral blood lymphocytes stimulated for two days with 
PHA and then expanded for five more days in medium containing IL2 were fixed, 
labeled with the anti-CD3 antibody OKT3 and 10 nm gold-conjugated protein A. 
Subsequently cell surface replicas were prepared and the number and size of the gold 
clusters present on the replicas of individual cells was examined by EM. Single gold 
particles and clusters of gold particles coexisted on the surface of both freshly isolated 
and PHA-activated peripheral blood T lymphocytes (fig. 1a). However, quantitative 
analysis indicated that the previously stimulated cells had a higher percentage of the 
larger TCR oligomers than freshly isolated cells (fig. 1b), and that the clusters were 
bigger in these cells. 
 Since staining efficiency in these experiments only reached 10-20%, the 
frequency and size of oligomeric TCRs detected by immuno-gold EM might be 
underestimated. To overcome this limitation, we analyzed the size distribution of the 
TCR by Blue Native polyacrylamide gel electrophoresis (BN-PAGE). When extracted 
with the mild detergent Brij96, TCR oligomers are kept intact and can be separated 
according to their size (Alarcon et al., 2006; Schamel et al., 2005). Membranes from 
PHA-activated and IL2-expanded T cells or from fresh blood T cells were lysed in 
Brij96 and subjected to BN-PAGE and immunoblotting (fig. 1c). In both T cell 
populations, monomeric TCR complexes with a αβεδεγζζ stoichiometry (Schamel et 
al., 2005; Swamy et al., 2007) were seen just below the f1 marker, as well as oligomeric 
complexes. However, there was a clear increase in the ratio of oligomeric to monomeric 
TCRs in PHA-activated cells when compared to naive T cells. This was not due to a 
mobility shift in the BN-gel caused by PHA-bound TCRs, as addition of PHA to the 
purified TCR before separation by BN-PAGE did not change the size of the TCR (not 
shown). When we quantified the ratio of oligomeric to monomeric TCRs measured by 
BN-PAGE at different times after T cell stimulation (fig. 1d), it increased gradually 
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before reaching a maximum after day 9. This slow increase in the TCR oligomer 
content of T cells further excluded crosslinking effects caused by the lectin stimulus that 
would be expected to occur within minutes or hours. Together these experiments 
indicated that a lasting change in distribution of the TCR complexes towards large pre-
formed TCR oligomers took place in antigen-experienced T cells several days after T 
cell stimulation. 
 To gain further evidence of the increase in oligomeric TCR complexes on 
antigen-experienced T cells, naive and memory CD4+ T cells were isolated from the 
spleen and lymph nodes of C57BL/6 mice based on their reciprocal CD62L and CD44 
expression (Budd et al., 1987; Lee and Vitetta, 1991). A depletion strategy was used in 
which only CD4+CD44loCD62Lhi (mostly naive) or CD4+CD44hiCD62Llo (mostly 
memory) T cells were spared (fig 2a). The size of the CD4+CD44hiCD62Llo T cells was 
similar to the size of the CD4+CD44loCD62Lhi T cells (fig. 2a, right panel), strongly 
suggesting that they were resting memory T cells and not recently activated CD44hi T 
cells. Both T cell populations were fixed and labeled with the anti-CD3 mAb 145-2C11, 
which was detected with gold-conjugated protein A. Analysis of cell surface replicas of 
these cells by electron microscopy showed an increase in the percentage of gold 
particles forming part of large oligomeric clusters on the memory T cell population (fig. 
2b and c). Thus, enrichment for more and larger oligomeric TCR complexes also 
occurred in vivo in polyclonal CD4+ memory T cells formed by encounter with their 
physiological antigens. 
 We then  analyzed murine CD8+, OT-1 TCR-transgenic (OT-1tg) T cells, specific 
for an ovalbumin-derived peptide (OVAp) bound to the H-2Kb molecule (Hogquist et 
al., 1994), which allowed us to compare naive and antigen-experienced T cells 
expressing identical TCRs. Naive OT-1tg T cells, purified from lymph nodes via 
depletion of CD4+ T cells and B cells, expressed low to intermediate levels of CD44 
(fig. 3a, left panel). In vitro stimulated and expanded OT-1tg T cells were obtained by 
stimulating splenic OT-1tg T cells with OVAp for 2 days and expanding them with IL2 
for another 6 days, at which point all these T cells expressed a high level of CD44 (fig. 
3a, right panel). Gold particles on cell surface replicas of naive OT-1tg T cells stained 
with anti-CD3 were mostly present as isolated particles with only a few, relatively small 
clusters. By contrast, replicas of previously stimulated OT-1tg cells were enriched in 
gold clusters that were also larger (fig. 3b and c).  
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 We assessed whether the increase in size and number of the TCR oligomers in 
previously stimulated OT-1tg T cells was correlated with greater sensitivity to antigen 
stimulation. Thus, OT-1tg T cells from spleen were stimulated and expanded as above, 
with the sole exception that IL2 was withdrawn from the culture the day before the 
assay. Overnight stimulation with OVAp of these previously stimulated cells increased 
the expression of CD25 at a 10-fold lower concentration of OVAp while IFNγ 
production started at a 100-fold lower concentration of OVAp than in naive OT-1tg T 
cells (fig. 3d). When we stimulated these cells with a soluble pentameric Kb-OVAp 
ligand, previously stimulated OT-1tg cells were 100 to 3000-fold more sensitive to 
stimulation with this pentameric MHC ligand, as evident by up-regulation of CD69 and 
the production of IFNγ (fig. 3e). Hence, the increased sensitivity of previously 
stimulated T cells was independent of changes in expression of adhesion molecules. 
 Finally, we generated OT-1tg memory T cells in vivo, in order to determine 
whether oligomeric TCR complex enrichment and increased sensitivity occurred in a 
physiologically relevant setting. Memory T cells were obtained by co-transferring naive 
OT-1tg T cells and OVAp-loaded bone marrow-derived DCs into CD45.1 congenic 
recipients. Six weeks later a small population of CD8+ donor-derived T cells was 
evident in the spleen and lymph nodes isolated from the recipient animals (fig. 4a). 
When compared with freshly isolated naive OT-1tg T cells, these cells were all CD44hi 
and expressed more LFA-1. Both cell types were of equal size and expressed equal 
amounts of CD8, indicating that the CD44hiLFA-1hi T cells were resting memory cells. 
The memory OT-1tg T cells were more sensitive to stimulation with Kb-OVAp tetramers 
than the naive OT-1tg T cells, as measured by the expression of CD25 and by IFNγ 
production (fig. 4b). As both populations expressed equal amounts of the MHC class I 
binding co-receptor CD8, this showed that the increased sensitivity of the memory OT-
1tg T cells was directly related to stimulation via the TCR. 
 The small population of memory T cells in the recipient animals (fig. 4a) did not 
allow us to purify enough of these cells to perform EM analysis and directly establish 
that OT-1tg memory T cells expressed more and larger oligomeric TCR complexes at 
the cell surface than naive OT-1tg cells. Therefore, we stimulated spleen cells obtained 
from the recipient animals and from non-manipulated OT-1tg mice with OVAp for two 
days in vitro, and then expanded them in the presence of IL-2 for six more days. 
Comparing the cell surface replicas of anti-CD3-labeled cells, in vitro activated cells 
derived from memory OT-1tg cells expressed significantly more and larger TCR 
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oligomers than in vitro activated cells derived from naive OT-1tg cells (fig. 4c). This 
suggested that the distribution of TCR complexes on the cell surface of memory T cells 
was different from that of naive T cells before in vitro activation, as otherwise no 
difference in distribution would be expected. This would also imply that repeated 
stimulation with antigen resulted in an additional increase in oligomeric TCR 
complexes. 
Thus, in the three different types of T cells studied, antigen-experienced T cells 
have more and larger TCR oligomers when compared to their naive counterparts. 
Furthermore, in the antigen-specific settings the increased size of TCR oligomers 
coincided with an increased sensitivity to antigen stimulation. 
 
A point mutation in the transmembrane region of CD3ζ disrupts TCR oligomers 
and reduces sensitivity to antigen 
 The data presented above highlighted the correlation between larger TCR 
oligomers and increased sensitivity to antigenic stimulation, in line with our previous 
observation that oligomeric TCR complexes are preferentially activated in the presence 
of small amounts of antigen (Schamel et al., 2005). To establish whether a causal 
relationship exists, we investigated the effect of mutations in TCR subunits that disrupt 
the formation of TCR oligomers without affecting TCR assembly and expression at the 
cell surface. 
 We focused our attention on CD3ζ, since earlier biophysical data showed that 
peptides representing the transmembrane domain of CD3ζ not only formed dimers, but 
also tetramers (Torres et al., 2002). Indeed, two leucine residues at positions 9 and 19 
(L9 and L19) are thought to be critical for tetramer formation but not for dimer 
formation. In 2006, the structure of the transmembrane domain of the CD3ζ was solved 
(Call et al., 2006), which showed that it formed a symmetrical dimer (reproduced in fig. 
5a). The L9 residue points towards the center of the dimer and it is implicated in 
interstrand hydrogen bonding between the two CD3ζ chains of the dimer. By contrast, 
L19 points outwards, in a position favorable to form potential contacts with a second 
dimer. Given the symmetry of the CD3ζ dimer and the finding that the transmembrane 
domains of CD3ζ could form tetramers (Torres et al., 2002), we tested whether mutation 
of L9 and L19 affected oligomeric TCR formation. 
 CD3ζ chains carrying a single L9A or L19A mutation were generated and 
expressed in the CD3ζ-deficient MA5.8 derivative of the murine T hybridoma 2B4, 

 - 9 - 
specific for a moth cytochrome c (MCC)-derived peptide (Sussman et al., 1988). Pools 
of cells expressing the L9A or L19A CD3ζ chains were analyzed for their ability to 
express the TCR complex at the cell surface (fig. 5b). MA5.8 cells transfected with 
L19A CD3ζ expressed similar levels of the TCR at the cell surface as MA5.8 cells 
transfected with wild type CD3ζ or the 2B4 line. However, L9A CD3ζ only partially 
reconstituted the cell surface expression of the TCR complex, consistent with the 
previously described effect of this mutation on dimer formation (Call et al., 2006). As 
the amount of TCR expressed at the cell surface could influence the distribution of the 
TCR and the sensitivity of T cells, we focused our attention exclusively on the L19A 
mutant. 
 Immunoprecipitation and immunoblot experiments showed that L19A CD3ζ 
formed homodimers and was able to assemble with the other CD3 components to a 
similar extent as wild type CD3ζ (fig. 5c). However, L19A CD3ζ transfectants 
expressed significantly smaller oligomeric TCR complexes at the cell surface than wild 
type CD3ζ-expressing cells (fig. 5d). L19A CD3ζ transfectants could respond to high 
concentrations of antigen in vitro, indicating that the L19A mutation did not perturb 
TCR signaling per se, but they were less responsive than wild type transfectants, when 
measured in terms of CD69 induction and IFNγ production (fig. 5e). Hence, oligomeric 
TCR complexes endow T cells with greater sensitivity to antigen. 
 
TCR oligomers increase the sensitivity of antigen-experienced primary T cells. 
 We wished to determine the relevance of oligomeric TCR complexes in vivo. 
We generated CD3ζ-GFP fusion proteins in order to facilitate detection of transduced 
cells. These fusion proteins recapitulated the properties of their counterparts without 
GFP when expressed in MA5.8 cells. Thus, wild type and L19A CD3ζ-GFP proteins 
were equally capable of rescuing the expression of the TCR complex at the cell surface 
and of associating with the other CD3 components. However the capacity of L19A 
CD3ζ-GFP expressing cells to form large TCR oligomers was significantly impaired 
and they were less sensitive to antigenic stimulation (fig. S1). 
 We transduced bone marrow cells isolated from OT-1tg, CD3ζ-deficient mice 
(Love et al., 1993) with lentiviral vectors encoding the wild type or L19A CD3ζ-GFP 
fusion proteins, or GFP alone, and reconstituted sub-lethally irradiated C57BL/6 mice 
with the transduced bone marrow cells. Mice were sacrificed four to six weeks after 
reconstitution and the capacity of the CD3ζ-GFP-transduced bone marrow precursors to 
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give rise to thymic and peripheral T cells was assessed. Wild type and L19A CD3ζ-GFP 
expressing thymocytes differentiated similarly into CD8 SP thymocytes, while GFP 
expressing thymocytes did not differentiate beyond the DP stage (fig. 6a). Hence, the 
L19A CD3ζ-GFP protein permitted the TCR signaling necessary for positive selection. 
Consistent with normal thymic differentiation, both wild type and L19A CD3ζ-GFP 
expressing CD8+ OT-1tg T cells were found in peripheral lymphoid organs (fig. 6b). 
These cells had similar amounts of the TCR at the cell surface, and their expression of 
CD69, CD25, CD28, LFA-1, CD44 and CD62L was very similar to that observed on 
control OT-1tg T cells, indicating that they were naive, resting T cells. Thus, the 
impairment of TCR oligomer formation by the L19A CD3ζ mutant did not appear to 
affect differentiation of T cell precursors into naive CD8+ T cells. 
 However, the sensitivity to restimulation with antigen was strongly diminished 
when previously stimulated OT-1tg T cells bearing the L19A mutation in CD3ζ were 
restimulated in vitro (fig. 6c). This loss of sensitivity coincided with a significant 
reduction in the number of oligomeric TCR complexes detected on these cells when 
compared to T cells reconstituted with the wild type CD3ζ chain (fig. 6d). These data 
indicated that the impairment of oligomeric TCR formation had a pronounced effect on 
the sensitivity of primary antigen-experienced T cells to antigen. 
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Discussion 
 We show here that antigen-experienced T cells, i.e. murine CD4+ memory T 
cells and murine and human primed T cells have an increased proportion of TCR 
complexes organized into larger oligomeric TCR complexes, as compared to their naive 
counterparts. Unlike the TCR microclusters that form upon ligation with pMHC 
(Yokosuka and Saito, 2010), the TCR clusters studied here pre-exist, independent of 
TCR ligands, are of nanometer dimensions, and could therefore be named TCR 
nanoclusters. Using OVAp-specific OT-1tg T cells, we show that the increase in TCR 
oligomer size is correlated with a greater sensitivity towards antigenic stimulation, 
suggesting that the reorganization of the TCR complexes is a mechanism by which 
effector and memory T cells acquire their increased antigen-sensitivity. Finally, using a 
mutant of CD3ζ that impairs oligomeric TCR formation, we provide direct evidence of 
the importance of oligomeric TCR complexes in the sensitivity of T cell lines and 
antigen-experienced primary T cells. 
 Our early studies on double TCR-transgenic mice, using FRET, co-modulation 
and co-precipitation techniques, showed that TCRs of different antigen specificity are 
physically associated (Fernandez-Miguel et al., 1999). BN-PAGE and immuno-gold 
EM analysis indicated that the TCR is expressed as a mixture of oligomers of different 
size in unstimulated resting T cells, ranging from single complexes to clusters of 20 or 
more TCR complexes arranged mainly in a linear manner (Schamel et al., 2005). By 
analysis of membrane sheets by EM, many membrane receptors have been seen to be  
non-randomly associated, forming “protein islands” supported by cholesterol and the 
underlying cytoskeleton (Lillemeier et al., 2006). The TCR is one such  receptors, as 
demonstrated by two high-resolution confocal microscopy techniques (high-speed 
photoactivated localization microscopy and dual-color fluorescence cross-correlation 
spectroscopy), in combination with electron microscopy of membrane sheets 
(Lillemeier et al., 2009). It could be argued that the pre-existing TCR oligomers we 
detected by EM are artificially produced by the antibody used to detect the TCR 
clusters. However, a series of controls argues against this notion. First, T cells were 
fixed with an aldehyde before incubation with the anti-CD3 antibody and maintained at 
0˚C throughout the whole procedure. Both these steps should block or limit the 
rearrangement of receptors in the membrane. Second, cholesterol extraction does not 
affect the density of the TCR in the membrane but it does disrupt the oligomeric TCRs 
(Schamel et al., 2005) arguing against an antibody-promoted effect. Third, the size of 
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the TCR oligomers differs for naive and antigen-experienced T cells, even if they are 
both analyzed with the same antibody. Fourth, the increase in size and number of 
oligomeric TCRs on antigen-experienced T cells can be detected with an independent 
method, namely BN-PAGE. Fifth, and more importantly, we demonstrate that 
oligomeric TCRs can be disrupted by genetically altering a single position in the 
transmembrane domain of the CD3ζ subunit, L19, having previously been predicted to 
participate in the formation of CD3ζ tetramers (Torres et al., 2002). Hence we believe 
our data does not simply reflect a technical artifact but rather, along with studies using a 
series of unrelated techniques (Lillemeier et al., 2009), this data shows that the TCR is 
expressed as pre-existing oligomers before the T cell is engaged by its pMHC ligand. 
Furthermore, the effect of the L19A mutation on sensitivity of antigen-experienced T 
cells suggests that the TCR is functionally multivalent in this population. However, 
TCRβ selection, positive selection and lineage commitment are not affected in OT-1tg 
thymocytes expressing L19A CD3ζ, suggesting a minor or non-existent contribution of 
oligomeric TCRs in the thymus. 
 Soluble bivalent MHC ligands have been shown to bind better to previously 
activated mouse 2Ctg CD8+ T cells than to their naive counterparts, suggesting that the 
distribution of the TCR changes after stimulation (Fahmy et al., 2001). We provide 
direct evidence here for such changes, and show that this leads to greater sensitivity for 
antigen. Interestingly, the bivalent MHC binding studies indicate the existence of 
uniform binding sites on naive CD8+ 2Ctg T cells. This coincides remarkably with the 
observation that the overwhelming majority of gold clusters on naive mouse CD4+ and 
CD8+ T cells have a size of 1-3 particles. Due to the inefficiency of the gold labeling 
procedure, (only up to 10-20% of the total TCR is detected), we cannot be sure of 
whether the TCR is mainly expressed in naive T cells as monomers or as small 
oligomers. What is clear is that activation and differentiation into memory T cells is 
accompanied by an increase in the size of the oligomers and this could be the 
mechanism underlying the increased avidity of the TCR for bivalent pMHC ligands 
(Fahmy et al., 2001). 
 The increase in the size of oligomeric TCR complexes during their 
differentiation from naive to antigen-experienced T cells is a cell-inherent process that 
takes several days. This redistribution is maintained in the absence of antigen or 
continued contact with APCs, as the oligomeric TCR complexes can be detected on T 
cells that have been maintained in single cell suspensions. It is dependent on the 
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presence of cholesterol in the membrane, as both oligomeric TCR comlexes (Schamel et 
al., 2005) and strong MHC-binding (Drake and Braciale, 2001; Fahmy et al., 2001; 
Uhlin et al., 2003) are lost in cells exposed to methyl-β-cyclodextrin. An increase in 
membrane-associated cholesterol in antigen-experienced T cells could be important to 
permit the generation of larger TCR oligomers. Such lipid changes do occur upon 
stimulation of T cells with anti-TCR antibodies and are stably acquired by memory T 
cells in vivo (Brumeanu et al., 2007; Kersh et al., 2003). Changes in the lipid 
composition of the membrane would also explain why the increase in the size of TCR 
oligomers takes several days (see fig. 1d). In addition, protein-protein interactions may 
also play a role in the formation of TCR oligomers, as suggested by the effect of the 
L19A mutation. The outward position of the L19 residue in the transmembrane domain 
of CD3ζ (Call et al., 2006) and its role in the formation of CD3ζ tetramers in vitro 
(Torres et al., 2002), suggest that the L19A mutation disrupts the interaction between 
neighboring TCR complexes. Accordingly, the CD3ζ transmembrane domain would be 
part of the TCR-TCR interaction surfaces. In this regard, the effect of Cα mutants on the 
dimerization of TCRα/TCRβ chimeras containing the signaling cytoplasmic tail of the 
erythropoietin receptor described recently (Kuhns et al., 2010) indicates that the C and F 
strands of Cα could constitute part of the same interaction site, together with the 
transmembrane domain of CD3ζ, or constitute opposing interaction sites (Fig. 7). 
 How might oligomeric TCRs increase the sensitivity of T cells? T cell activation 
is dependent on the interaction with multivalent pMHC ligands (Boniface et al., 1998; 
Cochran et al., 2000), which induces a structural rearrangement in the TCR complex 
required for signaling (Minguet et al., 2007). Indeed, the MHC molecules on the cell 
surface of APCs can form clusters that may even be enriched for particular antigenic 
peptides (Anderson et al., 2000; Kropshofer et al., 2002). However, stimulation by 
adjacent MHC molecules presenting identical antigenic peptides does not appear to be 
absolutely required for T cell activation, as soluble bivalent MHC complexes presenting 
one antigenic peptide in combination with another unrelated peptide can stimulate T 
cells (Krogsgaard et al., 2005). Thus, a pMHC cluster in which at least one of the bound 
peptides is an agonist for the TCR of the interacting T cell could trigger activation of 
this T cell. TCR oligomers would enhance the avidity to such multimeric pMHC, which 
would be especially critical if an agonist peptide is presented next to low affinity self-
peptides. In addition, TCR oligomers could allow spreading of TCR activation from the 
agonistic pMHC-engaged TCR to the adjacent ones. For example, this lateral spreading 
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could be mediated via lateral ITAM phosphorylation within the TCR oligomer by 
agonist pMHC-dependent Lck recruitment. Alternatively, the TCR itself could cause 
this lateral spreading. Conformational changes can serve as a means to transmit 
information on ligand binding to the cytoplasmic tails of the CD3 signaling subunits 
(Gil et al., 2002) Hence, TCR oligomers could facilitate signal spreading by permitting 
the transmission of the active conformation from agonist pMHC-contacted TCRs to 
others within the same oligomer (Schamel et al., 2006). Such a cooperative effect was 
recently demonstrated by expressing a conformational inactive mutant of CD3ε in T 
cells that carry an excess of endogenous wild type CD3ε (Martinez-Martin et al., 2009). 
Expression of the conformational inactive mutant prevents the active conformation from 
being adopted by the TCRs containing wild type CD3ε. Therefore, in addition to higher 
avidity for antigen derived from the multivalency of the TCR oligomers, the 
organization of the TCR into oligomeric structures would facilitate extensive 
cooperativity between agonist pMHC-engaged TCRs and TCRs engaged by self-
peptide/MHC complexes. Accordingly, it would be plausible that previously activated 
and memory T cells would have greater antigen sensitivity than naive T cells because 
more and larger TCR oligomers would increase the chance of a multivalent TCR-MHC 
interaction and permit more extensive signal spreading. 
 In summary, our data provide evidence that the extent of antigen-independent 
oligomerization of the TCR increases in the transition from naive to antigen-
experienced T cells and that this oligomerization of the TCR provides these antigen-
experienced T cells with greater sensitivity. Future studies should focus on the 
molecular mechanisms that enable the formation and enrichment of oligomeric 
complexes, thereby providing a potential tool to strengthen or weaken T cell responses 
at will. 
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Materials and methods 
 
Mice. C57BL/6 mice, CD3ζ-deficient mice (Love et al., 1993), (acquired from the 
Jackson Laboratories), OT-1tg mice (Hogquist et al., 1994) and CD45.1-congenic 
C57BL/6 mice (kindly provided by Dr C. Ardavin, Centro Nacional de Biotecnología, 
Madrid) were maintained under SPF conditions at the animal facility of the ‘Centro de 
Biología Molecular Severo Ochoa’ in accordance with current national and European 
guidelines. All animal procedures were approved by the ethical committee of the 
‘Consejo Superior de Investigaciones Científicas’. 
 
T cell purification and culture. Human PBLs were obtained via density centrifugation of 
whole blood and grown in RPMI with 10% FCS in the presence of PHA (2 μg/ml). 
After two days, cultures were washed in PBS and expanded for three more days in 
medium containing IL2. At this point >90% of the culture was positive for staining with 
the anti-CD3ε mAb OKT3. Unstimulated human peripheral blood T cells were enriched 
from whole blood by density centrifugation, followed by panning of macrophages and 
monocytes on tissue culture plates, and the removal of B cells through nylon wool 
columns. The remaining population contained over 80% of T cells. Murine CD4+ 
CD44hiCD62Llo and CD62LhiCD44lo T cells were enriched from the spleen and 
superficial lymph nodes of C57BL/6 mice using mouse CD4 memory and naive T cell 
enrichment kits (R&D Systems). Naive OT-1tg T cells were purified by depleting lymph 
nodes from OT-1tg mice of CD4+ and CD24+ cells using magnetic beads (Dynal 
Biotech). Previously stimulated OT-1tg T cells were generated by stimulating spleen 
cells of OT-1tg mice with 10 pM of OVAp (SIINFEKL, synthesized in our proteomic 
facility via f-moc chemistry) and anti-CD28 (0.5 μg/ml, clone 37.51, BD Pharmingen) 
in RPMI-10% FCS, supplemented with 2 mM glutamine, 1 mM sodium pyruvate and 
1x10-5 M β-mercaptoethanol (R10 medium). After two days, the cells were washed and 
cultured for six more days in fresh medium supplemented with saturating amounts of 
recombinant IL2. 
 
Immunogold labeling, replica preparation and EM analysis. Immunogold labeled cell 
surface replicas were obtained as described previously (Pinto da Silva and Kan, 1984; 
Schamel et al., 2005). T cell preparations were washed in PBS and fixed in 1% 
paraformaldehyde, before they were labeled on ice with the anti-human CD3 mAb 
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OKT3 or the anti-murine CD3 mAb 145-2C11 and 10 nm gold-conjugated protein A 
(Sigma-Aldrich; Cell Microscopy Center, University Medical Center Utrecht). Labeled 
cells were adhered to poly-L-lysine-coated mica strips and post-fixed with 0.1% 
glutaraldehyde. Samples were covered with another mica sheet and plunge frozen in 
liquid propane. Frozen sandwiches were split under liquid nitrogen and mounted on the 
sample table of a Balzers400T freeze fracture (FF) apparatus. Samples were placed in 
the FF unit cooled at -150 ºC and etched for 12 min to remove excess of ice, after 
switching the stage temperature from -150 ºC to -90 ºC. The samples were shaded with 
platinum (2 nm at 45º angle) and coated with carbon (20 nm at 90º angle) before they 
were floated overnight on a domestic bleach solution to remove the organic material. 
The replicas were extensively washed in distilled water, mounted on 400 mesh copper 
grids and examined on a JEM1010 electron microscope (Jeol, Japan) operating at 80 
kV. Images were taken with a slow scan CCD camera (Bioscan, Gatan, Pleasanton, 
CA). 
 
BN-PAGE, IP, SDS-PAGE and Western blotting. Membrane fractions for BN PAGE  
were prepared by disrupting T cells with a Dounce homogenizer in hypotonic buffer (10 
mM HEPES pH 7.4, 42 mM KCl, 5 mM MgCl2, and protease inhibitors) and pelleting 
the membranes by ultracentrifugation at 150,000 g. The membranes were lysed in 250 
μl BN lysis buffer (500 mM 6-aminohexanoic acid, 20 mM NaCl, 10% glycerol, 2 mM 
EDTA, 1% Brij96, 20 mM BisTris pH7.0, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 1 
mM PMSF), and BN-PAGE gradient gels (4%–9%) were prepared and run as described 
(Schagger and von Jagow, 1991; Swamy et al., 2006). Ferritin was used as the marker 
protein in its 24-mer and 48-mer forms (f1, 440 kDa; f2, 880 kDa). MA5.8 cells were 
lysed in Brij lysis buffer (0.33% Brij96, 150 mM NaCl, 20 mM Tris-HCl pH 7.8), and 
protease inhibitors), followed by immunoprecipiation with anti-CD3ζ serum (448) (San 
Jose et al., 1998) or anti-CD3 mAb (145-2C11) and protein G sepharose beads. SDS-
PAGE and Western blotting were performed according to standard protocols, and the 
membranes were probed with the anti-CD3ζ serum and the anti-CD3ε mAb M-20 
(Santa Cruz) and visualized by ECL detection. Quantification was performed on ECL 
autoradiography films using ImageJ software. 
 
Generation of mutated CD3ζ chains. The L9A and L19A mutations of CD3ζ were 
introduced by PCR-based site-specific mutation protocols using the pGEM3z-CD3ζ 
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plasmid as template in combination with the QuickChange-XL kit (Stratagene). L9A 
and L19A mutant and wildtype CD3ζ-coding sequences were re-amplified with flanking 
oligos containing XhoI restriction sites and inserted into the XhoI site of pSRα. The 
CD3ζ-GFP fusion constructs were generated by introducing a BglII site directly 
upstream of the stop codon of wild type and L19A mutant CD3ζ by PCR, cloning of the 
XhoI-BglII fragment directly upstream of EGFP of the XhoI-BamHI-digested pLEGFP-
N1 retroviral vector (Clontech). CD3ζ-GFP fusion constructs were finally cloned into 
the lentiviral expression vector pHRSIN-CSGW-dlNotI (kindly provided by Dr J.A. 
Pintor, CABIMER-CSIC, Sevilla) by introducing a NotI site directly downstream of the 
stop codon of the CD3ζ-GFP fusion constructs in pLEGFP-N1, and cloning the BglII-
NotI fragment into BamHI-NotI-digested pHRSIN-CSGW-dlNotI. All constructs 
generated by PCR were verified by DNA sequencing. 
 
MA5.8 reconstitution. MA5.8 cells were transfected with the pSRα-CD3ζ constructs by 
electroporation and stably expressing pools of cells were obtained through selection 
with geneticin (G418) for 3 weeks. CD3ζ-GFP fusion protein expressing MA5.8 cells 
were obtained by transducing these cells with lentiviral particles (see below). For 
biochemical and EM analysis of these cells, populations were sorted for GFP+ cells on a 
FACSVantage cell sorter (Becton-Dickinson). 
 
Bone marrow reconstitution. Lentiviral particles were produced by cotransfecting HEK 
293T cells with the pHRSIN CSGW-dlNotI-CD3ζ vectors and the pCMVΔR8.2 and 
pMDG plasmids (Zufferey et al., 1997) with JetPEI reagent (PolyPlus Transfection). 
Culture supernatants obtained after 48 hours in culture were used to transduce target 
cells. For transduction of bone marrow cells, 8-10 week old CD3ζo/oOT-1tg mice were 
inoculated i.p. with 5-fluorouracil (150 mg/kg) and were sacrificed two days later. Bone 
marrow cells were collected from the femurs and cultured for 12 hours at 37°C in 
Iscove’s medium supplemented with 10% FBS, 25 ng/ml IL-7, 25 ng/ml IL-6, 50 ng/ml 
SCF, and 50 ng/ml Flt3-ligand (all cytokines from Peprotech). Bone marrow cells were 
then transduced by addition of filtered 293T cell supernatants, followed by 
centrifugation for 90 min at 975g and 32 °C in 24-well culture plates in presence of 8 
μg/ml polybrene. The cells were harvested 24 hours later, washed and i.v. injected in 
sub-lethally irradiated (6 Gy) C57BL/6 or C57BL/6 CD45.1-congenic recipient mice (3-
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5x106 cells/mouse). Recipient mice were kept on drinking water supplemented with 
tetracycline (200 μg/ml, Sigma) for 6-8 weeks before sacrifice and analysis. 
 
T cell stimulation assays. Thioglycolate-induced primary macrophages from C57BL/6 
mice were grown in R10 medium at 7x104 cells per well in flat bottom 96 well plates 
the day before the stimulation assay. The macrophages were loaded with OVAp for 7 to 
10 hours and they were then washed with PBS before adding 0.5-2x105 cells per well in 
R10 medium. Biotinylated KbOVAp pentamers (ProImmune) and KbOVAp tetramers 
(Daniels and Jameson, 2000), generated by incubation of pre-folded c-terminally 
biotinylated soluble KbOVAp complexes (kindly provided by Dr E. Palmer, University 
of Basel) with unlabeled streptavidin, were added to 2-5x105 lymph node cells at the 
start of culture in R10 medium in round bottom 96 well plates. MA5.8 cells were 
stimulated at 1x105 cells per well in flat bottom 96 well plates containing a monolayer 
of 5x104 I-Ek- and CD80-transfected DCEK fibroblasts (a gift of Dr R. Germain, NIH, 
Bethesda, MD) loaded with MCCp (ANERADLIAYLKQATK, synthesized in our 
center by f-moc chemistry). T cells were cultured for the times indicated before 
assessing the expression of CD25 and CD69 and IFNγ production. To measure 
intracellular IFNγ, cells were treated for the last 4 hours of culture with Brefeldin A 
(BFA, 2.5 μg/ml). 
 
Flow cytometry. Cells were pre-incubated with the anti CD16/32-specific mAb 2.4G2 in 
PBS, 1% BSA, 0.02% sodium azide before they were labeled with saturating amounts 
of the indicated fluorochrome-labeled or biotinylated mAbs and, where applicable, 
fluorochrome-labeled streptavidin (reagents purchased from BD Pharmingen, 
eBioscience, Immunotools and Miltenyi). To detect intracellular IFNγ, BFA-treated 
cells were surface-stained before fixation and permeabilization using a commercial kit 
(BD Pharmingen), and they were then stained with an anti-murine IFNγ mAb. Labeled 
cells were acquired on a FACSCalibur or FACSCanto II flow cytometer (Becton-
Dickinson) and the data analyzed with FlowJo software (TreeStar). 
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Figure legends 
 
Figure 1 - Distribution of TCRs on previously stimulated and freshly isolated human 
peripheral blood T cells. (A). High magnification images (100,000x) showing the 
distribution of gold particles on the cell surface replicas (scale bar: 50 nm). (B). 
Quantification (mean +/- sem) of gold particles in clusters of the indicated sizes for 
freshly isolated (grey bars) and previously stimulated (black bars) human T cells. The 
inset shows the distribution of gold between clusters of 1, 2, 3, 4 or more particles and 
the statistical analysis (1-tailed Student’s T test: * p<0.05; ** p<0.01; *** p<0.001). 
Replicas of 19 PHA-activated T cells (9414 particles) and 9 freshly isolated T cells 
(2707 particles) were counted. (C). T cells were purified from blood of a healthy human 
donor, and an aliquot of the freshly isolated cells was frozen. The rest of the cells were 
stimulated for 2 days with PHA and subsequently with IL2 for a further 7 days. The 
cells were harvested, frozen and membrane fractions were prepared from stimulated and 
non-stimulated cells. The sizes of the Brij96-solublized TCRs were analyzed by BN-
PAGE and anti-CD3ζ immunoblotting. The marker protein is ferritin (f1, 440 and f2, 
880 kDa forms). (D). The same experiment as in C was performed, but aliquots of the 
stimulated cells were taken at various time points during their expansion. The ratio of 
the oligomeric and monomeric TCRs was quantified and plotted as a function of time 
(h, hour; d, day). 
 
Figure 2 - Incidence of oligomeric TCR complexes on murine CD62LhiCD44lo and 
CD44hiCD62Llo CD4+ T cells. (A). Enrichment of CD62Lhi and CD44hi CD4+ T cell 
populations. The overlay plot shows the FSC profiles of the CD62Lhi and CD44hi CD4+ 
T cells. (B). High magnification images (100,000x) of cell surface replicas of CD62Lhi 
and CD44hi CD4+ T cells (scale bar: 100 nm). (C). Quantitative analysis (mean +/- 
sem) of distribution of gold particles between clusters of the indicated sizes for 
CD62Lhi (grey bars) and CD44hi (black bars) CD4+ T cells. The inset shows the 
distribution between clusters of 1, 2, 3, 4 or more particles and statistical analysis (* 
p<0.05; ** p<0.01; *** p<0.001). Quantification of 5 replicas of CD62Lhi cells (2718 
particles) and 5 CD44hi cells (3198 particles). 
 
Figure 3 - Analysis of naive and previously stimulated OT-1tg T cells. (A). Phenotype 
and purity of naive and previously stimulated OT-1tg T cell populations. (B). High 
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magnification images (100,000x) of cell surface replicas of naive and previously 
stimulated OT-1 Ttg cells (scale bar: 100 nm). (C). Quantification (mean +/- sem) of the 
gold particles on naive (grey bars) and previously stimulated (black bars) OT-1tg T cells. 
The inset shows the distribution of gold particles between clusters of 1, 2, 3, 4 or more 
particles, and the statistical analysis (* p<0.05; ** p<0.01; *** p<0.001). Quantification 
of 10 naive cells (3733 particles) and 9 previously stimulated cells (2928 particles) is 
shown. (D). Expression of CD25 (upper panel) and IFNγ production (lower panel) by 
naive and previously stimulated OT-1tg T cells (open and black circles, respectively) 
after overnight stimulation with OVAp presented by macrophages. (E). Expression of 
CD69 (upper panel) and IFNγ production (lower panel) by naive and previously 
stimulated OT-1tg T cells (open and black circles, respectively) upon stimulation with an 
H-2Kb-OVA pentamer for 3 and 24 hours, respectively. Data are representative of at 
least 2 experiments. 
 
Figure 4 - Further skewing towards larger oligomeric TCR complexes in re-activated 
OT-1tg memory T cells. (A). Phenotypic comparison of OT-1tg memory T cells 
generated in vivo. The dot plot shows the proportion of CD45.2+CD8+ OT-1tg T cells in 
the superficial lymph nodes of a CD45.1+ recipient 6 weeks after adoptive transfer of 
naïve CD45.2+ OT-1tg T cells and OVAp-loaded DCs. Overlay plots compare the cell 
size and expression level of the molecules indicated on CD45.2+CD8+ lymph node cells 
from the CD45.1 recipient (black lines) and a non-manipulated CD45.2+ OT-1tg mouse 
(grey lines). (B). Expression of CD25 and IFNγ production by memory and naive OT-
1tg T cells (black and open circles, respectively) after a 2 days of stimulation with H-
2KbOVAp tetramer. Data are representative of 3 experiments (C). Quantification (mean 
+/- sem) of gold particles on cell surface replicas of naive and memory OT-1tg T cell-
derived cells, stimulated and grown in vitro for seven days (grey and black bars, 
respectively). The inset shows the distribution of gold particles between clusters of 1, 2, 
3, 4 or more particles, and the statistical analysis (* p<0.05; ** p<0.01; *** p<0.001). 
Quantification of replicas of 7 naive cells (4284 particles) and 7 memory cells (5491 
particles). 
 
Figure 5 - A mutation in the transmembrane region of CD3ζ impairs oligomeric TCR 
formation. (A). Representation of the transmembrane region of the CD3ζ dimer, as 
determined by NMR (Call et al., 2006). The α-helix forming backbone is shown as a 
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ribbon diagram with all amino acids implicated in tetramer formation represented in 
blue and with side chain residues as lines. The L9 and L19 residues are indicated and 
their side chains represented as sticks. The amino acid sequences of wild type and L9A 
and L19A CD3ζ are shown below. (B). Flow cytometric measurement of CD3ε 
expression by MA5.8 cells (filled grey histogram), 2B4 cells (dashed black line), and 
MA5.8 cells transfected with wild type CD3ζ (grey line), L9A CD3ζ (dashed grey line) 
and L19A CD3ζ (black line). (C). Assembly of wild type or L19A CD3ζ chains within 
the TCR complex. Whole lysates or immunoprecipates with the indicated antibodies 
were run on non-reducing SDS gels, and immunoblots were probed with the antibodies 
indicated. (D). Quantification (mean +/- sem) of the TCR complex in oligomeric 
clusters on MA5.8 cells reconstituted with wild type (black bars) or L19A CD3ζ (grey 
bars). The inset shows the distribution of gold particles between clusters of 1, 2, 3, 4 or 
more particles and the statistical analysis (* p<0.05; ** p<0.01; *** p<0.001). 
Quantification of replicas of 15 WT CD3ζ-reconstituted cells (12041 particles) and 21 
L19A CD3ζ-reconstituted cells (8348 particles) is shown. (E). Cell surface expression 
of CD69 (upper panel) and IFNγ production (lower panel) by wild type (black circles) 
or L19A CD3ζ (open circles) reconstituted MA5.8 cells after overnight stimulation with 
MCCp. Data are representative of 2 experiments. 
 
Figure 6 - The role of oligomeric TCR complexes in vivo. (A). Differentiation capacity 
of thymocytes from CD3ζ-deficient, OT-1tg bone marrow precursors transduced with 
the indicated constructs. (B). Expression of the L19A CD3ζ-GFP chain permits the 
generation of naive OT-1tg CD8+ T cells. Overlay plots show expression of the 
molecules indicated on Vα2+ cells of OT-1tg mice (shaded histogram) and Vα2+GFP+ 
cells from wild type (dashed black line) and L19A (grey line) CD3ζ-GFP reconstituted 
animals. (C). Functional analysis of WT (black circles) or L19A (open circles) CD3ζ-
expressing T cells obtained by previous stimulation and expansion in presence of IL2. 
Cells were re-stimulated overnight with OVAp-loaded macrophages or with Kb-OVA 
tetramers and CD69 (top panel) and IFNγ production (bottom panel) were measured by 
flow cytometry. IFNγ production index is the product of the percentage of IFNγ+ cells 
and the MFI of the IFNγ signal. (D). Quantification (mean +/- sem) of TCR complex 
oligomer distribution on the cell surface of T lymphoblasts expressing WT (black bars) 
or L19A (grey bars) CD3ζ-GFP chains. The inset shows the distribution of gold 
particles between clusters of 1, 2, 3, 4 or more particles and statistical analysis (* 
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p<0.05; ** p<0.01; *** p<0.001). Quantification of 7 WT CD3ζ-GFP reconstituted 
cells (3137 particles) and 7 L19A CD3ζ-GFP reconstituted cells (4257 particles) is 
shown. Data are representative of 4 independent reconstitutions and a total of 6 WT and 
6 L19A reconstituted animals. 
 
Figure 7 - Models of CD3ζ-dependent TCR oligomerization. (A). Oligomerization via  
interactions between individual TCR complexes (boxes) dependent on a heterotypic, 
L19-dependent interaction between CD3ζ dimers (A-face) and another, as yet undefined 
TCR component (B-face) (top line) or on the alternation of homotypic, L19-dependent 
interactions between CD3ζ dimers and homotypic interactions between the other TCR 
components (bottom line). The B-face could be formed primarily by the Cα domain, 
according to recent findings that the C and F strands of Cα play an important role in the 
dimerization of TCRαβ heterodimers (Kuhns et al., 2010). (B). TCR oligomerization 
mediated by concatenation of homotypic L19-dependent interactions between CD3ζ 
dimers. This model assumes that due to its symmetry, the CD3ζ dimer can interact on 
both sides with adjacent CD3ζ dimers. This model is compatible with that of Davis and 
colleagues (Kuhns et al., 2010), since the A-face could consist of both the Cα 
ectodomain and the transmembrane domain of CD3ζ. The lower part of the figure 
provides a hypothetical ordering of the transmembrane regions (circles) of the TCR 
components indicated, taking into account the proposed orientation of these segments in 
digitonin-solubilized ER microsomes (Call et al., 2002) and making it compatible with 
the data of Davis and colleagues (Kuhns et al., 2010). The red squares indicate the 
interaction between the CD3ζ dimers and the dashed lines the interaction face between 
the ectodomais of Cα. 
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Kumar et al., Figure S1 related to Figure 6 
 
 
 
Supplementary Figure 1 - Reconstitution of MA5.8 cells with GFP-linked wild type 
and L19A CD3ζ. (A). Cell surface expression of the TCR complex in MA5.8 cells 
transduced with wild type and L19A CD3ζ-GFP chains. 2B4 cells and MA5.8 cells 
reconstituted with GFP alone are included as controls. Cells were surface-stained with a 
mAb against CD3ε and signals for both this staining and GFP were measured by flow 
cytometry. Note that both constructs can rescue TCR cell surface expression to a similar 
extent and that they quantitatively associate with CD3ε. (B). Biochemical analysis of 
homodimer formation by wild type and L19A GFP-linked CD3ζ, and their capacity to 
interact with TCRαβ and CD3ε. Whole cell lysates (WL) and immunoprecipitates of the 
anti-TCRβ mAb H57.597 or the anti-CD3ζ serum of Brij96-solubilized cells were 
separated by non-reducing SDS-PAGE and immunoblots were probed with the 
indicated antibodies. (C). Quantification (mean +/- sem) of the distribution of the TCR 
complex on the surface of MA5.8 T cells reconstituted with wild type or L19A GFP-
linked CD3ζ chains. The inset shows the distribution of gold particles between clusters 
of 1, 2, 3, 4 or more particles and the statistical analysis (* p<0.05; ** p<0.01; *** 
p<0.001). Quantification of 6 WT CD3ζ-GFP reconstituted cells (5375 particles) and 6 
L19A CD3ζ-GFP reconstituted cells (6462 particles) is shown. (D). IFNγ production by 
reconstituted MA5.8 cells upon stimulation by DCEK cells loaded with MCCp (black 
circles: wild type GFP-linked CD3ζ; open circles L19A GFP-linked CD3ζ). 
  
